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ABSTRACT  
G protein-coupled receptors (GPCRs) comprise the largest family of cell-surface receptors 
involved in sensing a multitude of ligands and are consequently attractive pharmacological 
targets. Their study is complicated by cross-talk between signalling pathways and altered 
receptor pharmacology due to, for instance, receptor oligomerization. Difficulties in obtaining 
structural information of the receptors hinder the understanding of oligomerization and 
therefore it is desirable to develop alternative approaches in which to study this 
phenomenon. 
The fungal pheromone GPCRs, STE2 and Mam2, from Saccharomyces cerevisiae and 
Schizosaccharomyces pombe respectively are both known to oligomerize and a GxxxG motif 
in the first transmembrane (TM) domain of STE2 has previously been shown to mediate 
receptor oligomerization. Previous work on polytopic proteins suggest that individual TM 
helices may be treated as individually stable domains, and it may therefore be possible to 
study oligomerization via single TM peptides as opposed to full-length receptor. This thesis 
describes the use of STE2 and Mam2 to explore TM helix oligomerization and the effects of 
mutations on receptor trafficking, localization and cellular signalling. The development of a 
luminescent reporter assay for Sz. pombe, which proved more sensitive than previously 
used assays and is capable of generating high-throughput data, is also discussed. 
It was found that STE2 could couple to the Sz. pombe pheromone-response pathway and 
mutations in the GxxxG dimerization motif affected both signalling and trafficking. Expression 
of the first TM GxxxG containing domain of STE2 was insufficient for oligomerization, in line 
with previous reports suggesting that the presence of the second domain is required for 
receptor oligomerization. In Mam2, a motif was identified that appeared homologous to the 
STE2 dimerization motif and mutations of this motif also affected trafficking and signalling.  
This domain could oligomerize in isolation, and mutations of the motif abolished 
oligomerization. In contrast the study of more polar TM domains appeared more 
complicated. These findings suggest that relatively hydrophobic TM domains can be studied 
as individually stable units, whereas more polar domains may require the presence of other 
TM domains.    
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AMINO ACID ABBREVIATIONS 
Figure i-1 show the 20 amino acids encoded by the genetic code with their one letter and 
three letter abbreviations and structure. The R-group is highlighted in blue.  
 
Figure i-1: The 20 amino acids encoded by the genetic code 
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1 GENERAL INTRODUCTION 
1.1 Main Objectives 
This thesis concerns the study of the oligomerization of G protein coupled receptors 
(GPCRs) and how specific amino acid interactions facilitate receptor interactions. In order to 
realize this objective, individual TM domains from two different GPCRs were studied, 
compared and contrasted using a range of diverse approaches. The development and 
optimization of a novel bioluminescent reporter assay is also discussed.  
1.2 Membrane Proteins 
Membrane proteins are involved in a range of biologically indispensable processes including; 
the transport of small molecules and ions, cell signalling, structural stability and cell-to-cell 
adhesion. Their correct functioning is critical to cells and organisms as implied by several 
diseases caused by malfunctioning membrane proteins, such as autoimmunity, diabetes and 
cancer (Sanders and Myers 2004; Bocharov, Volynsky et al. 2010). Membrane proteins 
targeted to the plasma membrane bridge the boundary between the exterior and interior of 
the cell and they are therefore amenable pharmacological targets. A remarkable ~60% of 
drugs are known to bind to the surface of cells (Overington, Al-Lazikani et al. 2006) with the 
majority binding to targets that include; GPCRs, ligand-gated ion channels, voltage-gated ion 
channels or protein kinases. The further understanding of membrane protein structure and 
function is therefore immensely important for pharmacological and economical reasons. 
1.2.1 Integral Membrane Proteins 
Integral membrane proteins span the lipid bilayer at least once and remain permanently 
attached to the membrane. The highly apolar environment of the membrane means that 
membrane proteins lose their 3D structure upon solubilisation, and consequently techniques 
used for the structural study of globular proteins are not readily applied to membrane 
proteins. Despite challenges in the structural characterization of membrane proteins, two 
main classes of integral membrane proteins have been described to date. These include the 
β-barrel class of membrane proteins  and  the  α-helical class of membrane proteins. The  α-
helical class is the largest which is reflected by their relative abundance in the Protein Data 
Bank (PDB) database where  86%  of  membrane  protein  structures  are  of  α-helical proteins 
(http://pdbtm.enzim.hu/ 2011).  
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1.2.2 The Membrane Environment  
Biological membranes provide a boundary between the exterior and interior of cells as well 
as compartmentalizing intracellular organelles. The membrane is a highly heterogenous 
environment; the plasma membrane contains ~50% phospholipids and ~50% protein and 
other structures such as steroids and carbohydrates also associate with the membrane. The 
fluid mosaic model describes the current view of membrane organization (Singer and 
Nicolson 1972) and is illustrated in Figure 1-1. In this model phospholipids provide the 
fundamental structural organization of the membrane. Phospholipids consist of a hydrophilic 
phosphate-containing head-group linked to two fatty acid hydrocarbon tails. Due to their 
amphipathic nature, phospholipids can spontaneously form lipid bilayers in solution. The 
lipid:water interface does not provide a sharp division between a hydrophobic and a 
hydrophilic environment. Rather, an interfacial region exists spanning ~15 Å, which is thick 
enough to accommodate an amphipathic helix (White and Wimley 1999). The thickness of 
the hydrophobic core is ~30 Å (White 2003) but can vary depending on the lipid composition 
of the bilayer (Lewis and Engelman 1983). An appropriately thick bilayer surrounding a 
membrane protein is important due to the cost of exposing hydrophobic residues to water. It 
has therefore been proposed that lipids may stretch or compress to match the span of 
membrane proteins, and conversely membrane proteins may also structurally adjust to 
shield hydrophobic residues, for instance via tilting of transmembrane (TM) domains (Lee 
2004). 
Integral membrane proteins traverse the membrane, whereas peripheral membrane proteins 
only associate with one face of the bilayer; either the side facing the extracellular matrix 
(ECM) or the cytosol. Carbohydrates associate with the bilayer on the extracellular face, via 
lipid domains or glycoproteins, and may serve a role in cell-cell interactions. Steroids also 
insert into the membrane and are involved in maintaining membrane fluidity and rigidity. In 
the fluid mosaic model, individual components of the membrane are allowed to freely diffuse. 
This can be exemplified by the fission yeast Schizosaccharomyces pombe (Sz. pombe) 
protein kinase Pom1p. Sz. pombe exhibit polarized growth, and a gradient of Pom1p at the 
cell-tip contributes to maintaining sites of cytokinesis, cell polarity and control of cell length. 
The cortical gradient of the kinase is achieved by insertion of the kinase at the cell tip, 
diffusion of molecules throughout the cortex, followed by its removal from the membrane 
(Padte, Martin et al. 2006; Pan, Saunders et al. 2011) resulting in higher densities of the 
kinase at the cell-tip compared to other areas of the membrane. The simplicity of the fluid 
mosaic model has recently been challenged by a more complex picture in which membranes 
are compartmentalized into regions of separate membrane domains, as previously reviewed 
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(Lindner and Naim 2009), although their roles, location and existence is debated. In another 
view, certain proteins favour interactions with certain lipids, although difficulties in 
determining the transient protein-lipid interactions make this phenomenon challenging to 
study (Lee 2004).  
 
Figure 1-1: The fluid mosaic model of biological membranes 
Biological membranes represent a heterogeneous environment containing various types of lipids 
associated with different proteins, which can either be integral to the lipid bilayer or peripheral. 
Carbohydrates are often associated with the membrane on the side facing the extracellular matrix 
(ECM), either via a lipid domain or via a glycoprotein. Steroids are also associated with the 
membrane, such as cholesterol in animals or ergosterol in fungi. On the cytosolic side the membrane 
is connected to the interior of the cell via cytoskeletal filaments, which serve a role in transport of 
molecules and structural support. 
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1.2.3 Membrane Protein Biogenesis and Exit to the Plasma 
Membrane 
1.2.3.1 The Endoplasmic Reticulum 
Not all biological membranes are able to translocate and integrate newly synthesised 
membrane proteins. Membranes that can include these of the endoplasmic reticulum (ER), 
mitochondria, chloroplasts and peroxisomes, whereas the plasma membrane and endocytic 
organelles are unable to do so (von Heijne 1990). Cells have therefore developed a 
secretory pathway that serves as a gateway for proteins destined for these organelles.  
Polytopic membrane proteins (i.e. proteins that span the membrane multiple times) are 
synthesised by ribosomes attached to the cytosolic side of the ER and enter the ER co-
translationally via the Sec61 translocation complex to which they associate via hydrophobic 
targeting sequences. Orientation signals within the protein (Higy, Junne et al. 2004) as well 
as molecular and lipid chaperones (van Voorst and De Kruijff 2000; Krebs, Noorwez et al. 
2004) aid the correct insertion, folding and orientation of the membrane protein, and proteins 
may undergo certain post-translational modifications such as disulfide-bond formation in the 
ER (Achour, Labbe-Jullie et al. 2008). Incorrectly folded membrane proteins however are 
exported to the ER-associated degradation pathway (ERAD) in the cytosol for degradation 
(Tsai, Ye et al. 2002).  
There is evidence that plasma-membrane signalling complexes may form in the ER. For 
instance the GABAB1 receptor forms a  complex  with  the  Gβγ  subunits of G proteins and the 
potassium channel Kir3 prior to reaching the plasma membrane, and this complex may form 
as early as the ER (David, Richer et al. 2006). Variations in complex formation may influence 
the pharmacology of the protein. In the case of the calcitonin receptor-like receptor (CRLR), 
interactions with receptor activity-modifying protein 1 (RAMP1) in the ER yields a receptor 
specific for binding calcitonin gene-related peptide at the cell surface whereas interactions 
with RAMP2/3 in the ER yields a receptor specific for binding adrenomedulin at the plasma 
membrane (McLatchie, Fraser et al. 1998; Ittner, Koller et al. 2005). Complex formation is 
essential for targeting of RAMPs to the plasma membrane because monomers display an 
ER retention signal, which is masked upon complex-formation (Steiner, Muff et al. 2002). 
Several other proteins have been found to chaperone membrane proteins to the plasma 
membrane and complex-formation is in some, but not all, cases essential for transport 
(Dong, Filipeanu et al. 2007).  
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1.2.3.2 Targeting to the Golgi Apparatus and Plasma Membrane 
Export from the ER occurs at ER  “exit  sites”  in  a  coat  protein  II  (COPII)-dependent manner 
(Achour, Labbe-Jullie et al. 2008).  Proteins destined for the Golgi accumulate at these sites 
that form buds when coated with the COPII associated proteins Sar1, Sec23-Sec24 and 
Sec13-Sec31. It has been proposed that integral membrane proteins interact with domains 
of Sar1 and Sec23-24 which labels them for transport (Barlowe 2003). Interaction sites vary 
but may involve a di-acidic motif composed of the amino acids DxE, a double phenylalanine 
motif, or other more complicated motifs, and is a rate-limiting step in COPII bud formation 
(Dong, Filipeanu et al. 2007). Multiple binding sites on Sec23 have been identified, which 
supports the theory that different interaction motifs on separate membrane proteins can bind 
to the same transport molecule (Miller, Beilharz et al. 2003).  
Following budding, the COPII transport vesicles are transported and fused to the Golgi 
apparatus and subsequently migrate through the network of flattened cisternae; from the cis-
Golgi network to the trans-Golgi network via the medial-Golgi and endo-Golgi. Each of these 
regions contain different enzymes involved in selective post-translational modification of 
cargo, such as glycosylation (Alberts, Johnson et al. 2002). N-linked glycosylation may be 
important for the transport of some proteins from the Golgi to the plasma membrane, 
although for others it is less clear what the target signals are (Dong, Filipeanu et al. 2007). 
It’s  been  suggested that in some cases, the same motifs involved in targeting proteins from 
the ER to the Golgi may be involved in targeting proteins from the Golgi to the plasma 
membrane, as has been found for the di-acidic motif (Nishimura, Plutner et al. 2002).  
1.2.3.3 Regulation of the Secretory Pathway 
The correct targeting and fusion of transport vesicles with membranes involves the inclusion 
of a V-SNARE inside the vesicle, which is specific to the target membrane and acts co-
operatively with a T-SNARE which is integral to the transport membrane (Lodish, Berk et al. 
2000). Timing of vesicle fusion is thought to be achieved through the accumulation of Rab-
GTP (part of the Ras superfamily of monomeric G proteins) although the exact mechanism is 
not known (Lodish, Berk et al. 2000; Dong, Filipeanu et al. 2007). There is however evidence 
that the secretory pathway may regulate storage of proteins, thereby playing a role in 
regulating the levels of proteins at the cell surface. For example the dopamine D1 receptor is 
stored in Golgi-derived vesicles and is only released to the plasma membrane following the 
activation of cell-surface expressed receptors (Brismar, Asghar et al. 1998; Kruse, Adachi et 
al. 2003). This has also been observed for the thrombin receptor and is separate from the 
recycling phenomenon that is seen in other cell surface receptors, because thrombin 
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receptors are irreversibly activated and targeted to lysosomes following activation (Hein, Ishii 
et al. 1994). Thrombin is retained in the Golgi by another membrane protein, p24A, and 
following activation of G protein-bound receptor at the cell surface, the G protein dissociates 
and targets p24A to trigger the release of Golgi-bound thrombin (Luo, Wang et al. 2007). For 
other receptors in contrast,   such   as   the   β2-adrenergic receptor, plasma membrane 
expression following the secretory pathway is constitutive (Hein, Ishii et al. 1994).    
1.2.4 Membrane Protein Internalization 
1.2.4.1 Endocytosis 
Endocytosis acts as a regulator of signalling through controlling the lipid-protein composition 
of the membrane. Three distinct cellular compartments are associated with the endocytic 
pathways; the early endosomes, late endosomes and lysosomes (or vacuoles in fungi). 
Internalized molecules first encounter the early endosomes. The mildly acidic pH of the 
lumen of these structures can cause ligands to dissociate from receptors, and receptors may 
therefore be recycled from the early endosomes via tubular structures back to the plasma 
membrane. Early endosomes mature into late endosomes, in which the lumen becomes 
increasingly acidic and there is a loss of the tubular structures needed for recycling, 
ultimately determining the fate of cargo for degradation by the lysosome (Lodish, Berk et al. 
2000). Actin filaments have been strongly implicated in the movement of vesicles between 
these compartments in yeast and in some, but not all, mammalian cell types (Kaksonen, Sun 
et al. 2003; Gachet and Hyams 2005). Endosomal cargo destined for degradation is targeted 
to the lysosome where contents are broken down into component parts such as amino acids 
from proteins, or cholesterol and fatty acids from cholesterol esters (Lodish, Berk et al. 
2000).  
1.2.4.2 Pathways Mediating Endocytosis 
Several different pathways for endocytic uptake in cells are known to exist. These include 
clathrin-mediated endocytosis (CME) where clathrin-coated pits develop, and progressive 
invagination of the pit ultimately leads to scission from the plasma membrane, and the 
formation of clathrin-coated vesicles. Adaptor proteins mediate bud formation and recruit 
Clathrin, which forms a lattice around the vesicle. Bin–Amphiphysin–Rvs (BAR) domain-
containing proteins in turn recruit dynamin and together they form the neck of the bud, and 
vesicles are ultimately formed by fission of the bud from the plasma membrane by the 
GTPase dynamin (Doherty and McMahon 2009). The clathrin-coat is subsequently lost from 
the vesicle before fusion with the target early endosomes. Much research has focused on 
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CME and it has been extensively reviewed in the literature (Mousavi, Malerod et al. 2004; 
Traub 2005; Roth 2006). 
The most commonly reported non-clathrin coated buds are known as caveolae. These flask-
shaped invaginations are rich in cholesterol, sphingolipids and the protein caveolin and are 
often observed in clusters, which can occupy as much as a third of plasma membrane area 
(Mayor and Pagano 2007). Caveolae are believed to perform multiple functions in the cell 
including lipid storage, responding to mechanical stress, and to play a role in cell signalling 
events such as Ca2+ signalling (Parton and Simons 2007). Caveolae can exist as immobile 
plasma membrane domains (Thomsen, Roepstorff et al. 2002) but can also couple to the 
endocytic pathway through internalization of vesicles coated with caveolin; a process that 
can be exploited by pathogens to gain entry into cells (Pelkmans, Kartenbeck et al. 2001). 
Other endocytic pathways also exist (Sandvig, Pust et al. 2011) which may involve coat 
proteins other than caveolin and clathrin, flotilin is another example, or different GTPases; 
for instance RhoA, cell division control protein 42 (CDC42) or ADP-ribosylation factor 6 
(ARF6). The mechanisms appear to vary greatly between cell-types making it difficult to 
propose specific general pathways (Mayor and Pagano 2007). 
1.2.4.3 Regulation of Internalization 
Internalization of membrane proteins may be constitutive or triggered by cellular activities 
(Mousavi, Malerod et al. 2004). Signals triggering the internalization of membrane proteins 
are diverse, and several pathways may internalize the same protein through different 
signals. The epidermal growth factor (EGF) receptor kinase for instance is internalized by 
CME (Willingham and Pastan 1982) but may be internalized via caveolin-dependent 
endocytosis in response to high doses of ligand (Sigismund, Woelk et al. 2005). It has been 
proposed that CME promotes recycling of the EGF receptor, to prolong signalling, whereas 
the clathrin-independent pathway targets the receptor for degradation (Sigismund, Argenzio 
et al. 2008). Signals for CME include tyrosine or leucine-based motifs in the C-terminal 
cytoplasmic tail of proteins, and some components of clathrin-coated pits also contain 
ubiquitin-binding domains (Mousavi, Malerod et al. 2004). Ubiquitylation, i.e. the conjugation 
of ubiquitin to a target protein, has also been implicated as a signal for caveolin dependent 
endocytosis (Sigismund, Woelk et al. 2005). Adaptor proteins mediate ubiquitylation and 
these may recognize their targets by a variety of methods including proteins that have 
become phosphorylated or the presence of polar TM domains in the target protein (Leon and 
Haguenauer-Tsapis 2008).  
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1.2.5 Protein Folding in the Membrane 
1.2.5.1 Integration of Proteins into the Membrane 
The process by which membrane proteins are integrated into lipid bilayers is currently not 
fully understood. Mothes and colleagues (1997) proposed a model in which membrane 
proteins laterally integrate into the ER membrane via the ribosome-translocon channel. In 
this model, the appearance of a hydrophobic stretch of polypeptide within the translocon 
causes a closing of the channel, and the segment moves laterally into the bilayer. This 
process may be repeated when translating a polytopic protein (Mothes, Heinrich et al. 1997). 
The hydrophobic stretches found in membrane proteins and adjacent residues appear 
sufficient to drive the integration of a protein into the membrane, partly because the 
introduction of a TM domain into cytosolic proteins can convert them into membrane proteins 
and also because model peptides will only partition into the membrane if they are sufficiently 
hydrophobic (MacKenzie 2006). The structural comparison of the translocon in a peptide-
bound form and inactive form provided further evidence for a lateral gate present in the 
translocon (Martinez-Gil, Sauri et al. 2011).  
Membrane proteins insert into the membrane because it is energetically favourable to bury 
hydrophobic residues, even though dehydrating the hydrophilic backbone comes at a cost. 
For example, the free energy for the insertion of the α-helical protein glycophorin A (GpA) is 
estimated to be -36 kcal/mol-1 due to burial of hydrophobic residues. Conversely the cost of 
dehydrating the backbone of GpA is +26 kcal/mol-1 (White 2003). Therefore, there is 
favourable net free energy of 10 kcal/mol-1 when inserting the helix into the membrane 
compared to leaving it in the cytosol (White 2003).  The formation of secondary structures 
within the membrane is also energetically favourable, and most integral membrane proteins 
adopt α-helical structures across the lipid bilayer. The cost of transferring a non-H-bonded 
peptide bond from a hydrophilic to hydrophobic environment is +6.4 kcal/mol-1 whereas 
transferring an H-bonded peptide bond to a hydrophobic environment is only +2.1 kcal/mol-1. 
There is thus a free energy cost of +4 kcal/mol-1 of disrupting a single H-bond in the 
membrane, meaning that the secondary structure is inherently stable and carries a lower 
energetic cost (White 2003). A typical transmembrane α-helix is right-handed and each 
residue contributes to a 100° turn and a 0.15 nm rise of the helix. The hydrophobic core of a 
lipid bilayer is ~30 Å thick meaning that typically 20 amino acids would be involved in 
spanning the hydrophobic core. This is not necessarily always true however; as previously 
discussed the lipids may influence bilayer thickness to some extent to accommodate longer 
or shorter helices. The helices themselves may also conform to bilayer thickness by tilting in 
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the membrane, and side-chain to main-chain hydrogen bonding may also increase the 
length of the helix (Lee 2004).  
1.2.5.2 The Two-Stage Model of Membrane Protein Folding 
The two-stage model of membrane protein folding provides an important conceptual 
framework in which to understand protein folding into the membrane (Popot and Engelman 
1990). According to the two-stage model (Figure 1-2) membrane proteins fold in two 
thermodynamically distinct stages. In the first stage, hydrophobic sequences insert into the 
lipid bilayer and form independently stable domains. This is driven by the hydrophobic effect. 
In the second stage, helical domains laterally interact to form the fully folded tertiary 
structure of the protein. This may be driven by energetically favoured bond-formation and 
packing between helices.  
Although the two-stage model appears simplistic, early studies on bacteriorhodopsin 
supported the model. Bacteriorhodopsin is a 7TM spanning proton pump involved in sensing 
light in archaea. Fragments of the receptor will fold independently, and will form the fully 
functional native structure upon mixing (Popot, Gerchman et al. 1987; Kahn and Engelman 
1992; Kataoka, Kahn et al. 1992). Since then, fragments of several other polytopic proteins 
have shown to integrate into membranes and fold independently of the full-length protein, 
and to form subsequent lateral interactions with each other via their TM domains, including 
lactose permease (Bibi and Kaback 1990), rhodopsin (Ridge, Lee et al. 1995), the red cell 
anion exchanger protein (Groves and Tanner 1995) and  the  yeast  α-factor receptor (Martin, 
Leavitt et al. 1999). A third stage was later added to account for protein quaternary 
structures and interactions with co-factors, lipids and water (Engelman, Chen et al. 2003). 
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Figure 1-2: The two-stage model of membrane protein folding 
The two-stage model of membrane protein folding was proposed by Popot and Engelman in 1990. In 
the first stage, independently stable trans-bilayer helices form in response to the hydrophobic effect 
and main-chain hydrogen bonds form in the non-aqueous environment. In the second stage helices 
interact to form the tertiary fold of the protein that may be driven by energetically favorable polar 
contacts between helices, or packing.  
  
  
 Page 11 
 
1.2.6 Transmembrane Domain Interactions  
The two-stage model predicts that individual TM domains initially form independently stable 
structures, before laterally interacting to form a polytopic protein or form quaternary 
structures. The model does not however postulate how lateral interactions are formed. The 
hydrophobic effect is an important force driving the folding of globular proteins (Tanford 
1978), but due to the low dielectric environment of the membrane other forces must drive the 
lateral association of membrane proteins. The study of the interactions within polytopic 
and/or oligomeric membrane proteins is not trivial and remains one of the biggest challenges 
in protein chemistry to this day. In the PDB only 2% of structures represent membrane 
proteins (http://pdbtm.enzim.hu/ 2011), however membrane proteins are believed to 
constitute 20-25% of all proteins (Boyd, Schierle et al. 1998; von Heijne 1999). Considering 
their pharmacological and economical importance, the lack of structural information of 
membrane proteins clearly reflects the challenges presented to structural biologists.  
1.2.6.1 The Structural Importance of Transmembrane Domains 
The TM spanning regions of membrane proteins were traditionally believed to merely anchor 
the protein to the membrane. Early studies on fragmented bacteriorhodopsin however 
showed that this is not the case. In bacteriorhodopsin a functional protein can be 
reconstituted only if all 7TM domains are expressed, and in contrast four of the six loop 
regions found outside of the hydrophobic core are dispensable, although they do influence 
folding stability and kinetics (Luneberg, Widmann et al. 1998; Marti 1998). This 
demonstrated that the transmembrane segments do not merely anchor membrane proteins 
to the lipid bilayer, but serve a purpose in maintaining protein structure.  
1.2.6.2 Motifs Known to Mediate Membrane Protein-Protein Interactions 
1.2.6.2.1 Motifs of Two Small Residues 
The study of single-spanning membrane proteins and designed peptides has contributed to 
much of our current understanding in how transmembrane domains interact, and several 
motifs have been identified that appear important in driving associations. For instance, the 
single TM-spanning protein GpA which is expressed in erythrocytes, dimerizes via a motif of 
two glycines spaced four residues apart (GxxxG) (Lemmon, Flanagan et al. 1992; Adams, 
Engelman et al. 1996). Due to their relative spacing in the primary sequence, the two 
glycines  appear  on   the  same  side  of   the  α-helix. The small size of the glycine side-chains 
allows two helices to come in close proximity and form stabilizing van der Waals interactions 
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by  a  “ridges-into-grooves”  packing  of  adjacent  β-branched residues into the grooves created 
by the glycine residues (MacKenzie, Prestegard et al. 1997). The ridges-into-grooves, or 
knobs-into-holes, packing of residues is illustrated in Figure 1-3. Statistical analysis revealed 
that the GxxxG motif is overrepresented in genomes (Russ and Engelman 2000) and since 
its  discovery  it’s  been  found  to  mediate  the  dimerization  of  several  other  membrane  proteins  
including the Heliobacter pylori vacuolating toxin (McClain, Iwamoto et al. 2003), the  yeast  α-
factor receptor (Overton, Chinault et al. 2003), Carnitine palmitoyltransferase 1 (Jenei, 
Borthwick et al. 2009), the Major Histocompatibility Complex Class II and invariant chain 
(King and Dixon 2010), among others. Sequence context is important to allow the ridges-
into-grooves packing and therefore large hydrophobic residues are often found immediately 
adjacent to the GxxxG motif and/or on the same face to assist interactions (Senes, Gerstein 
et al. 2000; Schneider and Engelman 2004). As a consequence, not all GxxxG motifs are 
involved in dimerization (McClain, Iwamoto et al. 2003). Since the discovery of the GxxxG 
motif, other variations have been found termed smallxxxsmall motifs because they all involve 
small residues (G, S, A) spaced four residues apart (Senes, Gerstein et al. 2000; Escher, 
Cymer et al. 2009). 
  
 Page 13 
 
 
 
Figure 1-3: Ridges-into-grooves packing of residues in dimeric glycophorin A 
The structure of the transmembrane dimer Glycophorin A exemplifies the ridges-into-grooves, or 
knobs-into-holes, packing of the GxxxG motif found in many membrane proteins. In the model shown 
here each helix in the dimer is represented by purple and blue respectively and a top-down view is 
shown for clarity. The residues involved in packing are shown as van der Waals spheres. The 
“groove”  formed  by  the  two G79 residues allow the V80 residues on the opposite helix to come in very 
close proximity to form  a  “ridges-into-grooves”   interaction.  A  similar   interaction  occurs  between  G83  
on each helix to V84 on the opposite helix. The model was created using the CHI software suite.  
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1.2.6.2.2 Heptad Repeats 
Heptad repeat motifs also drive the association of membrane proteins. In contrast to the 
GxxxG motif mainly found in right-handed helix interactions, this motif is generally found in 
left-handed helix interactions. The heptad motif is driven by repeats of seven residues and 
helices ultimately achieve a knobs-into-holes packing (Langosch and Heringa 1998; 
MacKenzie 2006).  
1.2.6.2.3 Polar Amino Acids 
The presence of polar amino acids in the hydrophobic core of a membrane is energetically 
unfavourable but can be compensated for by the surrounding hydrophobic residues. The 
high energetic cost of breaking H-bonds in the hydrocarbon core of a bilayer means that 
polar contacts provide a strong stabilising force for helix association. For instance, the 
introduction of a single asparagine residue into a hydrophobic model peptide can transform 
the peptide from monomeric species to dimeric species both in an in vitro and in an in vivo 
system (Zhou, Cocco et al. 2000). The strongly polar amino acids, including histidine, 
glutamic acid, arginine and aspartic acid, show the highest propensity to form inter-helical H-
bonds in the membrane (Sodt and Head-Gordon 2010). Other polar amino acids also induce 
oligomerization, including asparagine and glutamine (Choma, Gratkowski et al. 2000; Zhou, 
Cocco et al. 2000; Zhou, Merianos et al. 2001). Threonine and serine residues tend to be 
overrepresented in transmembrane domains compared to other polar residues (Curran and 
Engelman 2003), however these residues, together with tyrosine, only appear to have a 
moderate effect on transmembrane domain oligomerization (Gratkowski, Lear et al. 2001; 
Zhou, Merianos et al. 2001). As with the smallxxxsmall motif, sequence context is important 
for associations. The membrane protein BNIP3 for instance, dimerizes strongly via a 
histidine residue but BNIP3 also contains a GxxxG motif on the same face of the helix as the 
histidine residue. Mutations of the GxxxG motif disrupts dimerization by not allowing the two 
monomers to come into close enough proximity for histidine to hydrogen bond (Sulistijo, 
Jaszewski et al. 2003; Lawrie, Sulistijo et al. 2010). 
1.2.6.2.4 Aromatic Residues 
Aromatic residues such as phenylalanine, threonine or tyrosine can also contribute to 
energetically favourable interactions between TM helices. Pairs of aromatic residues can π-
π   stack, or the π   electrons   of   the aromatic ring of a single aromatic residue can form a 
cation-π   interaction to a positively charged residue such as arginine, lysine or histidine. 
Cation-π  interactions  and π-π  stacking  has  been  found  both  in  model  peptides and in native 
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membrane proteins and interactions can be four-fold stronger than those arising from knobs-
into-holes packing (Dougherty 1996; Johnson, Hecht et al. 2007). For each of these 
interactions two possible conformations are possible. For the interaction of two aromatic 
residues, the interaction can either be stacking or edge-to-face, the former typically involving 
extensive van der Waals contact whereas the latter involve a CH-π   interaction.   For   the  
cation-π  interaction  the  positively  charged  residue  can  either  be  perpendicular  or  parallel   to 
the aromatic ring (Johnson, Hecht et al. 2007). Cation-π  interactions  are interesting because 
they allow a polar, yet hydrophobic, interaction in the membrane i.e. they can bind ions but 
are composed of hydro-carbons (Dougherty 1996). This type of interaction is not exclusive to 
membrane protein-membrane protein interactions, but has also been observed between 
receptor and ligand (Tantry, Ding et al. 2010). 
1.2.6.3 Effects of Proline Residues on Membrane Protein Structure 
Prolines present in the transmembrane domains can also influence helix packing and their 
importance in membrane proteins is reflected by the phenotypic consequences of mutating 
prolines in human membrane proteins (Partridge, Therien et al. 2004). The amide nitrogen of 
proline cannot form backbone hydrogen bonds and proline residues therefore introduce 
distinct kinks in transmembrane domains. Proline is present at 60% of transmembrane helix 
deformation sites and it has been proposed that in cases where proline is not present, the 
proline could have been lost with time as the kink became stabilized by other molecular 
forces (Yohannan, Faham et al. 2003). Proline residues in transmembrane domains are 
most often found in the middle of the helices (Barlow and Thornton 1988).  
On a molecular level, prolines are believed to reduce the stability and rigidity of 
transmembrane helices due to the loss of the NH...O=C bond. In one specific class of integral 
membrane proteins, the 7TM spanning GPCR receptors, this allows a rotational switch upon 
activation (EIling, Frimurer et al. 2005). In this model, upon receptor activation the 
extracellular side of the receptor undergoes an inward movement which closes the ligand-
binding site whereas the cytoplasmic side opens up to allow downstream signalling. This 
movement is achieved via a see-saw motion of TM6 and TM7 which pivots about the centre 
of the helices, and it has been suggested the pivoting is achieved via the proline residues 
(Schwartz, Frimurer et al. 2006). Mutations of transmembrane proline residues have been 
shown to have an effect on both ligand-binding and activation of GPCRs (Ladds, Davis et al. 
2005; Reis, Santos et al. 2007; Mazna, Grycova et al. 2008) 
These studies show that lateral interactions between membrane spanning domains are most 
likely driven by non-covalent interactions (van der Waals forces, electrostatic interactions 
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and hydrogen bonding) and the presence of certain motifs and residues in transmembrane 
domains can be strong predictors of transmembrane helix-helix interactions.  
1.2.7 Methods for Studying Transmembrane Helix Interactions 
1.2.7.1 Membrane Protein Structural Determination 
Many biophysical techniques exist to study interactions between transmembrane peptides in 
vitro. These techniques include, among others, sodium dodecyl sulphate polyacrylamide gel-
electrophoresis (SDS-PAGE), analytical ultracentrifugation (AUC), chemical cross-linking, 
solution-state nuclear magnetic resonance (NMR), or solid-state NMR and are often 
performed in detergent micelles or synthetic lipid bilayers (MacKenzie, Prestegard et al. 
1997; Fisher, Engelman et al. 1999; Liu, Crocker et al. 2003; Doura, Kobus et al. 2004; 
Jenei, Borthwick et al. 2009). The biophysical characterization of polytopic proteins provides 
an even greater challenge. X-ray crystallography is the only currently available method for 
obtaining full-length polytopic membrane protein structures (Henderson, Baldwin et al. 1991) 
although it may be possible to piece together structural information on receptor fragments 
from NMR to generate an image of the full-length protein (Toyoshima, Nakasako et al. 
2000).  
Apart from being highly artificial systems, these biophysical techniques come with other 
challenges. Detergent micelles can destabilize helices for instance, through interactions 
between amino acids and the polar head-groups of the detergent, thereby allowing 
increased side-chain flexibility in the amino acid chain or disrupting inter-helical bonds 
thereby distorting the structure (Langosch, Brosig et al. 1996; MacKenzie 2006). 
Furthermore, only a handful of structures of large polytopic proteins have been solved to 
date by X-ray crystallography. This is largely due to difficulties in obtaining large quantities of 
protein and purifying them in their native form. Much research is therefore currently focused 
on improving techniques (Bill, Henderson et al. 2011).      
1.2.7.2 Reporter Systems to Study Protein-Protein Interactions in the 
Membrane 
A range of indirect techniques has been developed to investigate interactions in biological 
membranes. These include an array of different luminescence-based techniques, for 
instance the Förster resonance energy transfer (RET) techniques including bioluminescence 
resonance energy transfer (BRET) and fluorescence resonance energy transfer (FRET) as 
well as protein fragment complementation assays (PCA) such as bimolecular fluorescence 
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complementation (BiFC) (Overton, Chinault et al. 2003; Milligan and Bouvier 2005; Gehret, 
Bajaj et al. 2006). Recently RET and PCA techniques have been combined to monitor the 
formation of large protein complexes (Vidi and Watts 2009). The BRET technique has also 
been used to monitor changes in protein conformation upon ligand binding (Percherancier, 
Yamina et al. 2005). 
Oligomerization of single transmembrane spanning domains can be readily studied using the 
TOXCAT assay (Russ and Engelman 1999). In this technique a TM domain of interest is 
expressed as an MBP-TM-ToxR chimera in the E. coli inner membrane. The maltose binding 
protein (MBP) drives the construct to the membrane and ensures its correct orientation. 
Interaction of two TM domains bring their ToxR domains in close proximity, leading to 
expression of chloramphenicol acetyl-transferase (CAT), (Figure 1-4) and levels of CAT 
expression can directly be quantified by its activity on a substrate. Since TOXCAT can only 
measure   interactions   between   the   same   domains   (“homo-oligomerization”)   an   alternative  
technique  was  developed   to  allow   the  studying  of   “hetero-oligomers”   i.e.  oligomers   formed  
by the interaction of different transmembrane domains (Schneider and Engelman 2003). 
Other assays involving protein fusions and reporter complementation also exist, such as the 
split-ubiquitin assay (Johnsson and Varshavsky 1994).  
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Figure 1-4: Principles of the TOXCAT assay.  
A protein chimera is expressed in E. coli consisting of the TM domain of interest, flanked by the ToxR 
DNA binding domain at the N-terminus, and the maltose binding protein (MBP) at the C-terminus. The 
MPB drives and anchors the TM to the membrane. If the two TM domains come in close proximity 
their respective ToxR DNA binding domains are brought together. ToxR dimers, but not monomers, 
bind the operator region of the ctx operon and activate the transcription of CAT. CAT confers 
chloramphenicol resistance by acetylating chloramphenicol.  
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1.3 Cell to Cell Communication 
The ability of cells to sense their environment and respond with appropriate cellular 
responses is crucial to survival. Social and multi-cellular organisms additionally require inter-
cellular communication in order to formulate coordinated responses. Vast arrays of cellular 
pathways have evolved to sense and respond to stimuli as diverse as nutrients, stress or 
developmental information. Some signalling pathways may involve the passive diffusion of 
signalling molecules into cells; estrogen for instance can cross the lipid bilayer. Most 
signalling pathways however rely on membrane bound receptors to sense external stimuli 
and to induce the appropriate response. In some cases, such as ligand- and voltage-gated 
ion channels or receptor tyrosine kinases, the receptor itself is involved in actively inducing 
the desired response. In other cases, such as GPCR signalling, the receptors merely relay 
the signal intracellularly.  
Many diseases that plague modern society are associated with the disruption of normal cell-
to-cell communication. These include, among many others, autoimmune disease, where an 
individual’s   immune   system   fails   to   recognise its own constituent parts, type-2 diabetes, 
where cells do not respond to insulin properly or cancer, where cells do not to respond to 
normal homeostatic control. The study of cell-to-cell communication is therefore important for 
understanding how to detect, and combat, such diseases.   
1.3.1 G Protein-Coupled Receptors  
GPCRs form a large ubiquitous family of signalling receptors; humans alone encode ~800 
GPCRs (Fredriksson, Lagerstrom et al. 2003) and they are found in all eukaryotic 
organisms. Although GPCRs do not share a high degree of sequence similarity they do 
share a highly conserved topology. GPCRs are involved in sensing a wide array of stimuli, or 
ligands, including light, odours, proteins, peptides, lipids, sugars, nucleotides and ions, and 
the extracellular signal is typically relayed within the cell via the G protein to promote a 
response.  
1.3.1.1 Conformational States of G Protein-Coupled Receptors 
GPCRs exist in a state of dynamic equilibrium between conformational states where 
receptors are in an  “on”  or  an  “off”  state  termed  R*  and  R  respectively (Kenakin 2002). Full 
agonists stabilize   the   “on”   state R* and inverse   agonists   stabilize   the   “off”   state   R. 
Antagonists in contrast do not shift the equilibrium but block the binding of other ligands. 
Most receptors exist in a state shifted towards R in the absence of ligands; however 
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examples of receptors that are constitutively active do exist, for instance the sphingosine-1-
phosphate receptors (Uhlenbrock, Gassenhuber et al. 2002) or the Mas and angiotensin II 
type 1 receptors (Kostenis, Milligan et al. 2005; Canals, Jenkins et al. 2006). 
1.3.1.2 G Protein-Coupled Receptor Families 
Due to the sheer size of the GPCR super-family, a classification system was created to 
subdivide the family. This classification scheme is based on homology, with receptors within 
the same group sharing ~25% sequence similarity in the TM core (Bockaert and Pin 1999; 
Pierce, Premont et al. 2002; Vroling, Sanders et al. 2010). The class A receptors is the 
largest class and include the well-studied  GPCRs   rhodopsin  and  β2-adrenergic receptors. 
These receptors may bind small ligands in their TM domains, such as light or odours, or 
peptides that mainly bind to the N-terminal region and extracellular loops. It also includes 
receptors that bind glycoprotein hormones and these have large extracellular domains to 
which the ligand binds. The class B receptors comprise a much smaller group of receptors 
and include the secretin-like receptors. These receptors are also characterized by their large 
extracellular domains to which large peptide hormones bind. Class C receptors include the 
metabotropic glutamate receptors, GABA-B, and receptors involved in sensing calcium. A 
number of additional small groups exist that are classified according to their respective 
organisms rather than sequence similarity, for instance the Class D yeast pheromone 
receptors, the Class E Dictyostelium discoideum cAMP receptors or the class F 
frizzled/smoothened group from Drosophila melanogaster.  
1.3.1.3 G Protein-Coupled Receptor Signalling 
GPCRs typically reside in the membrane in the inactive R state bound to the inactive 
heterotrimeric  Gαβγ-GDP complex (Figure 1-5). Ligand binding promotes a rotation about 
TM6 and TM3, leading to R to R* isomerisation, typically triggered by a tryptophan residue in 
TM6 located two residues prior to a highly conserved proline residue (Gether, Lin et al. 1997; 
Shi, Liapakis et al. 2002; Xu, Wu et al. 2011). Receptors may acquire constitutively active 
mutations (CAMs) that stabilize the R* state (Ladds, Davis et al. 2005), and many human 
disease states are associated with CAMs (Seifert and Wenzel-Seifert 2002). In the activated 
R* state, GPCRs function as guanine nucleotide exchange factors (GEFs) and promote the 
dissociation of GDP and subsequent association of GTP on the Gα-subunit (Pierce, Premont 
et al. 2002). This  frees  the  Gα  and  Gβγ  complex  from  the  receptor  and  the  subunits  are  free  
to regulate downstream signalling effectors. Hydrolysis of  Gα-GTP to GDP, either by intrinsic 
Gα-GTPase activity or by regulator of G protein signalling (RGS) proteins causes the re-
association  of  Gαβγ-GDP with receptor and return to the R state.  
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Figure 1-5: Generalized schematic of G protein-coupled receptor signalling 
Ligands bind to regions of the GPCR located on the extracellular side. Binding of ligand activates the 
receptor through inducing conformational changes. This promotes intrinsic GEF activity in the 
receptor thereby  promoting  GDP  for  GTP  exchange  on  the  associated  Gα  subunit.  Gα  and  Gβγ  can  
then interact with intracellular effector proteins to bring about a cellular response. The signalling 
response is terminated upon   Gα-GTP hydrolysis and reformation of the complete inactive 
heterotrimeric  Gαβγ  protein. Gα  often contains intrinsic GTPase activity but hydrolysis of GTP may be 
enhanced by RGS proteins. 
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1.3.2 G Protein-Coupled Receptor Structure 
1.3.2.1 Conserved Topology of G Protein-Coupled Receptors 
Knowledge of the 3D structure of proteins is of utmost importance to the pharmaceutical 
industry because it enables the computerized screening and design of drugs, thereby 
reducing the cost and time-frame for drug development (Costanzi 2010). As mentioned in 
section 1.2.7, few structures of GPCRs have been solved to date but advances are being 
made (Bill, Henderson et al. 2011). The overall topology of GPCRs consists of seven TM 
spanning domains connected by three intracellular loops (IC) and three extracellular loops 
(EC). The N-terminus is positioned in the ECM and the C-terminus in the cytoplasm (Figure 
1-6). Some GPCRs contain an additional amphipathic helix in the C-terminal tail (helix 8 or 
H8 in the diagram) and they may contain post-translational modifications such as disulphide 
bonds, shown to connect EC2 and TM3 in Figure 1-6. 
 
 
Figure 1-6: Topology of G protein-coupled receptors 
G protein-coupled  receptors  contain  seven  transmembrane  α-helical domains, denoted TM1-7 in the 
schematic. The TM domains are connected by three intracellular (IC) and three extracellular (EC) 
loops. The N-terminus is positioned on the extracellular side and the C-terminus is positioned in the 
cytosol. GPCRs may also contain an amphipathic helix in the C-terminal tail (H8) and post-
translational modifications such as disulphide bonds (illustrated in yellow).   
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1.3.2.2 Crystal Structures of Inactive G Protein-Coupled Receptors 
Rhodopsin when bound to its inverse agonist 11-cis retinal, was the first GPCR to be 
sequenced and to have its structure solved to atomic resolution (Hargrave, McDowell et al. 
1983; Palczewski, Kumasaka et al. 2000). This was possible largely due to its high 
expression levels in retinal rod cells enabling the purification of large amounts of protein, and 
consequently the study of rhodopsin has pioneered much research in the GPCR field. Since 
then, a handful of other inactive GPCR structures have been solved to atomic resolution 
including (but not limited to); human   β2-adrenergic receptor in complex with the inverse 
agonist carazolol (Cherezov, Rosenbaum et al. 2007; Rasmussen, Choi et al. 2007), the 
turkey  β1-adrenergic receptor bound to the antagonist cyanopindolol (Warne, Serrano-Vega 
et al. 2008), human adenosine A2A receptor in complex with the antagonist ZM241385 
(Jaakola, Griffith et al. 2008), human dopamine D3 receptor in complex with the antagonist 
eticlopride (Chien, Liu et al. 2010) and human CXCR4 chemokine receptor bound to the 
antagonist peptide IT1t (Wu, Chien et al. 2010). 
Sequence conservation between these class A GPCRs is highest within the TM core and the 
overall fold of the TM bundles are highly similar with root mean square deviations (RMSD) 
ranging from 0.7 for   the   β1- and   β2-adrenergic receptors to 2.4 Å for rhodopsin and the 
adenosine A2A receptor (Hanson and Stevens 2009). Some differences can be found in the 
tilt and length of TM domains, which may reflect the ability of the GPCRs to bind highly 
diverse ligands.   The   binding   pocket   of   the   β-adrenergic receptors are similar to that of 
rhodopsin where the long axis of the ligand is parallel to the membrane and makes contact 
with TM3, TM5, TM6 and TM7. In these structures cyanopindolol and carazolol do not make 
contact with the tryptophan residue involved in the rotational switch in activation of the  β-
adrenergic receptors (see section 1.3.1.3), retinal in contrast does make contact with this 
residue (Rosenbaum, Cherezov et al. 2007). In contrast, the binding pocket of the adenosine 
A2A receptor is quite different, and the ligand binds perpendicular to the membrane rather 
than parallel and mainly contacts the EC2 loop (Hanson and Stevens 2009). Rhodopsin and 
the   β-adrenergic receptors differ greatly in their extracellular region. In rhodopsin there is 
extensive structure to this region that serves to exclude solvent from the binding site, 
whereas  the  β-adrenergic receptors adopt a more open conformation, possibly to allow the 
ligand access to the binding site (Hanson and Stevens 2009).  
Interestingly, the crystal structure of the CXCR4 chemokine receptor reinforced data 
suggesting that this receptor forms dimeric complexes (Wu, Chien et al. 2010). Homo- and 
hetero-dimerization of the CXCR4 receptor is believed to have pharmacological effects 
important to human disease states. For instance WHIM syndrome (warts, 
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hypogammaglobulinemia, infections and myelokathexis) result from the heterozygous 
expression of mutant CXCR4 receptor unable to internalize and wild-type receptor, where 
dimerization is believed to cause the dominance of mutant CXCR4 over the wild-type 
receptor (Balabanian, Lagane et al. 2005; Lagane, Chow et al. 2008). Surprisingly the 
dimeric interface of the CXCR4 GPCR did not involve the core of the TM bundle, which is 
implicated in the dimerization of many membrane proteins including some GPCRs, but 
instead appeared to be driven by hydrophobic interactions at the extracellular side of TM5 
and TM6 (Wu, Chien et al. 2010).  
Comparisons between the intracellular regions are hindered by the addition of T4 lysozyme 
in the IC3 loop area of all solved structures except rhodopsin. This enzyme was added 
because IC3 is highly flexible thereby allowing helices to move and the introduction of T4 
lysozyme restricts the movement of helices whilst maintaining the polar surface needed for 
crystallization (Rosenbaum, Cherezov et al. 2007). Rhodopsin, but not the   β-adrenergic 
receptors and adenosine A2A receptor, was found to contain an ionic lock formed by a salt-
bridge between a highly conserved E/DRY motif in TM3 and a glutamate residue in TM6. 
This ionic lock is believed to keep the receptor in an inactive state, and mutations of these 
residues  in  the  β2-adrenergic receptor result in a CAM phenotype. It was therefore surprising 
that the ionic lock is absent from the structure of the β-adrenergic receptors and adenosine 
A2A receptor, and two possible explanations were proposed. Either the ionic lock is absent 
altogether from these receptors, which could explain their higher basal activity compared to 
rhodopsin (but does not explain why mutations induce the CAM phenotype) or is because 
the T4 lysozyme interferes with the residues that form the ionic lock (Rosenbaum, 
Rasmussen et al. 2009). In contrast the crystal structure of the human dopamine D3 
receptor revealed that this receptor contains an ionic lock despite the presence of T4 
lysozyme (Chien, Liu et al. 2010).  
1.3.2.3 Crystal Structures of Activated G Protein-Coupled Receptors 
Recently, several structures of activated receptors have been published. These include the 
activated   form   of   rhodopsin   “opsin”   and   its   active metarhodopsin II intermediate (Park, 
Scheerer et al. 2008; Scheerer, Park et al. 2008; Choe, Kim et al. 2011). The most notable 
changes compared to rhodopsin include two openings in the retinal binding pocket, which 
may allow the dissociation of retinal upon activation. The tryptophan residue implicated in 
the rotation of TM6 has moved into space previously occupied by retinal (Rosenbaum, 
Rasmussen et al. 2009). The ionic lock is also lost and the arginine residue on TM3 involved 
in forming the ionic lock instead appear to interact with a Gα-derived peptide included in the 
structure (Scheerer, Park et al. 2008).  
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The structure of adenosine A2A receptor bound to an adenosine derivative was recently 
released (Xu, Wu et al. 2011). In this structure, ligand binding was much more extensive 
compared to when bound to the structurally smaller antagonist ZM241385, thereby 
stabilizing the active state. Rotation about the conserved tryptophan residue in TM6 was 
also observed in this receptor, allowing extensive remodelling of TM5 and TM7. In both 
opsin and adenosine A2A there is a conserved NPxxY motif in TM7, which also undergoes a 
rotational switch upon activation. In the adenosine A2A receptor, movement was much more 
pronounced than for opsin, and involved extensive tilting of TM7. Furthermore, the residues 
that may be involved in the ionic lock (but were not resolved in the inactive structure) were 
observed to move apart.  
These studies all reflect the structural diversity among the class A GPCR family, despite 
their relatively high sequence conservation. It will be interesting to see how similar, or 
dissimilar, the other classes of GPCRs are compared to these receptors and the release of 
more structures will aid the computational modelling of receptor:drug interactions. 
1.3.3 G proteins and Effector Systems 
1.3.3.1 G Protein Activity 
Guanosine nucleotide binding proteins (G proteins) represent a diverse family of signalling 
proteins involved in the regulation of many cellular processes such as secretion, motility or 
transcription, by regulating proteins such as transporters, ion channels, or metabolic 
enzymes (Neves, Rarn et al. 2002). G Proteins are involved in both relaying the message 
from an activated GPCR, as well as regulating GPCR signalling pathways.  
G proteins contain an α-helical domain involved in upstream protein specificity and a 
GTPase domain involved in nucleotide binding and effector specificity. G proteins function as 
molecular switches; when  bound  to  GDP  they  are  “off”  and  when  bound  to  GTP  they  are  “on”  
(illustrated in Figure 1-7). GEFs facilitate the dissociation of GDP thus allowing the more 
cellularly abundant GTP to bind, and thereby promoting the  “on”  state.  When switched on G 
proteins can bind downstream effectors to promote the cellular response (Gulbins, 
Coggeshall et al. 1994; Lambright, Noel et al. 1994). Most G proteins contain some level of 
intrinsic GTPase activity to turn off activity, although intrinsic activity tends to be slower than 
needed for rapid physiological changes and hydrolysis can be accelerated ~1000 fold by 
GTPase accelerating proteins (GAPs) (Ahmadian, Stege et al. 1997). G proteins with 
intrinsic GTPase activity contain a conserved arginine residue which is inserted into the G 
protein catalytic site to promote hydrolysis of GTP and convert the  G   protein   to   the   “off”  
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state, and GAPs may stabilize this conformation. In G proteins with no intrinsic GTPase 
activity, the GAP itself  may  contain  and  insert  this  “arginine  finger” (Ahmadian, Stege et al. 
1997; Resat, Straatsma et al. 2001). G proteins may be held in the inactive state by 
guanosine nucleotide dissociation inhibitors (GDIs).  
1.3.3.2 Monomeric G Proteins 
Many G proteins can exist as stable monomers including the Ras oncogenes, or the Ras-like 
families of GTPases ARF and Rab (mentioned previously in sections 1.2.3.3 and 1.2.4.2), or 
Rho. Rac1 is an example of the Rho family of GTPases and is involved in cell adhesion, 
endocytosis, the immune response, transcription and the cell cycle (Bosco, Mulloy et al. 
2009). Its numerous involvements in cellular processes clearly emphasize the importance of 
monomeric G proteins to cellular function.  
1.3.3.3 Heterotrimeric G Proteins 
G proteins can also exist in a heterotrimeric  arrangement  of  three  subunits;;  Gα,  Gβ  and  Gγ 
that associate with GPCRs to relay signals. This complex can be viewed as a dimer, 
because  signalling  can  either  occur  via  the  Gα  subunit or the Gβγ  subunits, and dissociation 
of the Gβγ   subunit   can   often   only occur under denaturing conditions (Neves, Rarn et al. 
2002). In GPCR signalling, GEF activity in the receptor, which may involve remodelling of 
the ionic lock to incur changes in the G protein (Scheerer, Park et al. 2008), results in the 
activated heterotrimeric G protein exposing effector binding sites. The activated G protein 
may dissociate to propagate the signal, or may exist in scaffolded signalling complexes 
(Wang, Golebiewska et al. 2009). In addition to the GPCR, heterotrimeric G protein 
activation may also be achieved via monomeric G proteins that function as GEFs; for 
example Rab3 (Cismowski 2006). Signalling is terminated upon GTP hydrolysis, which 
promotes  the  reassociation  of  Gαβγ  and  return  to  the  inactive  state (Figure 1-5). 
1.3.3.3.1 Gα-Families 
 subunits that share 35-95% 
sequence identity and are divided into four distinct families that affect a range of targets, 
which may be overlapping (Khafizov, Lattanzi et al. 2003). The Gs family includes G proteins 
that are activated by many GPCRs, notably including the olfactory receptors, and primarily 
stimulate Ca2+ channels and adenylyl cyclase, though they may have an inhibitory role on 
Na+ channels. The Gi family in contrast has an inhibitory role on adenylyl cyclase, and may 
close Ca2+ channels but stimulate K+ channels. Both Gs and Gi may stimulate the tubulin 
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GTPases, indicating the functional overlap between classes of G proteins. The Gi family also 
include Gt which is activated by vertebrate rhodopsin to stimulate phosphodiesterase 6 in 
vision (Neves, Rarn et al. 2002). The invertebrate squid rhodopsin in contrast, signals via a 
G protein from the Gq  family, which activates phospholipase C (PLC) (Murakami and 
Kouyama 2008). Finally, the G12/13 family of G proteins activate many monomeric G proteins 
such as Rho and Ras (Neves, Rarn et al. 2002). Although the effector proteins appear 
relatively  specific  to  the  various  types  of  Gα,  the  same  is  not  observed  for  the  targets  of  Gβγ  
or  even  the  Gα  subunit  that  they  couple  to  (Wang, Golebiewska et al. 2009). 
In  addition  to  signalling  via  the  Gα,  GPCR  signalling  cascades  may  also  be  activated  by  the  
Gβγ  heterodimer.  This is for instance observed in the yeast Saccharomyces cerevisiae (Sc. 
cerevisiae) pheromone-response signalling   cascade   where   Gβγ   activates   the mitogen 
activated protein kinase (MAPK) cascade  and   the  Gα  subunit   instead  adopts  an   inhibitory  
role on signalling (Dohlman 2002). Signalling cascades may also be activated independently 
of the  G  protein  altogether,  which  has  been  observed  in  β2-adrenergic receptor upon binding 
arrestin (Shenoy, Drake et al. 2006). 
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Figure 1-7: The GTPase cycle 
Schematic of the G protein GTPase cycle. GEFs stimulate the GDP for GTP exchange on the G 
protein. Many G proteins contain intrinsic GTPase activity and can hydrolyse the γ-phosphate thus 
returning to the GDP-bound conformation. Hydrolysis can be accelerated by a GAP. 
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1.3.3.4 Second Messengers 
The effector molecules themselves affect   “second   messenger”   levels. PLC for instance 
cleaves fatty acids to produce the second messengers DAG (diacylglycerol) and IP3 (inositol 
triphosphate). IP3 can then diffuse through the cytosol and activate IP3 receptors. Targets of 
IP3 receptors include calcium channels in the ER, which cause cytosolic calcium levels to 
increase and lead to further changes in the cell. DAG in turn remains bound to the 
membrane and may activate protein kinase C (PKC) together with the increased levels of 
Ca2+, and upon activation PKC phosphorylates other molecules. The direct binding of G 
proteins to ion channels in contrast can affect the membrane potential, or have a direct effect 
on calcium levels (Lodish, Berk et al. 2000).  
The second messenger cyclic AMP (cAMP) is produced from adenylyl cyclase and broken 
down by cAMP phosphodiesterases. Different isoforms of adenylyl cyclase in mammals are 
regulated either by G proteins or by Ca2+ (and as mentioned in the previous paragraph, both 
Gs and Gi may affect Ca2+ levels, as well as directly regulating adenylyl cyclase). Upon 
adenylyl cyclase activation, there is a rise in cellular cAMP and consequently there is a rise 
in activated protein kinase A (PKA) (as illustrated in Figure 1-8), the target of cAMP. 
Released subunits of PKA move into the nucleus, where they phosphorylate the cAMP 
regulatory element binding protein (CREB; several different subtypes exist). CREB recruits 
the co-activator CREB binding protein (CBP) and together they stimulate transcription. 
Different cell types may respond differently to increasing levels of cAMP, and this pathway 
regulate the transcription of many genes including hormone synthesis in endocrine cells or 
proteins in the brain involved in long term memory. Furthermore, many ligands may activate 
adenylyl cyclase in the same cell type. Despite this diversity, the same cell type may 
respond in the same way independent of ligand type. For instance, four different hormones 
that all stimulate cAMP production in adipose cells all lead to the breakdown of 
triacylglycerol to fatty acids (Lodish, Berk et al. 2000; Alberts, Johnson et al. 2002). 
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Figure 1-8 Regulation of gene transcription by G protein stimulated adenylyl cyclase 
Activation of the GS protein following the activation of the GPCR leads to activated adenylyl cyclase. 
Activated adenylyl cyclase rapidly converts ATP   to   3’5’-AMP. Increased levels of AMP leads to 
increased levels of activated PKA (protein kinase A) in the cytosol. PKA consists of two regulatory 
and two catalytic subunits, which are separated upon cAMP binding. Upon activation the catalytic 
subunits dissociate and are free to move into the nucleus and phosphorylate CREB (cAMP regulatory 
element binding protein). CREB can in its phosphorylated form recruit the co-activator CBP and 
together they up-regulate gene transcription. 
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1.3.4 Regulators of G Protein-Coupled Receptor Signalling 
1.3.4.1 Regulation of G Protein-Coupled Receptor Expression 
GPCR signalling is regulated on many levels. GPCRs and associated signalling molecules 
may be up- or down-regulated at a transcriptional level through transcription factor activity 
(Sugimoto, Iino et al. 1991; Pashkov, Huang et al. 2011) and some GPCRs may even 
regulate their own transcription through a positive feedback loop. This is seen, for instance, 
with the Sz. pombe transcription factor Ste11, which is activated through the MAP Kinase 
cascade triggered by the activated GPCR Mam2, and up-regulates Mam2 transcription to 
achieve increased sensitivity of the receptor (Kjaerulff, Lautrup-Larsen et al. 2005; Wood, 
Kwon et al. 2011). Mam2 mRNA may further be stabilized by the RNA binding protein Csx1 
and because Mam2 is needed for mating Csx1- mutants are sterile (Matia, Sotelo et al. 
2011). Instead of up-regulating GPCR plasma membrane expression at a transcriptional 
level, some GPCRs may be stored in intracellular compartments and released to the plasma 
membrane following agonist activation (Hein, Ishii et al. 1994; Brismar, Asghar et al. 1998), 
thereby sensitizing the pathway (Achour, Labbe-Jullie et al. 2008).  
1.3.4.2 Binding of Ligand 
One GPCR may bind several different ligands, and the type of ligand may alter the coupling 
that the GPCR has for different G proteins (Ladds, Davis et al. 2003). This may be attributed 
to the many molecular switches that can occur in GPCR activation, and ligands may trigger 
different switches, leading to altered G protein specificity and ultimately altered cellular 
responses (Ahuja and Smith 2009). Ligand-specificity in turn may be controlled, as 
discussed in section 1.2.3.1 through the single transmembrane spanning proteins RAMP 
(McLatchie, Fraser et al. 1998). RAMPs regulate many additional aspects of GPCR 
signalling (Kuwasako, Shimekake et al. 2000) including chaperoning trafficking during 
endocytosis (Kuwasako, Shimekake et al. 2000) and trafficking from ER to Golgi (Bouschet, 
Martin et al. 2005). For some receptors RAMP expression is absolutely necessary for 
trafficking explaining difficulties in expressing some GPCRs in heterologous systems 
(Parameswara and Spielman 2006).  
1.3.4.3 Activators of G Protein Signalling 
Heterotrimeric G proteins may achieve activation in the absence of receptor, a mechanism 
mediated by activator of G protein signalling (AGS) proteins, and these proteins may be 
subdivided into three distinct functional groups (Blumer, Cismowski et al. 2005; Cismowski 
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2006; Sato, Blumer et al. 2006). Group one currently has two members which act as GEFs 
and activate heterotrimeric G proteins independently of GPCRs but inhibit signalling via the 
Gβγ   complex (Hill, Goddard et al. 2009). Group two comprise a larger group with four 
members which act as GDIs   and   prevent   signalling   via  Gα  but   allow   the  Gβγ  complex   to  
dissociate.  The  third  group  has  three  members  and  all  bind  the  Gβγ  complex  in  the  absence  
of receptor, and facilitate interactions with effectors.  
1.3.4.4 Receptor Internalization 
GPCRs may be down-regulated via endocytosis as discussed in section 1.2.4. For GPCRs 
specifically, endocytosis may occur in the presence of ligand or constitutively and can be 
mediated by CME or non-CME pathways (Scarselli and Donaldson 2009). Phosphorylation 
of serine and threonine residues in the IC3 loop or C-terminal tail-region is a common 
mechanism to target the receptor for internalization. Phosphorylation may be mediated by G 
protein-coupled receptor kinases (GRKs) or the second messengers protein kinase A (PKA) 
or protein kinase C (PKC), and different kinases may phosphorylate different sites in the 
receptors (Tobin, Butcher et al. 2008). One function of GRK phosphorylation is to increase 
the rate of arrestin recruitment to the GPCR, and phosphorylation by different GRKs result in 
variations in the rate of recruitment to   the   β2-adrenergic receptor (Violin 2006). 
Phosphorylation by PKA in contrast does not lead to arrestin recruitment to the β2-
adrenergic receptor. This can possibly be explained by that phosphorylation by GRKs 
increase the negative charge at the arrestin binding site, which might be needed to promote 
arrestin binding. Phosphorylation at sites other than the arrestin binding site may therefore 
not affect arrestin binding (Violin 2006).  
Arrestin binding has two effects on GPCR signalling; it occludes the binding site for the 
heterotrimeric G protein thereby preventing its activation, and it links the receptor to CME 
(Figure 1-9). Arrestin binding to a receptor exposes a binding site for clathrin and AP2. 
Following internalization the arrestin may rapidly dissociate,   as   observed   with   the   β2-
adrenergic receptor, or remain tightly bound, as seen with the vasopressin type II receptor. 
The biological significance of the different dissociation rates is unclear, but it may play a role 
in delaying receptor recycling (Oakley, Laporte et al. 1999) or it has been speculated that 
some receptors that remain bound to their heterotrimeric G proteins may continue to signal 
from the endosomes (Jalink and Moolenaar 2010) although this hypothesis is controversial 
(DeFea 2011).  
Arrestins do not solely function as signal terminators, but may also serve as scaffolds for 
signalling via many pathways, including amongst many others the MAPK cascade, 
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independently of heterotrimeric G proteins (Shenoy, Drake et al. 2006) although this does 
not appear to be typical (DeFea 2011). Like with many GPCR regulating mechanisms, the 
precise mechanism determining the fate of arrestin-bound receptors; be it recycling, 
degradation or G protein independent signalling, are unclear.  
 
 
 
 
 
 
Figure 1-9: G protein-coupled receptor internalization via  β-arrestin 
The GPCR is initially expressed at the plasma membrane. Following phosphorylation by a protein 
kinase the heterotrimeric G protein is displaced by arrestin. Association of arrestin with the GPCR 
expose a clathrin/AP2 binding domain and the complex is recruited into clathrin coated pits. Upon 
budding of the pit, clathrin is lost. Following arrestin dissociation, the GPCR may be recycled back to 
the plasma membrane or be degraded in lysosomes.   
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1.3.5 G Protein-Coupled Receptor Oligomerization 
An additional layer adding to the complexity of GPCR regulation is the notion that some 
GPCRs are capable of forming homo- or hetero-oligomers. Although the area has been 
surrounded by some controversy (Chabre and le Maire 2005) it is now generally accepted 
that some GPCRs form oligomeric complexes of functional importance. The formation of 
these complexes play a role in a number of cellular functions including receptor trafficking, 
ER quality control, signal amplification, trans-activation, ligand sensitivity, G protein 
specificity, internalization or pharmacology, and has been extensively reviewed in the 
literature (Park, Filipek et al. 2004; Terrillon and Bouvier 2004; Skrabanek, Murcia et al. 
2007; Gurevich and Gurevich 2008; Ferré, Baler et al. 2009). 
1.3.5.1 A Functional Role for Receptor Oligomerization 
The chemokine receptors provide an interesting case study for GPCR oligomerization. The 
chemokine receptors represent a family of 19 GPCRs in humans involved in chemotaxis of 
many cell types, for instance leukocytes, and they primarily signal through a Gαiβγ complex 
(Moser, Wolf et al. 2004). Chemokine receptor signalling involves activation of PLC and 
promote the release of calcium from intracellular stores via DAG and IP3 (see section 1.3.3), 
which activate a MAPK cascade and lead to chemotaxis. The crystal structure of the 
chemokine receptor CXCR4 indicate that this receptor exist in a dimeric form (Wu, Chien et 
al. 2010) and is the only crystal structure of a dimeric GPCR to date. CXCR4 is also able to 
form hetero-dimers with other chemokine receptors and ligand binding does not promote or 
dissociate either homo- or hetero-oligomers (Percherancier, Yamina et al. 2005). The 
CXCR7 receptor can bind the same chemokine ligand as CXCR4, however it cannot couple 
to Gi and for this reason it was initially classified as an orphan receptor. A recent study 
demonstrated that CXCR7 can hetero-oligomerize with CXCR4 to form a complex that 
constitutively signal via arrestin whereas Gi signalling is suppressed. Cells signalling via this 
pathway show enhanced chemotaxis compared to when signalling via CXCR4 alone 
(Decaillot, Kazmi et al. 2011) demonstrating a distinct functional role for receptor hetero-
association. 
GPCR hetero-dimerization is also implied in GPCR transport, for instance in the case of 
GABABR1. When expressed alone, the GABABR1 receptor is retained in the ER but when 
co-expressed with GABABR2, GABABR1 is released from the ER and is transported to the 
cell surface. Hetero-dimerization of the two receptors masks an RxR-based ER-retention 
signal in the GABABR1 tail, thereby allowing its export from the ER (White, Wise et al. 
1998). 
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1.3.5.2 Effects of Oligomerization on the R* State 
The importance of homo-dimer formation on GPCR function is not yet fully understood, but 
different ligands may influence the dimeric state. For  instance  in  the  β2-adrenergic receptor, 
agonist binding stabilizes the dimeric form whereas binding of inverse agonist favours the 
monomeric form (Hebert, Moffett et al. 1996). One hypothesis is that oligomer formation may 
be involved in allosteric regulation (Maurice, Kamal et al. 2011). For instance, in the 
dopamine D2 receptor, agonist binding to one protomer in a dimer induces activation of both 
receptors. When another agonist is introduced into the second protomer, the functional 
response is inhibited whereas introduction of an inverse agonist enhance signalling. Binding 
of inverse agonist to the second protomer appear to stabilize the R* state (which is shifted 
towards R* due to binding of agonist to the first protomer and conformational changes in the 
first protomer are translated to the second), in contrast, binding of a second agonist has 
negative allosteric effects, possibly due to incompatibility between the different structural 
conformations adopted by the protomers when bound to different ligands. Although these 
structural conformations each alone can signal, they may not cooperatively be able to (Han, 
Moreira et al. 2009). This same effect has been observed in homo-dimers of oxytocin 
(Albizu, Cottet et al. 2010) and heterodimers of adenosine A2A-μ-opioid receptors (Vilardaga, 
Nikolaev et al. 2008).  
1.3.5.3 Interactions Governing Receptor Oligomerization 
Despite the abundance of data supporting the existence of GPCR oligomers, little 
information is available on the mechanism for interactions, and predictions are often 
restricted to whole TM domains rather than specific amino acids. For instance there is 
evidence to suggest that some GPCRs interact via TM1-TM1 interactions as well as TM4 
and/or TM5, for instance the C5a receptor (Klco, Lassere et al. 2003), STE2 (Wang and 
Konopka 2009), the mouse delta opioid receptor (Johnston, Aburi et al. 2011) or rhodopsin 
(Liang, Fotiadis et al. 2003), although the occurrence of rhodopsin oligomers is debated 
(Edrington, Bennett et al. 2008). The specific residues involved in the interactions however 
are largely unknown. 
For some receptors however, individual residues have been shown to be involved in 
oligomerization. For instance, there is evidence for TM6-TM6   interactions   in   the   β2-
adrenergic receptor via a GxxxG motif (Hebert, Moffett et al. 1996) and there is also 
evidence that the STE2 pheromone receptor dimerizes via a GxxxG motif in TM1 (Overton, 
Chinault et al. 2003). Not all dimerization events are mediated by transmembrane 
interactions; the metabotrobic glutamate receptors for instance dimerizes via a disulphide 
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bond in the extracellular domain (Romano, Yang et al. 1996; Kunishima, Shimada et al. 
2000). The CXCR4 receptor also dimerizes via interactions outside of the TM bundle 
although in this receptor interactions appear to be driven via the hydrophobic effect, 
involving the extracellular regions of TM5 and TM6 (Wu, Chien et al. 2010). 
1.4 Yeast Models 
GPCR signalling is difficult to study in mammalian systems for a number of reasons. In 
humans, ~1000 GPCRs couple   to   ~20   Gα,   5 Gβ,   and   12 Gγ   subunits in various 
combinations as well as coupling to many different regulators. Furthermore, different 
receptors may be activated by the same ligands, and substantial cross-talk can occur 
throughout the signalling cascades (Zaugg and Schaub 2004). This makes it extremely 
challenging to study individual component parts of the signalling pathways. Metazoa are 
additionally relatively difficult to study per se, and research is therefore often done in cell 
lines as opposed to whole organisms. Mammalian cell lines in turn are difficult to handle, 
meaning that much research is performed in vitro using cell extracts. 
Many cellular events are conserved between yeast and higher eukaryotes. In contrast to 
higher eukaryotes, yeast are relatively easy to manipulate, simple to culture and are fast-
growing; making it an excellent model organisms in which to study eukaryotic cellular 
processes. Yeast are unicellular eukaryotic organisms that may grow by budding, as 
observed with Sc. cerevisiae, or by binary fission, as observed in Sz. pombe. Despite both of 
these yeasts being unicellular ascomycete fungi, they are not closely related. Estimates of 
their divergence range from 330-420 million years ago, making fission yeast and budding 
yeast as distantly related to each other as mammals are to either yeast (Sipiczki 2000). Their 
relative evolutionary distance is reflected in their genome content where 75% of fission yeast 
genes are conserved in budding yeast, compared to 71% conserved to metazoan genes 
(Wood 2006). Most house-keeping genes are conserved between fungi and metazoa and 
differences are mainly found in organism-specific processes such as spore-formation in fungi 
or development in metazoa. Sequence identity between fission yeast and budding yeast 
range from 60-90% which is similar to the metazoan homologs (Moreno, Klar et al. 1991), 
although some metazoan processes appear more similar in Sz. pombe compared to Sc. 
cerevisiae, for instance cell-cycle control, centromere structure, cytokinesis or mitochondrial 
maintenance and regulation (Kuhl, Dujeancourt et al. 2011; Wood 2011). The similarities of 
these two fungi to metazoa make them suitable model organisms for many higher eukaryotic 
processes, and their relative difference makes the study of both valuable.   
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1.4.1 Studying G Protein-Coupled Receptor Signalling in Budding 
Yeast 
Sc. cerevisiae has extensively been used as a model organism to overcome the difficulties 
of studying GPCR signalling systems in mammalian cells. Sc. cerevisiae contain two GPCR 
signalling pathways; one involved in glucose-sensing, and one involved in mating. Several 
important findings about GPCR signalling were discovered in Sc. cerevisiae including 
signalling   via   Gβγ   (Whiteway, Hougan et al. 1989) and the existence of RGS and AGS 
proteins (Dohlman and Thorner 1997; Cismowski, Takesono et al. 1999). Sc. cerevisiae has 
also been utilized to investigate many human GPCR signalling components, discoveries 
including ligands for orphan GPCRs (Ladds, Goddard et al. 2005). There are however 
limitations to studying GPCR signalling in Sc. cerevisiae. For example, budding yeast signal 
via the Gβγ   subunit   in   the   pheromone-response pathway,   and   the   Gα   has   a   negative  
regulating role (Dohlman 2002). This may create problems when expressing human 
components in the yeast such as RGS proteins to  investigate  Gα  function,  because they will 
regulate a negative regulator rather than a stimulatory   Gα.   Furthermore, only ~50% of 
heterologous GPCRs couple to the pheromone pathway in Sc. cerevisiae (Dowell and Brown 
2002) which  may  reflect  difficulties  in  coupling  to  Gα,  incorrect  protein  folding,  incorrect post-
translational modifications, issues with trafficking, or an inability of the ligand to cross the cell 
wall (Ladds, Goddard et al. 2005). 
1.4.2 Studying G Protein-Coupled Receptor Signalling in Fission 
Yeast 
Similar to Sc. cerevisiae, Sz. pombe contain two distinct GPCR signalling pathways; one 
involved in glucose-sensing via the GPCR Git3 and the activation of adenylate cyclase 
(Welton and Hoffman 2000; Ivey and Hoffman 2005) and one involved in pheromone-
sensing via the GPCR Mam2 or Map3 and activation of a MAP kinase cascade (Davey 
1992; Tanaka, Davey et al. 1993). Activation of the glucose-sensing pathway prevents the 
activation of the pheromone-responsive pathway through repression of the transcription 
factor Ste11 by activated PKA (Maeda, Mochizuki et al. 1990), but apart from this regulation 
there is no known cross-talk between the two signalling cascades (see (Davey 1998; 
Hoffman 2005) for reviews). Unlike in Sc. cerevisiae, signal propagation in the Sz. pombe 
GPCR   signalling   pathways   are   mainly   achieved   via   the   Gα   subunits meaning that they 
resemble the majority of metazoan GPCR signalling pathways more closely. Heterologous 
GPCRs and downstream signalling components have in many cases been successfully 
investigated in Sz. pombe via the pheromone-sensing pathway (Ladds, Davis et al. 2003; 
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Ladds, Goddard et al. 2005; Ladds, Goddard et al. 2007) although without  Gα  modifications  
(Ladds, Davis et al. 2003) human GPCRs may fail to couple to the Sz. pombe signalling 
cascade despite high expression levels (Sander, Grünewald et al. 1994; Arkinstall, Edgerton 
et al. 1995; Ficca, Testa et al. 1995).  
1.4.2.1 The Fission Yeast Pheromone-response  
Sz. pombe exist in one of two mating states; M (minus) or P (plus). During vegetative growth 
cells exist in a haploid state but under conditions of nitrogen starvation, cells arrest in G1 
and mating of cells of opposite phenotype is initiated, resulting in the formation of diploid 
zygotes (Nielsen 2004), followed by meiosis and sporulation (Yamamoto 2004). M cells 
express the GPCR Mam2 which sense P-factor, secreted by P cells. P cells in turn sense M-
factor through the GPCR Map3, which is secreted by M cells. Both M-factor and P-factor are 
short polypeptide pheromones, 9 and 23 amino acids long respectively (Davey 1992; Imai 
and Yamamoto 1994).  
Stimulation of Map3 or Mam2 by pheromone promotes activation of the Gα  subunit  Gpa1  
(Obara, Nakafuku et al. 1991). Unlike in the glucose-sensing pathway, there is no confirmed 
Gβγ  complex  coupling  to  the  pheromone-response pathway. A putative Gβ-subunit has been 
described in the literature however and although it is not required to propagate the signalling 
response it acts as a negative regulator of signalling. The deletion phenotype of this gene 
can be rescued by the expression of human Gβ-subunits (Goddard, Ladds et al. 2006). The 
activation of the Sz. pombe pheromone-response leads to the induction of two individual 
cellular response-pathways; one resulting in the transcription of genes involved in mating 
and one resulting in morphological changes in the cell (Figure 1-10). At the initiation point of 
the pheromone-response, the G protein-coupled receptor Mam2 or Map3 is activated upon 
binding of ligand, and conformational changes in the receptor cause a GDP for GTP 
exchange in the G protein Gpa1 (Ladds, Davis et al. 2005). The immediate downstream 
target of Gpa1 is yet uncharacterized but results in activation of the monomeric G protein 
Ras1 via one of the GEFs Ste6 or Efc25, which are believed to be in competition with each 
other. Activation of Ras1 via Ste6 leads to the transcriptional response whereas activation of 
Ras1 via Efc25 results in morphological changes in the cell (Sipiczki 1988; Papadaki, pizon 
et al. 2002; Forfar 2007).  
In the transcriptional response, Ras1 activate the MAP kinase kinase kinase (MAPKKK) 
Byr2. Activated Byr2 in turn phosphorylate the MAP kinase kinase (MAPKK) Byr1, whose 
target is the MAP kinase (MAPK) Spk1. Activated Spk1 is translocalized to the nucleus 
where it activates the transcription factor Ste11, partly by direct phosphorylation of the 
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transcription factor and partly by inhibiting the regulatory Pat1 kinase (Kjaerulff, Lautrup-
Larsen et al. 2005). The high mobility group (HMG) box transcription factor Ste11 is 
responsible for the increased expression of most of the 163 proteins upregulated in 
response to pheromone and binds A-rich DNA regions (Sugimoto, Iino et al. 1991; Xue-
Franzen, Kjaerulff et al. 2006)  
Activation of Ras1 via the GEF Efc25 in contrast, leads to morphological changes in the cell 
starting with the activation of Scd1. Scd1 is the exchange factor for Cdc42 – a Rho-like 
GTPase, which phosphorylates the p21 activating kinase (PAK) Shk1. Activated Shk1 
phosphorylates a number of proteins including Orb6 and Tea1 (Kim, Yang et al. 2003) and 
the Rho-GAP Rga8 involved in negative regulation of the Shk1 mediated growth pathway 
(Yang, Qyang et al. 2003), which aid controlling changes in cell morphology by modulating 
microtubule activity and the actin cytoskeleton. Orb6 is a serine/threonine kinase involved in 
cytoskeleton organization and cell cycle control (Verde, Wiley et al. 1998). Tea1 establishes 
growth at the cell tips (Glynn, Lustig et al. 2001) together with other proteins including Pom1 
and Tea3 (Niccoli, Arellano et al. 2003). Morphological changes in the cell as a result of the 
pheromone-response include growing from the tip of the cell towards the source of 
pheromone,   resulting   in   elongated,   ‘shmooing’,   cells   with   increased   cell   volume (Davey 
1991).  
The shmoo response brings cells of opposite mating type into physical contact, resulting in 
hydrogen bond formation between the mating-type specific agglutinins Mam3 (expressed by 
M-cells) and Map4 (expressed by P-cells) at the cell tips (Sharifmoghadam, Bustos-
Sanmamed et al. 2006). Agglutination results in fusion of the two cells and their nuclei, 
thereby producing a diploid. Four spores are then formed by meiosis, containing haploid 
nuclei.  
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Figure 1-10: The Sz. pombe pheromone-response 
The G protein Gpa1, consisting of a GDP-bound Gα-subunit and a possible Gβγ-complex, forms a 
complex with the inactive GPCR Mam2 or Map3. Binding of pheromone to the receptor promotes the 
GDP for GTP exchange on the Gα-subunit Gpa1, and its subsequent dissociation from the Gβγ-
complex. Gpa1-GTP activates a downstream effector leading to Ras1 activation. Interactions of 
activated Ras1 with the Ste6 GEF stimulate the transcriptional response through a MAPK cascade 
and activation of transcription factor Ste11. Interactions of activated Ras1 with the Efc25 GEF in 
contrast stimulate the morphological response leading to chemotropic elongation (shmooing) and 
other changes in cell morphology. Attenuation of the pheromone-response can be achieved at several 
levels.  
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1.4.2.2 Regulation of the Fission Yeast Pheromone-response 
Several mechanisms exist to regulate the Sz. pombe pheromone-response and allow cells 
unable to find a mating partner to resume mitotic growth (Davey and Nielsen 1994; Imai and 
Yamamoto 1994). The RGS protein Rgs1 for instance has been shown to have a dual role in 
the regulation of signalling in both M and P-cells. Rgs1 attenuates the pheromone-response 
by   enhancing   the   intrinsic   GTPase   activity   of   the   Gα   Gpa1   (Watson, Davis et al. 1999; 
Pereira and Jones 2001). Via the same mechanism it also acts as a positive regulator of 
pheromone-signalling   because  Gα-GTP may only activate effectors at a 1:1 stoichiometry 
per activation round, and deactivation thus releases Gα   back   to   the pool of possible 
activators (Smith, Hill et al. 2009). Attenuation of the pheromone-response may also occur 
further downstream in the signalling pathway. The MAP kinase phosphatase Pmp1 for 
instance is needed to dephosphorylate Spk1, and cells lacking Pmp1 have a prolonged 
recovery rate in resuming mitotic growth (Didmon, Davis et al. 2002). 
An extracellular regulatory mechanism also exists whereby M-cells secrete the peptidase 
Sxa2, which removes the C-terminal leucine residue of P-factor, inhibiting its binding to 
receptor. Expression of sxa2 is under the control of the transcription factor Ste11 making it 
an integral part of the pheromone-response (Imai and Yamamoto 1992; Ladds, Rasmussen 
et al. 1996; Ladds and Davey 2000). In fact, the expression of both sxa2 and rgs1 is 
positively regulated by the pheromone-response. Interestingly, cells that lack Rgs1 are 
sterile because they cannot form conjugates despite being hyper-sensitive to pheromone 
and Sxa2 may be required for zygote formation. This suggests that down-regulation of the 
pheromone-response may be pre-requisite for successful completion of mating, aside from 
allowing recovery upon failure to mate (Pereira and Jones 2001). Other regulatory 
mechanisms of the pheromone-response are likely to exist. Sc. cerevisiae for instance 
internalizes receptor in response to pheromone (Hicke and Riezman 1996; Hicke, Sanolari 
et al. 1998) but this has not yet been characterized in Sz. pombe.  
1.4.3 Schizosaccharomyces pombe Reporter Systems 
Several methods exist for quantifying the Sz. pombe pheromone response. Early 
quantitative studies of the Sz. pombe pheromone-response pathway included measuring the 
morphological response via cell volume measurements (Davey 1991) and northern blot 
analysis (Davey and Nielsen 1994). In comparison to reporter assays however, which 
quantify the transcription of genes under the control of a promoter, these assays can be 
time-consuming or less sensitive. The identification of the sxa2 gene provided a suitable site 
for the incorporation of an endogenous reporter of the pheromone-response in Sz. pombe 
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(Imai and Yamamoto 1992). As previously discussed, Sxa2 is a serine carboxypeptidase up-
regulated in response to pheromone, that degrade extracellular P-factor by removal of the C-
terminal leucine residue (Ladds and Davey 2000), and this site has extensively been 
exploited for reporter-purposes. The creation of a sxa2>lacZ reporter strain allowed the 
quantification of the time and pheromone dependent transcriptional pheromone-response 
(Didmon, Davis et al. 2002). The sensitivity of the lacZ reporter is however limited by protein 
quantity;;  lower  amounts  of  β-galactosidase available result in a reduced rate of formation of 
functional   tetramer   units,   and  endogenous   cellular   activity   can   cleave   the   substrate   for   β-
galactosidase generating background noise (Nichtl, Buchner et al. 1998). The assay is also 
time-consuming and not suitable for high-throughput generation of data. An Sxa2>GFP 
reporter was subsequently created to allow continuous time-resolved measurements of cells 
(Smith 2009).  Detection of the pheromone-response using the GFP reporter however 
appeared   less   sensitive   than   the   β-galactosidase reporter and required higher 
concentrations of pheromone despite the relative brightness of GFP. The signal also 
appeared to increase linearly with time, rather than reflecting the down-regulation of the 
pheromone-response with time, or display the typical dose-response sigmoidal curve. This 
could reflect the long maturation process of GFP due to post-translational modifications 
(Tsien 1998), low sensitivity at low expression levels due to high background activity, the 
long half-life of GFP, or other problems with the assay.  
1.4.3.1 The Role of Individual Transmembrane Domains in Yeast 7TM 
Receptors 
To date, there are no crystal structures of full-length yeast GPCR receptors. Due to the 
difficulties in resolving the structure of full-length  GPCR’s   to  atomic   resolution,   techniques 
have been developed to study 7TM receptors using receptor fragments. Work utilizing this 
approach emerged in   the   1980’s   and   focussed   on   the   Archaean   7TM receptor 
bacteriorhodopsin (Popot, Gerchman et al. 1987). Early discoveries included the observation 
that most TM helices when expressed independently of the rest of the receptor would 
reconstitute a functional protein fold even in the absence of extracellular loops (Kahn, 
Engelman et al. 1992; Kataoka, Kahn et al. 1992) lending support to the two-stage model of 
membrane protein folding (Popot and Engelman 1990) and credibility to the concept of 
studying TM domains from polytopic proteins individually. Peptide fragments are now widely 
used for the biophysical study of specific regions of polytopic integral membrane proteins.  
This approach has to date been utilized in yeast for the study of the Sc. cerevisiae α-factor 
GPCR STE2. Experiments performed in dodecylphosphocholine (DPC) and SDS micelles 
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revealed   that   the  TM  domains   of   the   α–factor receptor indeed adopt a α–helical structure 
capable of forming higher order oligomers (Neumoin, Arshava et al. 2007; Cohen, Arshava 
et al. 2008). Although certain TM domains have been implicated in the oligomerization of the 
receptor (Overton and Blumer, 2002) and biochemical analysis indicate a role for ligand 
binding in stabilization of the oligomeric form of the receptor (Shi, Paige et al. 2009; Wang 
and Konopka 2009), the nature of the interactions between receptors on an atomic, or even 
an amino acid based level remain elusive. More extensive, mutational analysis of individually 
epressed TM domains may therefore shed light on the nature of these interactions.  
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1.5 Aims of the Work Presented in this Thesis 
The overall aims of the work presented in this thesis were to gain further insight into the role 
of receptor oligomerization during GPCR signalling in the fission yeast Sz. pombe. In order 
to realize these aims, work was undertaken to characterize the oligomerization-motif GxxxG 
in the first transmembrane domain of the Sc. cerevisiae GPCR STE2 expressed in Sz. 
pombe. Specifically, mutational effects of this motif were investigated in order to elucidate its 
influence on full-length receptor oligomerization, TM-TM oligomerization, receptor 
localization, and its overall effects on pheromone signalling in Sz. pombe. Findings in STE2 
were contrasted to mutational studies on small residues found in the Sz. pombe pheromone 
receptor Mam2, in order to investigate whether a motif with similar functional consequences 
could be identified in the fission yeast receptor.  
A second aim of this thesis was to produce a novel Sz. pombe pheromone reporter strain, 
using the ultra-sensitive Renilla reniformis luciferase gene, under the control of the sxa2 
promoter. The intention behind this strain development was to create a reporter strain that 
allowed a highly sensitive read-out of the pheromone response and that also allowed 
quantitative, high-throughput generation of data. 
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2 MATERIALS AND METHODS 
2.1 Materials 
2.1.1 General Laboratory Reagents 
The general laboratory reagents were supplied by Sigma-Aldrich Co. Ltd. (Poole, Dorset, 
UK) and Merck BDH Laboratory Supplies (Poole, Dorset, UK). All were of analytical grade.  
2.1.2 Molecular Biology Reagents 
Restriction enzymes, T4 DNA ligase, T4 DNA kinase, Taq DNA polymerase (from Thermus 
Aquaticus) and all oligonucleotides were supplied by Invitrogen Ltd (Paisley, Scotland, UK). 
FastStart DNA polymerase and alkaline phosphatase was supplied by Roche Diagnostics 
Ltd.  
2.1.3 Electrophoresis Reagents 
Ultrapure type-I Agarose was supplied by Invitrogen Ltd (Paisley, Scotland, UK). 
2.1.4 Pheromones 
The Sz. pombe P-factor pheromone was synthesized by AltaBioscience, Birmingham, UK. 
The Sc. cerevisiae α-factor pheromone was synthesized by Keck Biotechnology Research 
Laboratory, Connecticut, USA.  
2.1.5 Growth Media 
All media was made using reverse osmosis (RO grade) H2O. Components for Defined 
Minimal Medium (DMM; Davey et al. (1995)) and yeast Amino Acid selective medium (AA) 
were supplied by Sigma Aldrich Co. Ltd. Yeast extract, Luria Broth and Select Agar were 
supplied by Invitrogen Ltd (Paisley, Scotland, UK). Rich Yeast Extract (YE) media was used 
supplemented with adenine, leucine and uracil (250  μg/mL) as required. Plates were made 
with 1.5% select agar.  
2.1.5.1 Yeast Defined Minimal Medium 
DMM (per litre): 
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NH4Cl  5 g 
Na2HPO4 2.2 g 
Phthalic Acid  3 g 
Glucose 20 g 
Salts 50x stock) 10 mL 
Vitamins (1,000x stock) 1 mL 
Minerals (10,000x stock) 100 μL 
  
50x stock salts (per litre): 
MgCl2.6H2O 52.5 g 
CaCl2.2H2O 735 mg 
KCl 50 g 
Na2SO4 2 g 
 
1000x stock solution of vitamins (per 100 mL): 
Nicotinic acid 1 g 
Inositol 1 g 
Pantothenic acid 100 mg 
Biotin 1 mg 
 
10000x stock solution of minerals (per 100 mL): 
Citric acid 1 g 
Boric acid 500 mg 
MnSO4.H2O 500 mg 
ZnSO4.7H2O 400 mg 
Molybdic acid 305 mg 
FeCl3.6H2O 200 mg 
KI 100 mg 
CuSO4.5H2O 40 mg 
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2.1.5.2 Yeast Amino Acid Selective Medium 
Yeast Amino Acid Selective Medium (AA) (per litre): 
Yeast nitrogen base           
(without amino acids) 
6.7 g 
Glucose 20 g 
Amino acid mix 1.5 g 
Select amino acid mix 0.5 g 
  
Amino acid mix: 
L-alanine 2 g 
L-arginine 2 g 
L-asparagine 2 g 
L-cysteine 2 g 
L-glutamine 2 g 
L-glutamate 2 g 
L-glycine 2 g 
L-isoleucine 2 g 
L-lysine 2 g 
L-phenylalanine 2 g 
L-proline 2 g 
L-serine 2 g 
L-threonine 2 g 
L-tryptophan 2 g 
L-tyrosine 2 g 
L-valine 2 g 
myo-inositol 2 g 
para-amino benzoic acid 0.4 g 
 
Select amino acid mix (components omitted as required for selection): 
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Adenine 2 g 
L-histidine 2 g 
L-leucine 4 g 
Uracil 2 g 
L-methionine 2 g 
 
2.1.5.3 Yeast Extract Medium 
Yeast Extract Medium (per litre): 
Yeast extract 5 g 
Glucose 30 g 
  
2.1.6 Bacterial Strains 
General cloning was performed using Escherichia coli (E. coli)  strain  DH5α  (supE44 hsdR17 
endA96 thi-1 relA1 recA1 gyrA96) supplied by Stratagene (Cambridge, UK).  
TOXCAT assays were performed using E. coli strain NT326 (F−(argF-lac)U169, rpsL150, 
relA1, rbsR, flbB5301,ptsF25, thi-1,   deoC1,   ΔmalE444,   recA,   srlA+, Strep25 resistance) 
kindly provided by Professor Donald M. Engelman (Yale University).  
2.1.7 Schizosaccharomyces pombe Strains 
Genes and gene products from the two yeasts studied were distinguished between by the 
use of upper-case or lower case letters. Sz. pombe genes were denoted in the style yfg1 
and proteins Yfg1. Sc. cerevisiae genes are denoted YFG1 and proteins YFG1.  
Standard nomenclature has been used to describe the Sz. pombe strains used in this study. 
A gene deletion is referred to as yfg1-D10 where 1000 base pairs (bp) of the yfg1 locus have 
been deleted. The disruption of a gene using the selectable ura4 cassette (Davis, Pateman 
et al. 1999) is referred to as yfg1::ura4+. Creation of reporter strains in which expression of a 
reporter gene is linked to the promoter of an endogenous gene at the original locus are 
termed pro1>rep1. 
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Strain Genotype 
JY522 mat1-M,   Δmat2/3::LEU2-, leu1-, ade6-M216, ura4-D18, cyr1-D51, 
sxa2::ura4+ 
JY544 mat1-M, Δmat2/3::LEU2-, leu1-32, ade6-M216, ura4-D18, cyr1-D51, 
sxa2>lacZ (Didmon, Davis et al. 2002) 
JY1169 mat1-M, Δmat2/3::LEU2-, leu1-32, ade6-M216, ura4-D18, cyr1-D51, 
mam2-D10, sxa2>lacZ (Ladds, Davis et al. 2003) 
JY1552 mat1-M, Δmat2/3::LEU2-, leu1-32, ade6-M216, ura4-D18, cyr1-D51, 
mam2-D10, sxa2>Rluc 
JY1553 mat1-M, Δmat2/3::LEU2-, leu1-32, ade6-M216, ura4-D18, cyr1-D51, 
mam2-D10, sxa2>Rluc8 
 
The constructs used in this study were cyr1 deletion mutants, The cyr1 gene product is 
adenylyl cyclase and the absence of this protein removes the requirement for nitrogen 
starvation in order to induce the pheromone-response (Maeda, Mochizuki et al. 1990; Davey 
and Nielsen 1994).  
The sxa2 gene product is a serine carboxypeptidase responsible for degrading extracellular 
P-factor (Ladds, Rasmussen et al. 1996; Ladds and Davey 2000). Deletion of this gene 
decreases down-regulation of the pheromone-response thereby prolonging the pheromone 
dependent response and increase functionality of reporter strains (Didmon, Davis et al. 
2002). 
The mat1-M, Δmat2/3 genotype is an M-cell incapable of switching mating type. Deleting the 
silent cassettes mat2 and mat3 prevent switching of mating type. Similarly, the mat1-P, 
Δmat2/3 genetype encodes a P-cell incapable of switching mating type (Klar and Miglio 
1986).  
JY544 refers to the sxa2>lacZ reporter strain where exposure of cells to P-factor lead to the 
production  of  β-galactosidase as part of the pheromone-response.  
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JY1169 is a variant of JY544 where the endogenous mam2 open reading frame (ORF) has 
been deleted. 
JY1552 refers to the Δmam2,  sxa2>Rluc reporter strain created from JY544 where exposure 
of cells to P-factor lead to the production of Renilla luciferase as part of the pheromone-
response. 
JY1553 refers to the Δmam2,   sxa2>Rluc8 reporter strain created from JY544 where 
exposure of cells to P-factor lead to the production of a modified version of Renilla luciferase 
termed Rluc8 (Loening, Fenn et al. 2006) as part of the pheromone-response. 
2.1.8 Plasmids and Constructs 
The Rluc reporter was purchased from Promega (Promega Corporation, Southampton, UK). 
The Rluc8 reporter was kindly donated by Professor Sanjiv S. Gambhir (Stanford University, 
USA). The TOXCAT plasmid was kindly donated by Professor Donald M. Engelman (Yale 
University, USA).  
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2.2 Methods 
2.2.1 Cloning Techniques 
General DNA manipulations were performed as described in (Sambrook, Fritsch et al. 1989).  
Restriction enzymes, alkaline phosphatase, T4 DNA kinase, T4 DNA ligase and other 
modifying enzymes were  used  according   to  manufacturers’  guidelines. 1.5% Agarose gels 
containing   0.5   μg/mL ethidium bromide were used to analyse DNA fragments by 
electrophoresis.  DNA fragments were recovered from agarose gels using the QIAquick Gel 
Extraction Kit supplied by Qiagen (Qiagen House, West Sussex, UK).  
2.2.2 Transformations 
2.2.2.1 Transformations of Schizosaccharomyces pombe 
Sz. pombe were transformed with circularised plasmid DNA or linear DNA fragments using 
the lithium acetate protocol as described by (Okazaki, Okazaki et al. 1990).  
2.2.2.2 Transformations of Escherichia coli  
Transformation competent cells were prepared using the calcium chloride method described 
in Sambrook and Russell (Sambrook and Russel 2001). 10 mL of a mid-exponential phase 
culture (OD600=0.6) was pelleted and re-suspended in 10 mL of 100 mM MgCl2 and 
incubated on ice for 5 min. The cells were then pelleted and re-suspended in 1 mL of 100 
mM CaCl2. Cells were incubated for 16 h at 4°C before use. 
Typically, 2 μL of plasmid DNA or 10 μL of a ligation mix was added to 0.1 mL of competent 
E. coli and incubated on ice for 30 min. The cells were then heat shocked at 42°C in a water 
bath for 90 sec, after which 0.5 mL of LB was added and the cells incubated at 37°C for 30 
min. The cells were pelleted and resuspended in 100 μL of LB before being spread on to 
agar plates containing ampicillin followed by incubation overnight at 37°C. 
2.2.2.3 DNA Sequencing  
The pREP series of plasmids were sequenced by the Molecular Biology Service at the 
University of Warwick. The pccKan series of plasmids were sequenced by GATC Biotech 
AG (Konstanz, Germany). 
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2.2.3 Polymerase Chain Reaction 
Taq DNA Polymerase was used to colony screen bacterial and yeast strains. FastStart high 
fidelity enzyme blend (Roche Diagnostics Ltd.) was used to amplify cloning fragments and 
for bipartite polymerase chain reaction (PCR). Hot-Start Pfu-TURBO™   DNA polymerase 
(Stratagene, UK) was used for QuikChange mutagenesis. All polymerases were used 
according to the manufacturers’ guidelines.  
2.2.3.1 Bipartite Polymerase Chain Reaction Using a Purified DNA 
Template 
Faststart high fidelity enzyme blend (Roche Diagnostics Ltd.) was used according to the 
manufacturer’s   guidelines   to  generate mutations in the pREP plasmids. The reaction was 
performed  in  50  μL  volumes  using  38 μL  filter  sterilized  dH2O,  0.5  μL  template  DNA,  2 μL  of  
each  (forward,  reverse)  primer  (10  μM),  1  μL  of  dNTP  mix  (containing  10  mM  of  each  dNTP),  
5 μL   of   Faststart 10x   PCR   reaction   buffer,   1   μL   DMSO,   and   0.5 μL   of   Faststart DNA 
polymerase (Roche Diagnostics Ltd.). A typical PCR reaction contained 29 cycles of the 
following three steps: denaturation at 95°C for 30 sec, annealing at 55°C for 1 min, and 
extension at 72°C for 2 min. 
2.2.3.2 QuikChange Mutagenesis Using a Purified DNA Template   
The PCR methods for creating deletion and single amino acid QuikChange mutations were 
carried out according to the Stratagene site directed mutagenesis kit manual (Stratagene, 
UK). The reaction was performed in 50 μL volumes using 40 μL filter sterilized dH2O, 1 μL 
wild type template DNA, 1 μL of each quick change (forward,  reverse)  primer  (10  μM),  1  μL 
of dNTP mix (containing 10 mM of each dNTP), 5 μL of Hot-Start Pfu-TURBO™  10x PCR 
reaction buffer and 1 μL of Hot-Start Pfu-TURBO™   DNA polymerase (Stratagene, UK). A 
typical PCR reaction contained 18 cycles of the following three steps: denaturation at 95°C 
for 30 sec, annealing at 55°C for 1 min, and extension at 68°C for 2 min. 
2.2.3.3 Colony Screens of Bacterial Cells 
Taq DNA polymerase (Invitrogen Ltd, Paisley, Scotland, UK) was used to screen bacterial 
and yeast colonies to check for insertion of linear DNA fragments into the genetic material of 
the organism i.e. plasmids or genome. A single colony was suspended in 100 μL of H2O. 1 
μL of this suspension was used in a 10 μL final volume PCR reaction.  
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2.2.3.4 Schizosaccharomyces pombe Integration Strains 
The ura4 cassette was disrupted in order to create strains JY1552 and JY1553. Cells lacking 
ura4 were isolated by growth on AA medium  incorporating  limited  uracil  and  5’  fluoro-orotic 
acid (FOA; purchased from Toronto Research Chemicals Inc., Ontario, Canada). FOA is 
converted  by  Ura4  into  the  toxic  compound  5’  fluoro-uracil (Grimm, Kohli et al. 1988). 
2.2.3.5 Screening Crude Preparations of Yeast Genomic DNA by 
Polymerase Chain Reaction 
2.2.4 Preparation of Yeast Genomic DNA 
Genomic DNA was isolated from Sz. pombe using a previously described method (Hoffman 
and Winston 1987). Cells were grown to mid-log phase and harvested by centrifugation. This 
was followed by a wash step in distilled water, and finally resuspended in 200 μL blue buffer 
(2% Triton X-100, 1% Sodium docecyl sulphate (SDS), 100 mM NaCl, 10 mM Tris-HCl pH 
8.0 and 1 mM ethylenediaminetetraacetic acid (EDTA)). This was followed by the addition of 
200 μL of a 1:1 phenol:chloroform solution and 400 μL acid-washed beads (425-600   μm  
diameter, provided by Sigma-Aldrich Co. Ltd.). The tubes were then vortexed for 3 minutes 
and 200 μL Tris-EDTA (TE) buffer pH 7.5 was immediately added and the tubes centrifuged 
for 5 minutes at 13000 rpm, 4°C. The aqueous phase was transferred to 1 mL ice-cold 
ethanol, mixed by inversion and centrifuged for 2 minutes at 13000 rpm, 4°C. The pellet was 
then washed with 70% ethanol, allowed to air-dry and resuspended in 50 μL TE buffer pH 
7.5. This method typically yields 10-20 ng of genomic DNA. 
2.2.5 Detection  of  Orotidine  5’-decarboxylase Activity  
Orotidine 5'-decarboxylase (Ura4) activity was detected in Sz. pombe using plate-based 
viability assays (Grimm, Kohli et al. 1988). Cells possessing Ura4 activity were selected via 
their ability to grow on AA medium lacking uracil. A counter selection for cells not expressing 
Ura4 was achieved by selecting colonies on AA medium containing uracil and FOA 
(purchased from Toronto Research Chemicals Inc., Ontario, Canada). FOA is converted into 
the toxic compound 5' fluoro-uracil by Ura4, and cells producing Ura4 do not survive (Grimm, 
Kohli et al. 1988). 
2.2.6 Cell Number and Size Analysis 
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Cell density and median cell volume of cultures were determined with a Z2 Coulter Particle 
Count and Size Analyzer, using Isoton II Azide-free electrolyte. These were supplied by 
Beckman Coulter (Luton, Bedfordshire, UK). 
2.2.7 β-galactosidase Assay 
Sz. pombe pheromone dose-response   β-galactosidase assays were performed using an 
adapted method (Dohlman, Apaniesk et al. 1995). Sz. pombe cells were cultured to a 
density of 1x106 cells/mL in AA media lacking thiamine. In the case of Mam2, 500 μL 
samples of culture were transferred to 2mL Safe-Lock Eppendorf tubes containing 0 or 10-9-
10-4 M P-factor pheromone dissolved in HPLC-grade MeOH. For STE2, tubes contained 0 or 
10-9-10-4 M α-factor pheromone dissolved in RO grade H2O. Tubes were incubated on a 
rotating wheel at 29°C for 16h unless otherwise stated. 50 μL from each tube was 
subsequently transferred to 750 μL fresh Z-buffer (made with RO grade H2O) containing 
2.25mM o-nitrophenyl-D-galactoside (ONPG; purchased from Sigma-Aldrich Co. Ltd.) and 
incubated for a further 90 minutes at 29°C on a rotating wheel. ONPG production was 
inhibited by the addition of 200 μL 2M Na2CO3.   β-galactosidase production was then 
calculated as the ratio of ONPG product formed (detected by optical density (OD) 
measurement at 420 nm using an Ultrospec 3000; Pharmacia Biotech, Uppsala, Sweden) 
per number of assayed cells, which was determined using a Coulter Channelyser; (Beckman 
Coulter, Luton, Bedfordshire, UK) using the formula OD420/106 assayed cells. 
Z-buffer: 
0.1M NaPO4 (pH 7.0) 
10mM KCl 
1mM MgSO4 
50mM  β-mercaptoethanol 
0.5% (w/v) chloroform 
0.005% (w/v) SDS 
 
2.2.7.1 Analysis of Dose-response Curves 
The GraphPad Prism suite version 4.0 (San Diego, CA, USA) was used to calculate the non-
linear regression of the dose-response data. The sigmoidal dose response curve (variable 
slope) was calculated   using   the   Hill’s   equation,   defined   in   Equation 1 where Y is the 
measured response as a function of the dose X and the four parameters: Bottom (the value 
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of Y at the minimal curve asymptote), Top (the value of Y at the maximum curve asymptote), 
logEC50 (the log of the half maximal effective concentration) and the Hill slope (denting the 
slope of the curve).  
 
 
Equation 1:  The  Hill’s  equation 
 
2.2.8 Western Blot Analysis 
2.2.8.1 Preparation of Escherichia coli Whole Cell Extracts 
E. coli NT326 expressing TOXCAT chimera from the pccKan plasmids were grown to OD600 
=0.6. Samples were diluted to OD600 =0.1 and a 1 mL sample was centrifuged and 
resuspended in 80 μL SDS loading buffer and analysed by SDS-PAGE. 
2.2.8.2 Preparation of Schizosaccharomyces pombe Whole Cell 
Extracts 
20 mL of yeast culture was incubated at 29°C to mid-log phase in AA. Cells were harvested 
by centrifugation (3000 rpm for 5 min) and washed once with TEN buffer (100 mM Tris pH 
6.8, 10 mM EDTA, 150 mM NaCl). The cells were then resuspended in 50 μL TEN buffer 
containing a dissolved Complete Mini protease inhibitor tablet (Roche Diagnostics Ltd.). 
Cells were homogenized by vortexing together with 425-600   μm   diameter   acid-washed 
beads after which 50 μL TEN buffer and 100  μL  sample buffer (125 mM Tris (pH 6.8), 8% 
glycerol,  5%  SDS,  1%  β-mercaptoethano, 0.02% bromophenol blue) was added.  
2.2.8.3 Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis 
SDS polyacrylamide gels were cast and run using the vertical Bio-Rad Mini Protean II gel 
electrophoresis system (Bio-RAD,   CA,   USA)   according   to   the   manufacturer’s  
recommendations based on a previously described method (Laemmli 1970). 17% separating 
gels were cast (acrylogel 2.6 (40%) solution (BDH)); 375 mM Tris-HCl pH 8.8, 0.1% SDS, 
0.02% APS, 0.06% TEMED), topped with water and left to set for 30 minutes. The 
separating gel was then topped with a stacking gel (5% acrylogel solution, 125 mM Tris-HCl 
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pH 6.8, 0.1% SDS, 0.6% APS, 0.06% TEMED). Samples were prepared by mixing with SDS 
sample loading buffer (125 mM Tris-HCl pH 6.8, 20% glycerol, 4% SDS, 0.02% 
bromophenol blue, 5% β-mercaptoethanol) and boiled for 10 minutes. Gels were run in a 
running buffer (25 mM tris; 250 mM glycine; 0.1% SDS) until the dye front migrated off the 
gel, typically around 3 h at 35 mA.  
2.2.8.4 Transfer of Protein to Polyvinylidene Fluoride Membrane 
Proteins were transferred from the acrylamide gels to polyvinylidene fluoride (PVDF) 
membrane (Amersham Biosciences, UK) using a semi-dry Western blotting system (Sigma 
Aldrich, UK) with Towbin transfer buffer (Towbin, Staehelin et al. 1979). The PVDF 
membrane was prepared by soaking in methanol and then in Towbin transfer buffer. 
Transfer was carried out by applying a constant current of 200 mA for 1.5 h. 
2.2.8.5 Detection of Maltose Binding Protein  
Following protein transfer, membranes were blocked in TTBS (30 mM Tris-HCl, 140 mM 
NaCl, 3 mM KCl, 0.1% Tween-20, pH 7.4) containing 3% milk for 1 h (or overnight at 4°C). 
This was followed by three 5 min wash-steps with TTBS. Membranes were then incubated 
for 1 h with the primary antibody anti-MBP (Sigma-Aldrich, UK), diluted 1/4000 with TTBS 
containing 3% milk. The wash step was then repeated. The secondary antibody, anti-mouse 
IgG (Sigma-Aldrich, UK), was used in a 1/10000 dilution with TTBS + 3% milk and incubated 
for 1 h, followed by washing. Finally, to detect MBP and its fusion proteins, one tablet from 
the   SigmaFast™   BCIP/NBT   kit   (Sigma-Aldrich, UK) was dissolved in ionized water. 
Membranes were incubated with the solution for 10 min, and upon visualization of bands, the 
membrane was scanned. 
2.2.8.6 Detection of Renilla Luciferase  
Following protein transfer, membranes were blocked in PBS (140 mM NaCl, 2.7 mM KCl, 
10.1 mM Na2HPO4, 1.8 mM KH2PO4, pH 7.2) containing 10% skimmed milk for 1 h (or 
overnight at 4°C). Membranes were then incubated for 1h with the primary antibody anti-
Rluc (Caltag-MedSystems Ltd., UK), diluted 1/1000 with PBS containing 1% milk, for 1h. 
This was followed by three 5 min washes with PBS-T (0.05% Tween-20 in PBS). The 
secondary antibody, anti-rabbit IgG (Caltag-MedSystems Ltd., UK), was used in a 1/10000 
dilution with PBS containing 1% skimmed milk and incubated for 1h, The wash step was 
then repeated. Finally, an enhanced chemiluminescence (ECL) western blotting substrate 
(Syngene, UK) was used to detect Rluc.  
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2.2.8.7 Coomassie Staining 
Following electrophoresis, the gel was placed in InstantBlue (Expedeon, Harston, 
Cambridgeshire, UK) and allowed to develop until the protein bands were visible. Gels were 
visualised and images were taken using a G:Box iChemi gel documentation system with 
GeneTools analysis software (Syngene, Cambridge, UK). 
2.2.9 TOXCAT Assays 
2.2.9.1 The malE Complementation Assay 
E. coli NT326 cells were transformed with pccKan plasmids encoding the TOXCAT 
chimeras. Cells were grown to mid-log phase at 37°C and streaked onto plates containing 
Maltose Minimal Media (M9 salts (48 mM Na2HPO4, 22 mM KH2PO4, 8.6 mM NaCl, 18.7 mM 
NH4Cl), 2 mM MgSO4,  100  μM  CaCl2; 0.4% maltose; 15% (w/v) agar) and incubated at 37ºC 
for 3 days. Cells able to express the chimera and transport and insert it into the inner 
membrane in the correct orientation are able to grow on maltose as a sole carbon source.   
2.2.9.2 The Quantitative Chloramphenicol Acetyl-Transferase Assay 
E. coli NT326 expressing TOXCAT chimera from the pccKan plasmids were grown to OD600 
= 0.6. 200 μL aliquots were pelleted and resuspended in 500 μL 100 mM Tris-HCl pH 8.0. 
Cells were lysed by adding 20 μL lysis buffer (100 mM EDTA, 100 mM DTT, 50 mM Tris-HCl 
pH 8.0) and a drop of toluene and were then incubated at 30ºC for 30 min. The lysed cells 
were then diluted 10-fold and a 60 μL sample was taken. The levels of CAT expression were 
assayed using the FAST CAT® Green (deoxy) Chloramphenicol Acetyltransferase assay kit 
(Invitrogen Ltd, Paisley, Scotland, UK)   according   to   the   manufacturer’s   instructions.   The  
fluorescence of the samples was determined using a Perkin Elmer LS50B fluorimeter. 
Samples were excited at 495 nm and emission at 525 nm was recorded. The fluorescence 
was normalised using to the positive control GpA. 
2.2.10 Fluorescence Microscopy 
Strains were cultured in the appropriate medium to a density of 1x106 cells/mL.  1 mL of 
culture was harvested via centrifugation at 2,000 rpm for 3 min and the cells washed twice in 
fresh growth medium.  Cells were resuspended in 20 μL of H2O.  2μL of cell suspension was 
transferred to poly-lysine-coated slides (Sigma-Aldrich Co. Ltd., Poole, Dorset, UK) and 
viewed using a Personal DeltaVision (Applied Precision, Inc).  
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2.2.10.1 Image Analysis 
The software suite ImageJ (Abramoff, Magalhaes et al. 2004) was used to analyse 
fluorescent images of individual cells. Cell segmentation was achieved using the BOA plugin 
for ImageJ which is part of the QuimP (Quantitative Imaging of Membrane Proteins) package 
(Dormann, Libotte et al. 2002; Zimmer, Zhang et al. 2006) modified by R. Tyson and W. 
Croft. Using the software, the cortex boundary was manually modified to calculate pixel 
intensity at the membrane and the interior of the membrane.  
2.2.11 Luminescence Assays Using Multi-well Microplate Reader 
2.2.11.1 Liquid Assays 
Cultures of Sz. pombe cells were grown to mid-log phase (cell density specified for each 
experiment) at 29°C and 135  μl  samples  were  treated  with  concentrations  of  pheromone  and  
for  lengths  of  time  as  specified  for  each  experiment.  60  μM  EnduRen  (Promega Corporation, 
Southampton, UK) was added 2 h prior to assaying unless otherwise stated. Prior to 
measurements, cells were transferred to a 96-well microplate (Berthold Technologies, UK). 
Plates were then installed into a Berthold Mithras LB940 BRET multimode microplate reader 
(Berthold Technologies (UK) Ltd, Harpenden, Hertfordshire, UK) preheated to 30°C. Using 
the accompanying MicroWin 2000 software, measurement times of 1 s were taken at 
intervals as specified for each experiment. Baseline measurements were taken for wells 
containing cell samples but no EnduRen. The baseline luminescence was subtracted from 
luminescence measurements and where appropriate, the corrected luminescence reading 
was divided by the amount of cells in the sample.  
2.2.11.2 Agarose-plug Assays 
24-well black clear-bottom microplates were prepared by adding 1.5% agarose dissolved by 
heating and mixing in AA media. The agar media was cooled to 50°C and pheromone was 
added at the specified concentration unless otherwise stated. 2.5 mL media was added to 
each well in the microplate and allowed to set in an aseptic flow cabinet. Cells were added 
and spread evenly onto each plugs at the concentrations and amounts specified for each 
experiment. Cells  were  cultured  to  densities  as  specified  in  each  experiment  at  29°C.  60  μM  
EnduRen was added to the specified amount of culture and spread evenly onto each agar 
plug. The baseline was determined using cultures not treated with EnduRen spread onto an 
agar well and this number was subtracted from the sample luminescence measurement. 
Plates were then installed into the measurement chamber of the Berthold Mithras LB940 
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BRET multimode microplate reader (Berthold Technologies (UK) Ltd, Harpenden, 
Hertfordshire, UK) preheated to 30°C. Using the accompanying MicroWin 2000 software, 
measurement times of 1s were taken at intervals as specified for each experiment 
2.2.12 Flow Cytometry 
The Invitrogen Live/Dead® FungaLight Yeast Viability Kit (Invitrogen Ltd, Paisley, Scotland, 
UK) was used to analyse cell viability. Sz. pombe was cultured to a density of 1x106 cells per 
mL in AA media. 1 mL of culture was then incubated with 0, 10-7 M or 10-4 M P-factor for 16 h 
on a rotating wheel. Cultures were washed once with 1 mL PBS (140 mM NaCl, 2.7 mM KCl, 
10.1 mM Na2HPO4, 1.8 mM KH2PO4, pH 7.2) and then resuspended in 1 mL PBS. This was 
followed  by   the  addition  of  0.5  μL 20 mM propidium iodide in DMSO  and  0.5  μL  3.34 mM 
SYTO9® in DMSO. The dye propidium iodide only labels cells with damaged membranes, 
whereas SYTO9® stains all cells. Viable cells are only stained with SYTO9® and fluoresce 
green whereas FRET between the two dyes present in dead cells results in red 
fluorescence. Flow cytometry was performed using an LSR II flow cytometer (BD 
Biosciences, Oxford, UK). Excitation of both dyes was achieved using a 488 nm blue laser, 
and emission was detected using a 550 nm long pass filter with a 575/26 nm band pass filter 
for propidium iodide and a 505 nm long pass filter with a 530/30 nm band pass filter for 
SYTO® 9. 
2.2.13 Computational Methods 
2.2.13.1 Transmembrane Helix Predictions 
Transmembrane domains were predicted using the freely available online software TMHMM  
(Krogh, Larsson et al. 2001) accessible at http://www.cbs.dtu.dk/services/TMHMM/.  
2.2.13.2 CHI Modelling 
The software suite crystallography and nuclear magnetic resonance searching of helix 
interactions (CHI) was used to compute oligomeric GPCR TM domain structures (Adams, 
Arkin et al. 1995; Adams, Engelman et al. 1996; Brunger, Adams et al. 1998). The 
calculations were performed using an 8 node dual 2.66 GHz Xenon processor Linux cluster 
(Streamline Computing, Warwick). CHI uses an implicit membrane solvent with a dielectric 
constant of 1. The starting geometries of  each  monomer  were  calculated  as  a  canonical  α-
helix with 3.6 residues per turn. The dimers incorporated both right-handed (-25°) and left-
handed (25°) crossing angles and an axis-to-axis distance between the helices of 10.4 Å. 
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Full searches were performed and helices were simultaneously rotated about their central 
axis with a sampling step size of 45°, from 0°-360°. For each oligomer, four trials were 
carried out for each rotation and crossing angle conformation using simulated annealing of 
all atomic coordinates during which rotation- and crossing angles were free to vary. Energy 
minimization of structures was carried out both before and after MD simulations. Groups of 
structures  with  a  backbone  RMSD  of  ≤1  Å were placed in clusters of 10 or more members, 
followed by a calculation of an average structure.   
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3 CREATION OF DNA CONSTRUCTS  
3.1 Generation of TOXCAT Constructs 
To investigate the propensity of individual TM helices from STE2 and Mam2 to form homo-
oligomers various lengths and frames of the transmembrane domains were cloned into the 
pccKan expression vector. The pccKan expression vector contains the ORF for MBP and 
ToxR that flank the transmembrane domain cloned into the plasmid upon expression of the 
construct. The pccKan vector (see Figure 3-1) incorporates the constitutively expressed 
ToxR promoter immediately upstream of the toxR ORF, and a BamHI site at the end of toxR. 
This is followed by the kanamycin resistance marker (aminoglycoside   3’-
phosphotransferase) and malE, encoding MBP. The malE region contains a NheI site near 
the N-terminal end. The pccKan vector also contains an ampicillin marker (encoding Beta 
Lactamase) allowing selection for expression of this plasmid on media containing Amp, and 
cat (encoding chloramphenicol acetyl transferase) to confer resistance to chloramphenicol if 
toxR is expressed, correctly transported to the membrane and in an oligomerized state. 
In order to express individual TM domains from Mam2 and STE2 the pccKan vector was 
digested with BamHI and NheI allowing the kanamycin resistance gene to drop out and thus 
yield the linearised pcc plasmid. One forward and one reverse oligonucleotide encoding the 
TM domain of interest and incorporating the same restriction sites were phosphorylated and 
hybridised. The primer dimer and the linear pcc plasmid were then ligated to yield a 
circularized plasmid containing the genetic TOXCAT chimera (as illustrated in Figure 3-1). 
Plasmids were sequenced for verification. The primers cloned into the pccKan plasmid are 
listed in Table 3-1 for STE2 constructs and Table 3-2 for Mam2 constructs. 
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Figure 3-1: Insertion of oligonucleotide sequences corresponding to GPCR TM domains into 
the pccKan expression vector 
The restriction enzymes NheI and BamHI were used to digest the pccKan vector, resulting in a 1736 
bp dropout of the kanamycin resistance gene. A forward and reverse oligonucleotide, corresponding 
to a transmembrane domain were phosphorylated and hybridized. The resulting pcc vector was 
ligated together with the oligonucleotide dimer to yield a vector expressing a ToxR-TM-MBP chimera. 
The vector also contains the ampicillin resistance gene bla as well as the ctx promoter, which when 
bound to a ToxR dimer leads to the expression of chloramphenicol acetyl transferase. 
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TM 
 
Name 
 
Expression 
Frame 
 
Forward Oligonucleotide 
Reverse Oligonucleotide 
 
1 1S13 A52-L64 ctagcGCTATTATGTTCGGTGTTCGTTGTGGTGCTGCTGCTTTAgg gatcccTAAAGCAGCAGCACCACAACGAACACCGAACATAATAGCg 
1 1S16 T50-T65 ctagcACTCAAGCTATTATGTTCGGTGTTCGTTGTGGTGCTGCTGCTTTAACTgg gatcccAGTTAAAGCAGCAGCACCACAACGAACACCGAACATAATAGCTTGAGTg 
1 1S16A V49-L64 ctagcGTTACTCAAGCTATTATGTTCGGTGTTCGTTGTGGTGCTGCTGCTTTAgg gatcccTAAAGCAGCAGCACCACAACGAACACCGAACATAATAGCTTGAGTAACg 
1 1S18 I53-W70 ctagcATCATGTTCGGAGTACGCTGCGGAGCAGCAGCATTAACATTAATCGTAATGTGGgg gatcccCCACATTACGATTAATGTTAATGCTGCTGCTCCGCAGCGTACTCCGAACATGATg 
1 1S19 V49-I67 ctagcGTTACTCAGGCCATTATGTTTGGTGTCCGCTGTGGTGCAGCTGCTTTGACTTTGATTgg gatcccAATCAAAGTCAAAGCAGCTGCACCACAGCGGACACCAAACATAATGGCCTGAGTAACg 
1 1S20 Q51-W70 ctagcCAGGCCATTATGTTTGGTGTCCGCTGTGGTGCAGCTGCTTTGACTTTGATTGTAATGTGGgg gatcccCCACATTACAATCAAAGTCAAAGCAGCTGCACCACAGCGGACACCAAACATAATGGCCTGg 
1 1S25 T50-R74 ctagcATGACATCGCGGACTCAAGCTATTATGTTCGGTGTTCGTTGTGGTGCTGCTGCTTTAACTTTAATCGTAATGTGGgg gatcccCCACATTACGATTAAAGTTAAAGCAGCAGCACCACAACGAACACCGAACATAATAGCTTGAGTCCGCGATGTCATg 
2 2S18 F81-Yl97 ctagcTTCATCATCAACCAAGTATCATTATTCTTAATCATCTTACACTCAGCATTATACgg gatcccGTATAATGCTGAGTGTAAGATGATTAAGAATAATGATACTTGGTTGATGATGAAg 
3 3S22 I133-F154 ctagcATCATCCAAGTATTATTAGTAGCATCAATCGAAACATCATTAGTATTCCAAATCAAAGTAATCTTCgg gatcccGAAGATTACTTTGATTTGGAATACTAATGATGTTTCGATTGATGCTACTAATAATACTTGGATGATg 
4 4S20 G163-I82 ctagcGGATTAATGTTAACATCAATCTCATTCACATTAGGAATCGCAACAGTAACAATGTACTTCGG gatcccGAAGTACATTGTTACTGTTGCGATTCCTAATGTGAATGAGATTGATGTTAACATTAATCCg 
5 5S23 T208-I230 ctagcACAATCTTATTAGCATCATCAATCAACTTCATGTCATTCGTATTAGTAGTAAAATTAATCTTAGCAATCgg gatcccGATTGCTAAGATTAATTTTACTACTAATACGAATGACATGAAGTTGATTGATGATGCTAATAAGATTGTg 
6 6S19 F244-F262 ctagcTTCCACATTTTATTAATTATGTCATGTCAATCATTATTAGTTCCTTCAATTATTTTCgg gatcccGAAAATAATTGAAGGAACTAATAATGATTGACATGACATAATTAATAAAATGTGGAAg 
6 6S23 F244-Y266 ctagcTTCCACATCTTATTAATCATGTCATGCCAATCATTATTAGTACCATCAATCATCTTCATCTTAGCATACgg gatcccGTATGCTAAGATGAAGATGATTGATGGTACTAATAATGATTGGCATGACATGATTAATAAGATGTGGAAg 
7 
 
7S21 
 
V276-A296 
 
ctagcGTATTAACAACAGTAGCAACATTATTAGCAGTATTATCATTACCATTATCATCAATGTGGGCAgg 
gatcccTGCCCACATTGATGATAATGGTAATGATAATACTGCTAATAATGTTGCTACTGTTGTTAATACg 
 
Table 3-1: List of STE2 wild-type single TM domain TOXCAT constructs 
The forward (sense) and reverse (antisense) oligonucleotides are detailed for insertion into the TOXCAT toxR-TM-MBP constructs of STE2 wild-type TM 
domains. The hybridised oligonucleotides were cloned into a BamHI/NheI site and the overhang bases are denoted in lower-case letters. Constructs were 
named XYZ such that X refers to the number of the TM domain in question, Y refers to the protein from which the TM insert is based on: S for STE2 and M for 
Mam2, and Z refers to the length of the TM construct. I.e. 1S13 is a 13 amino acid long insert from the first TM domain of STE2. 
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TM 
 
Name 
 
Expression 
Frame 
 
Forward Oligonucleotide 
Reverse Oligonucleotide 
 
1 1M13 G49-L61 ctagcGGTATGACTTTATCAGCTCAATTAGCTTTAGGTGTTTTAgg gatcccTAAAACACCTAAAGCTAATTGAGCTGATAAAGTCATACCg 
1 1M13A R45-A57 ctagcCGGTTATTAACTGGTATGACTTTATCAGCTCAATTAGCTgg gatcccAGCTAATTGAGCTGATAAAGTCATACCAGTTAATAACCGg 
1 1M16 L46-L61 ctagcTTATTAACTGGTATGACTTTATCAGCTCAATTAGCTTTAGGTGTTTTAgg gatcccTAAAACACCTAAAGCTAATTGAGCTGATAAAGTCATACCAGTTAATAAg 
1 1M18 L46-I63 ctagcTTATTAACTGGTATGACTTTATCAGCTCAATTAGCTTTAGGTGTTTTAACTATTgg gatcccAATAGTTAAAACACCTAAAGCTAATTGAGCTGATAAAGTCATACCAGTTAATAAg 
1 1M20 L46-M65 ctagcTTATTAACTGGTATGACTTTATCAGCTCAATTAGCTTTAGGTGTTTTAACTATTCTGATGgg gatcccAATAGTTAAAACACCTAAAGCTAATTGAGCTGATAAAGTCATACCAGTTAATAACATCAGg 
1 1M25 R45-L69 ctagcCGGTTATTAACTGGTATGACTTTATCAGCTCAATTAGCTTTAGGTGTTTTAACTATTCTGATGGTGTGCGACGACgg gatcccGTCGTCGCACACAATAGTTAAAACACCTAAAGCTAATTGAGCTGATAAAGTCATACCAGTTAATAACATCAGCCGg 
2 2M23 V79-I101 ctagcGTTTTCGTTTTCAATTCAGCTTCAATTGTTGCTATGTGTTTACGTGCTATTTTAAATATTGTTACTATTgg gatcccAATAGTAACAATATTTAAAATAGCACGTAAACACATAGCAACAATTGAAGCTGAATTGAAAACGAAAACg 
3 3M20 Y122-A141 ctagcTATGTTCACGTTTTCAATATTTTAATTTTATTATTAGCTCCTGTTATTATTTTCACTGCTgg gatcccAGCAGTGAAAATAATAACAGGAGCTAATAATAAAATTAAAATATTGAAAACGTGAACATAg 
4 4M17 I162-W178 ctagcATTATGACTGTTATTTCAGCTTGTTTAACTGTTTTAGTTTTAGCTTTCTGGgg gatcccCCAGAAAGCTAAAACTAAAACAGTTAAACAAGCTGAAATAACAGTCATAATg 
5 5M19 Y207-F225 ctagcTATTTCATTGCTAAAATTTTATTCGCTTTCTCAATTATTTTCCACTCAGGTTCATATgg gatcccATATGAACCTGAGTGGAAAATAATTGAGAAAGCGAATAAAATTTTAGCAATGAAATAg 
6 6M19 C249-I267 ctagcTGTATTTTAGTTATTTCATGTCAATGTTTAATTGTTCCTGCTACTTTCACTATTATTgg gatcccAATAATAGTGAAAGTAGCAGGAACAATTAAACATTGACATGAAATAACTAAAATACAg 
7 
 
7M19 
 
F277-W295 
 
ctagcTTCTCATCAATGACTCAATGTTTATTAATTATTTCATTACCTTTATCATCATTATGGgg 
gatcccCCATAATGATGATAAAGGTAATGAAATAATTAATAAACATTGAGTCATTGATGAGAAg 
 
Table 3-2: List of Mam2 wild-type single TM domain TOXCAT constructs 
The forward (sense) and reverse (antisense) oligonucleotides are detailed for insertion into the TOXCAT toxR-TM-MBP constructs of Mam2 wild-type TM 
domains. The hybridized oligonucleotides were cloned into a BamHI/NheI site and the overhang bases are denoted in lower-case letters. Constructs were 
named XYZ such that X refers to the number of the TM domain in question, Y refers to the protein from which the TM insert is based on: S for STE2 and M for 
Mam2, and Z refers to the length of the TM construct. I.e. 1S13 is a 13 amino acid long insert from the first TM domain of STE2. 
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3.2 Creation  of  Constructs  Used  in  the  β-galactosidase Assay  
Four vectors are used in this thesis for the expression of receptors in Sz. pombe. pKS is the 
vector pBluescript KS(-) that has been digested with PvuII and ligated with a PCR product 
containing the multi-cloning site (MCS) of a modified pREP3x vector. The modified pREP3x 
vector incorporates an EcoRV site in the MCS and will be referred to as pREP3x throughout 
this thesis. The pREP4x vector is similar to pREP3x but contain an ura4 marker in place of 
the LEU2 marker on pREP3x. The pKS vector in contrast is smaller than both pREP3x and 
pREP4x, and is therefore more amenable to ORF manipulations was therefore used 
throughout this study as the templates for creation of Mam2 and STE2 variants.  
3.2.1 Creation of pREP3x-Receptor Point Mutants Using Outward 
PCR 
Outward PCR was utilized in order to create the Mam2 point mutants incorporating the A57G 
and A57L mutations that  were  investigated  using  the  β-galactosidase assay. JD3218 (pKS-
Mam2) was used as a template for outward PCR together pairs of forward and reverse 
primers; JO2602 (GAATGACTTTGTCTGCCCAACTTGGTTTAGGAGTCCTTAC) and 
JO2606 (CAGTTAAAAGTCTATCTCTTTCATATGCAT) for the A57G mutation and JO2600 
(GAATGACTTTGTCTGCCCAACTTCTTTTAGGAGTCCTTACC) and JO2606 
(CAGTTAAAAGTCTATCTCTTTCATATGCAT) for the A57L mutation.  The forward primers 
contained the desired mutations. The PCR product was then digested with Dpn1, 
phosphorylated and ligated. After confirmation of incorporation of mutation in the receptor by 
sequencing, receptors were excised from the pKS vector using a double XhoI and BamHI 
digest. Similarly, pREP3x vector was digested with XhoI and BamHI and the two cut 
products were ligated to yield a pREP3x-Receptor fusions with the A57G or A57L mutation 
in the Mam2 receptor. See Figure 3-2 for a schematic.  
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Figure 3-2: Generation of point mutations in the Mam2 receptor 
Outward PCR was utilized in order to create the point mutations A57G and A57L in the Mam2 
receptor in the pKS vector (JD3218) using forward primers JOJO2602 
(GAATGACTTTGTCTGCCCAACTTGGTTTAGGAGTCCTTAC) and JO2606 
(CAGTTAAAAGTCTATCTCTTTCATATGCAT) for the A57G mutation and JO2600 
(GAATGACTTTGTCTGCCCAACTTCTTTTAGGAGTCCTTACC) and JO2606 
(CAGTTAAAAGTCTATCTCTTTCATATGCAT) for the A57L mutation. The resulting PCR products 
were self-ligated prior to digestion with XhoI and BamHI, and the digests were subsequently ligated 
together with XhoI and BamHI digested pREP3x.  
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3.2.2 Creation of pREP-3x-Receptor-GFP Constructs 
To label mutated Mam2 receptors with GFP, the pREP3x construct containing the desired 
receptor (JD3591 for the Mam2 A57G mutation and JD3592 for the Mam2 A57L mutation) 
was digested with EcoRV and BamHI. This resulted in a 900 bp dropout fragment due to an 
internal EcoRV site in the receptor. JD2232 containing pKS-Mam2-GFP was also digested 
with EcoRV and BamHI and the dropout fragment from this construct (containing C-terminal 
receptor and GFP) was ligated together with pREP3x containing the N-terminal part of the 
receptor with the desired mutation, to generate pREP3x-Receptor-GFP fusions. See Figure 
3-3 for a schematic. 
 Page 68 
 
 
Figure 3-3: GFP-tagging of mutated pREP3x-Mam2 constructs 
JD3591 and JD3592 containing the A57G and A57L mutations in Mam2 respectively were digested 
with EcoRV and BamHI to drop out the region of the receptors downstream of the mutations. 
Likewise, JD2232 was digested with EcoRV and BamHI to drop out the corresponding downstream 
region of wild-type Mam2 fused to GFP. These fragments were then ligated to yield pREP3x 
constructs containing mutated receptors fused to GFP.  
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3.3 Creation of Bioluminescence Resonance Energy Transfer 
Constructs 
3.3.1 Generation of pKS-Rluc and pKS-Rluc8 
To label receptors with Rluc for BRET assays, Rluc was first cloned into the pKS vector. 
Template Rluc was amplified from the pRL-SV40 vector (Promega Corporation, 
Southampton, UK) containing Rluc using sense primer JO2627 
(aaatctagaacgtcagctgATGACTTCGAAAGTTTATGATCCAG) and antisense primer JO2628 
(aaaaagatctggatccttagatgatatcTTGTTCATTTTTGAGAACTCGCTC). The sense primer 
contains a full XbaI site and PvuII site and the antisense primer contains a full EcoRV, 
BamHI and BglII site. The XbaI and BglII sites were used to ligate the Rluc ORF into the pKS 
vector digested with XbaI and BamHI (illustrated in Figure 3-4). The resulting construct was 
called JD3454.  
The same strategy was used to create a pKS-Rluc8 construct. Rluc8 is a modified version of 
Rluc. This construct was created using forward primer JO2689 
(aaatctagaacgtcagctgATGGCTTCCAAGGTGTACGACCCC) and reverse primer JO2690 
(aaaaagatctggatccttagatgatatcGTCGACCTGCTCGTTCTTCAGCAC). The resulting 
construct was called JD3513. 
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Figure 3-4: Creation of pKS-Rluc 
The Rluc ORF was amplified with the sense oligonucleotide JO2627 and antisense oligonucleotide 
JO2628 using template JD3648. This yielded a fragment flanked by an XbaI site and a BglII site which 
were used for ligation into the pKS vector digested with BamHI and XbaI. The resulting pKS-Rluc 
plasmid contains a PvuII site for N-terminal tagging, and an EcoRV site for C-terminal tagging.  
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3.3.2 Generation of Receptor-Rluc Fusions 
Fusions of receptors with Rluc to be used as donors in BRET assays were made by cloning 
receptors into the pKS-Rluc construct and subsequent incorporation into the pREP3x vector. 
Receptor ORFs were amplified from pKS vectors without their stop codons (see Table 3-3 
for oligonucleotide sequences). The resulting PCR products were ligated into EcoRV 
digested JD3454 (pKS-Rluc) where the EcoRV site immediately precedes Rluc. This 
generated pKS-receptor-Rluc fusions.   
These fusions were then cloned into the pREP3x vector. The pKS-Receptor-Rluc construct 
was first digested with PvuI, which cuts in the AmpR region. This was followed by a 
XhoI/BamHI digest which generated two small and one large fragment, the large fragment 
corresponding to Receptor-Rluc. The isolated Receptor-Rluc fragment was then ligated into 
XhoI/BamHI digested pREP3x vector (JD3387) to generate pREP3x-Receptor-Rluc 
constructs (Figure 3-5). A pREP3x-Rluc construct was also created using the same method 
but without incorporating a receptor.  
 
  Forward primer Reverse primer   
Receptor JO # Oligonucleotide sequence JO # Oligonucleotide sequence Construct 
Mam2  
JD1627 1508 ATGAGACAACCATGGTGG 1509 CGTCCACTTTTTAGTTTCAG JD3562 
STE2  
JD2343 1372 ATGTCTGATGCGGCTCCTTC 2108 TAAATTATTATTATCTTCAGTCCAGAAC JD3511 
Mam2G49A  
JD2753 1508 ATGAGACAACCATGGTGG 1509 CGTCCACTTTTTAGTTTCAG JD3602 
Mam2G49A,S53A  
JD2757 1508 ATGAGACAACCATGGTGG 1509 CGTCCACTTTTTAGTTTCAG JD3603 
Mam2G49L,S53L  
JD2781 1508 ATGAGACAACCATGGTGG 1509 CGTCCACTTTTTAGTTTCAG JD3604 
      Table 3-3 Sequence of oligonucleotides to create Receptor-Rluc fusions 
 
3.3.3 Generation of pREP4x Receptor-GFP Fusions 
Fusions of receptors with GFP to be used as acceptors in BRET assays were made by 
subcloning XhoI/MluI fragments from the pREP3x-Receptor-GFP constructs and 
incorporating them into XhoI/MluI cut pREP4x vector.  
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Figure 3-5: Generation of Receptor-Rluc fusion constructs 
Receptor ORFs were amplified without the stop codon. The resulting PCR product was ligated into 
EcoRV digested JD3454 (pKS-Rluc) to generate Receptor-Rluc fusions. This was digested with Pvu1 
and then XhoI and BamHI with the coding region ligated into XhoI and BamHI digested pREP3x to 
generate pREP3x-Receptor-Rluc fusions.  
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3.4 Creation of Constructs to Integrate Rluc and Rluc8 into the 
Schizosaccharomyces pombe genome 
Two Sz. pombe strains were created that incorporated the bioluminescent reporters Rluc or 
Rluc8 into the genome at the sxa2 locus. In order to integrate Rluc and Rluc8 into the Sz. 
pombe genome, Rluc and Rluc8 were amplified by PCR from plasmids JD3648 and JD3650 
using forward primer JO2681 (ggggatccATGACTTCGAAAGTTTATGATCCAG) and reverse 
primer JO2628 (aaaaagatctggatccttagatgatatcTTGTTCATTTTTGAGAACTCGCTC) for Rluc 
and forward primer JO2691 (ggggatccATGGCTTCCAAGGTGTACGACCCC) and reverse 
primer JO2690 (aaaaagatctggatccttagatgatatcGTCGACCTGCTCGTTCTTCAGCAC) for 
Rluc8. The PCR products were cut with BamHI and cloned into the pSP72 vector JD854 
(created by Dr. Alan Goddard, University of Warwick) cut with BglII. In JD854 the 5' and 3' 
untranslated regions (UTRs) of Sxa2 flank the BglII site meaning that inserts are part of an 
insertion cassette that can be integrated into the genome (see Figure 3-6). This generated 
the constructs pSP72-sxa2UTR-Rluc-sxa2UTR (named JD3649) and pSP72-sxa2UTR-
Rluc8-sxa2UTR (named JD3647). 
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Figure 3-6: Creation of the Rluc-Sxa2 and Rluc8-Sxa2 insertion cassettes 
The JD854 construct created by Dr. Alan Goddard (University of Warwick) was used to introduce the 
Rluc and Rluc8 ORFs into the Sxa2 locus of yeast strain JY522. The Rluc and Rluc8 ORFs were 
digested with BamHI and ligated into BglII cut JD854 (pSP72-sxa2 UTRs, created by Dr. Alan 
Goddard, University of Warwick) to create JD3649 and JD3647. A SpeI/BamHI digest can be 
performed to excise the Rluc or Rluc8 ORFs flanked by the 5' and 3' UTRs of sxa2.  
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4 EFFECT OF MUTATIONS ON THE FIRST 
TRANSMEMBRANE DOMAIN OF STE2 AND MAM2 
4.1 Background 
The existence of GPCR oligomers is now widely accepted within the research community 
(Milligan, Ramsay et al. 2003; Park, Filipek et al. 2004; Ferré, Baler et al. 2009). GPCR 
oligomerization may affect biological processes as diverse as receptor trafficking to the 
membrane (White, Wise et al. 1998), receptor internalization (Rocheville, Lange et al. 2000) 
or receptor pharmacology (Jordan and Devi 1999; Waldhoer, Fong et al. 2005; Ciruela, 
Gomez-Soler et al. 2011). The pharmacological implications of GPCR oligomerization makes 
it an important research area since a better understanding of the phenomenon may lead to 
the development of more specific therapeutics.  
The Sz. pombe GPCR Mam2 has previously been shown to form dimers as well as higher 
order oligomers, and these oligomers appear to be of functional importance as receptors can 
activate each other in trans (Ladds, Davis et al. 2005). The Sc. cerevisiae STE2 pheromone 
receptor has also been shown to oligomerize, and receptor-receptor interactions seem to 
form between the first transmembrane domains (Overton and Blumer 2000; Overton and 
Blumer 2002; Overton, Chinault et al. 2003; Gehret, Bajaj et al. 2006). The first 
transmembrane domain of STE2 contain a GxxxG motif, common to many membrane 
proteins that oligomerize, and disruption of this motif cause a loss of STE2 oligomerization 
as well as altered signalling dynamics (Overton, Chinault et al. 2003). Altered signalling 
dynamics in oligomerization defective GPCR mutants is common to many GPCRs (Jordan 
and Devi 1999; Jordan, Trapaidze et al. 2001; Overton, Chinault et al. 2003; Ciruela, 
Gomez-Soler et al. 2011).  
The Mam2 receptor also contains a motif of two small residues in its first transmembrane 
domain, however the functional importance of this motif is not known. The work described in 
this chapter sought to characterize mutations in the smallxxxsmall motif in the Mam2 
receptor, and compare this to the effects of mutations in the GxxxG motif in the first 
transmembrane domain of STE2, expressed in Sz. pombe. This was achieved by quantifying 
the pheromone-signalling response by means of a reporter gene, and through a novel 
quantitative analysis of the cellular localization of receptors. The significance of the 
transmembrane motif was contrasted between the two receptors.   
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4.2 Effect of Expressing Fluorescently Tagged Receptors from 
Vectors 
4.2.1 Expression of Mam2 from the pREP3x Vector  
The GPCRs investigated in this chapter were expressed from the pREP3x vector under the 
control of the repressible nmt1 (no message in thiamine) promoter (Maundrell 1993). The 
pREP3x vector contains the selectable marker LEU2 from Sc. cerevisiae. Plasmids 
expressed in the JY544 strain (sxa2>lacZ) or JY1169 (sxa2>lacZ, Mam2-) can therefore be 
maintained through the exclusion of substrates from media because these strains have a 
nutritional requirement for leucine in the absence of LEU2 (see section 2.1.7 for full 
genotype). The large size of the Sz. pombe centromeres prevent their incorporation into 
shuttle vectors and consequently a 1:1 plasmid to cell copy number cannot be maintained. It 
was therefore of interest to see whether strain JY1169 expressing Mam2 from the pREP3x 
plasmid displayed altered pheromone-response signalling dynamics to the strain JY544 
expressing Mam2 under its endogenous promoter.  
The strains JY544, transformed with pREP3x, and JY1169, transformed with pREP3x-
Mam2, were grown to a density of 5x106 cells in AA media. Cells were incubated with 0-10-4 
M P-factor pheromone and incubated on a rotating wheel for 16 h. Figure 4-1A shows the 
transcriptional pheromone-response and Figure 4-1B shows the morphological pheromone-
response of cells. Figure 4-1C shows the change in cell volume calculated as the increase 
above the median cell volume of unstimulated cells. The pEC50 values (the negative 
logarithm of the EC50 value which represents the concentration of pheromone at which 50% 
of the cells in the population have responded) are shown in Figure 4-3D together with the 
maximal value (Top) calculated using the Hill equation defined in section 2.2.7.1.   
The dose-response curve generated by JY1169 transformed with pREP3x-Mam2 resembled 
that of JY544 transformed with pREP3x. The maximum of the dose-response curve was 
slightly elevated for the JY1169 strain, however this difference was not statistically significant 
as calculated by an unpaired two-tailed t-test (p>0.05). This suggests that the Mam2 
receptor can be expressed heterologously with minimal effect on the pheromone-response. 
Interestingly the response appeared to decrease towards the higher concentrations of 
pheromone (>10-6 M), which may reflect down-regulation of the pheromone-response.   
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Figure 4-1: Comparison of 
endogenous and 
heterologous Mam2 activity 
The strain JY544 (sxa2>lacZ) 
was transformed with pREP3x 
and JY1169 (sxa2>lacZ, 
mam2-) was transformed with 
pREP3x-Mam2. Cells were 
cultured in AA media to a 
density of 5x106 cells/mL and 
incubated with 0 to 10-4 M P-
factor. Results shown are 
means of triplicate independent 
determinations ±SE. A: The  β-
galactosidase activity 
(OD420/106 cells) of 
transformants to measure the 
transcriptional response. B: 
Median cell volumes of 
transformants to quantify the 
morphological response. C:  
Change in cell volume 
calculated as the increase 
above the median cell volume 
of unstimulated cells. D: pEC50 
and maximal signalling values 
calculated from the dose-
response curves in A and C. 
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4.2.2 A Fluorescent Tag has Little Effect on Receptor Function  
GPCRs analysed in this chapter were tagged with green fluorescent protein (GFP) for cell 
localization purposes. Additionally, the GFP tag can be used as the acceptor for BRET 
experiments. To investigate whether the fluorescent tag has an effect on receptor function, 
the pheromone-response of cells expressing Mam2 from the pREP3x vector was compared 
to cells expressing Mam2-GFP from the pREP3x vector. 
The Sz. pombe reporter strain JY1169 (sxa2>lacZ, Mam2-) was transformed with pREP3x, 
pREP3x-Mam2 or pREP3x-Mam2-GFP under the control of the repressible nmt1 promoter 
(Maundrell 1993). Cells were grown to mid log-phase in selective AA media and incubated 
with 0-10-4 M pheromone on a rotating wheel for 16 h before assays were performed. Figure 
4-2A   shows   the   β-galactosidase activity to measure the activation of the transcriptional 
pathway, Figure 4-2B the median cell volumes to measure the shmoo response in the 
morphological pathway and Figure 4-2C the change in cell volume calculated as the 
increase above the median cell volume of unstimulated cells. The pEC50 and maximal 
signalling values as calculated from the dose-response are shown in Figure 4-3D.  
With respect to the transcriptional response, Mam2 and Mam2-GFP exhibited comparable 
pEC50 values. The maximal signalling response calculated was however slightly lower for 
Mam2-GFP than for Mam2 alone, but this difference was not statistically significant as 
calculated by an unpaired two-tailed t-test (p>0.05). Cells transformed with vector alone did 
not respond to pheromone, as was expected. The transcriptional response appeared to 
decrease  when   cells  were   exposed   to   the   higher   concentrations   of   pheromone   (≥10-6 M), 
which can possibly be attributed to the down-regulation of the pheromone-response as 
discussed in section 1.4.2.2.  
The morphological response was also similar in the two receptors, although very slightly 
higher for cells expressing Mam2 alone. The maximal increase in median cell volume was 
30.80% for cells transformed with Mam2 compared to 26.45% for cells transformed with 
Mam2-GFP, however this difference was not found to be statistically significant by an 
unpaired two-tailed t-test (p>0.05). These experiments therefore suggest that the GFP tag 
has little effect on Mam2 function.  
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Figure 4-2: Comparison of 
the activity of Mam2 and 
Mam2-GFP  
JY1169 (sxa2>lacZ, mam2-) 
was transformed with 
pREP3x, pREP3x-Mam2 or 
pREP3x-Mam2-GFP. Cells 
were cultured in AA media to 
a density of ~5x106 cells/mL 
and incubated with 0 to 10-4 M 
P-factor. Results shown are 
means of triplicate 
independent determinations 
±SE. A: The   β-galactosidase 
activity (OD420/106 cells) of 
transformants to measure the 
transcriptional response. B: 
Median cell volumes of 
transformants to quantify the 
morphological response. C:  
Change in cell volume 
calculated as the increase 
above the median cell volume 
of unstimulated cells. D: 
pEC50 and maximal signalling 
values calculated from the 
dose-response curves in A 
and C.  
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4.2.3 STE2 Activates the Pheromone-Response Similarly to Mam2 
when Expressed in Schizosaccharomyces pombe 
This chapter will discuss the effects of mutations in the Sc. cerevisiae STE2 receptor when 
expressed in Sz. pombe. The behaviour of cells transformed with wild-type STE2-GFP, 
Mam2-GFP or GFP alone was therefore compared to validate expressing STE2-GFP in Sz. 
pombe. Receptors were expressed from the pREP3x plasmid under the control of the 
repressible nmt1 promoter (Maundrell 1993) and plasmids were transformed into the JY1169 
strain (sxa2>lacZ, mam2-). STE2 has previously been shown to couple to the Sz. pombe 
pheromone-response pathway by binding   its  native  α-factor ligand and coupling to the Sz. 
pombe G-protein (Forfar 2007). However it is not known whether the signalling efficiency of 
the STE2 receptor is similar to the efficiency of Mam2. It was therefore of interest to 
compare the activity of wild-type STE2 and Mam2 expressed in Sz. pombe to see that 
expressing STE2-GFP instead of Mam2-GFP does not adversely affect the signalling 
response.  
Figure 4-3 shows the pheromone dose-response profiles of Sz. pombe cells transformed 
with pREP3x-Mam2-GFP, pREP3x-STE2-GFP and pREP3x-GFP. Cells were incubated with 
concentrations of pheromone (α-factor or P-factor) ranging from 0 to 10-4 M. Cells 
transformed with vectors containing STE2-GFP were treated with α-factor and cells 
transformed with vectors containing Mam2-GFP were treated with P-factor. Cells were 
grown to mid log-phase and exposed to pheromone on a rotating wheel for 16 h before 
assays were performed. Figure 4-3A   shows   the   β-galactosidase activity to measure the 
activation of the transcriptional pathway, Figure 4-3B the median cell volumes in to measure 
the shmoo response in the morphological pathway and Figure 4-3C the change in cell 
volume calculated as the increase above the median cell volume of unstimulated cells. The 
pEC50 and maximal signalling values calculated from the dose-response are shown in Figure 
4-3D. Both the transcriptional and the morphological response of cells transformed with 
STE2-GFP and Mam2-GFP were observed to decrease in response to pheromone 
concentrations in excess of 10-6 M. This may be attributable to down-regulation of the 
pheromone-response. As expected, cells transformed with GFP alone did not respond. 
In the transcriptional response the pEC50 values (Figure 4-3D) of the two receptors were 
indistinguishable. Interestingly, the maximal signalling measured appeared different for the 
two receptors with 16.6 β-galactosidase units per 106 cells for STE2-GFP and 21.2 for 
Mam2-GFP. This difference was found to be statistically significant by an unpaired two-tailed 
t-test (p<0.05). Similarly, maximal shmoo formation in cells expressing STE2-GFP was 
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significantly different from shmoo formation in cells expressing Mam2-GFP (calculated by an 
unpaired two-tailed t-test, p<0.05). This implies that although Mam2-GFP and STE2-GFP 
initiate the transcriptional response at similar levels of pheromone, STE2-GFP does not drive 
the transcriptional response as efficiently as Mam2.  
This could be due to a number of reasons including an inability to couple efficiently to other 
components involved in the pheromone-response. For instance, STE2 is unable to bind the 
Rgs1 protein (McCann 2010). Although Rgs1 has a role in attenuating the pheromone-
response, it is also involved in its positive regulation (Smith, Hill et al. 2009). The positive 
regulatory function arises from the inability of Gα-GTP to activate the effector more than 
once per activation round. Deactivation via GTP hydrolysis mediated by Rgs1 thus release 
the  Gα  back  to  the  pool  of  possible  activators.  This  may  also  explain  why  the  pEC50 values 
are comparable for cells expressing either receptor; Mam2-GFP and STE2-GFP initiate the 
transcriptional  response  at  similar  levels  of  pheromone  when  Gα  is  unlimited,  however,  cells  
expressing STE2-GFP  cannot  sequester  Gα-GTP as quickly as cells expressing Mam2-GFP 
and consequently STE2-GFP does not drive the response as efficiently as Mam2. 
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Figure 4-3: Comparison of the activity 
of Mam2-GFP and STE2-GFP 
expressed in Sz. Pombe 
JY1169 (sxa2>lacZ, mam2-) was 
transformed with pREP3x-GFP, pREP3x-
Mam2-GFP or pREP3x-STE2-GFP. Cells 
were cultured in AA media to a density of 
~5x106 cells/mL and incubated with 0 to 
10-4 M pheromone. Cells transformed with 
STE2  were  exposed   to  α-factor and cells 
transformed with Mam2 were exposed to 
P-factor. Results shown are means of 
triplicate independent determinations ±SE. 
A: The  β-galactosidase activity (OD420/106 
cells) of transformants to quantify the 
transcriptional response. B: Median cell 
volume in transformants to measure the 
morphological response. C:  Change in 
cell volume calculated as the increase 
above the median cell volume of 
unstimulated cells. D: pEC50 and maximal 
signalling values calculated from the dose-
response curves in A and C. Statistically 
significant differences between Mam2-
GFP and STE2-GFP are denoted by 
asterisks. The number of asterisks reflects 
the p-value such that *=p<0.05, 
**=p<0.01, ***=p<0.001. 
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4.2.4 STE2-GFP Accumulates in Cells 
Following the functional analysis of receptors tagged with GFP, their sub-cellular localization 
was determined using confocal microscopy. This was of interest in order to compare the 
cellular localization of STE2 and Mam2, as well as to determine whether the signalling 
mutants characterized later in the chapter were mis-localized. JY1169 (sxa2>lacZ, mam2-) 
was transformed with pREP3x-GFP, pREP3x-STE2-GFP or pREP3x-Mam2-GFP. Cells 
were cultured in AA media lacking leucine to mid-exponential phase and examined using 
confocal microscopy.  
Figure 4-4 shows confocal images of representative cells expressing GFP (A), STE2-GFP 
(B) and Mam2-GFP (C) with visible organelles marked out as; ER (endoplasmic reticulum), 
N (nucleus), PM (plasma membrane) and V (vacuole). GFP when expressed alone is not 
targeted to a specific compartment within the cell but is found throughout the cytoplasm and 
nucleus, with the exception of a number of spherical structures where fluorescence is 
absent. These structures have previously been described as vacuoles (Takegawa, Iwaki et 
al. 2003; Ladds, Goddard et al. 2005). The absence of GFP from the plasma membrane is 
expected as GFP lacks a plasma membrane targeting signal. This also explains its absence 
from the vacuoles as vacuoles are made up from fusions of internalized plasma membrane 
(Brooker, Widmaier et al. 2007).  
An ImageJ/QuimP10 analysis was performed to quantify the amount of receptor on the 
membrane, as well as the ratio of receptor on the membrane to the interior of the cell (Figure 
4-5A and B respectively). The average pixel intensity at the plasma membrane and the 
average percentage of fluorescence found at the plasma membrane compared to the interior 
of the cell is displayed in Figure 4-5C. The images of cells expressing STE2-GFP and 
Mam2-GFP show that both receptors are present on the plasma membrane. From the 
QuimP10 analysis of the images it appears as though there is more STE2-GFP found at the 
cell cortex compared to Mam2-GFP (Figure 4-5A), however this difference was not found to 
be statistically significant (calculated by an unpaired two-tailed t-test, p<0.05). This agrees 
with the findings from the pheromone-response assay where STE2-GFP and Mam2-GFP 
displayed comparable reporter activities. 
The fluorescence microscopy images suggest that the two receptors predominantly localize 
to different intracellular compartments. Mam2-GFP internal to cells appears to predominantly 
localize to the ER of the cells (Figure 4-4B). STE2-GFP internal to cells in contrast appears 
to associate with structures resembling endosomes and/or vacuoles (Figure 4-4C). 
Furthermore, there was a statistically significant difference of the amount of receptor internal 
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to cells when expressing Mam2-GFP compared to when expressing STE2-GFP (Figure 4-5A 
and calculated by an unpaired, two-tailed t-test, p<0.05). Increased amounts of STE2 in 
endosomes or vacuoles may be due to ineffective targeting of STE2 for degradation. Like in 
the pheromone-response, this may again be due to an inability of STE2 to couple to the Sz. 
pombe cellular machinery effectively. In Sc. cerevisiae STE2 has previously been shown to 
get trapped in the late endosomal stage if successful protein-protein interactions cannot be 
formed (Gabriely, Kama et al. 2007) and it is possible that a similar effect is observed when 
the receptor is expressed in Sz. pombe.  
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Figure 4-4: Representative images showing the localization of GFP, Mam2-GFP and STE2-GFP 
in Sz. pombe 
JY1169 (sxa2>lacZ, mam2-) was transformed with the pREP3x vectors containing GFP (A), Mam2-
GFP (B) or STE2-GFP (C). Cells were cultured in AA media lacking leucine to mid-exponential phase 
and examined using confocal microscopy.  Organelles apparent in the images are marked ER for 
endoplasmic reticulum, N for nucleus, PM for plasma membrane and V for vacuoles. Images were 
generated using a Personal DeltaVision (Applied Precision, Inc).  
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Figure 4-5: Measured fluorescence intensities at the cell membrane of GFP, STE2-GFP and 
Mam2-GFP 
JY1169 (sxa2>lacZ, mam2-) was transformed with pREP3x-GFP, pREP3x-STE2-GFP or pREP3x-
Mam2-GFP. Cells were cultured in AA media lacking leucine to mid-exponential phase and examined 
using confocal microscopy. Images were generated using a Personal DeltaVision (Applied Precision, 
Inc) and the intensity of cytoplasm and membrane fluorescence was determined using the software 
QuimP10. Values shown are means ±SEM of 30 independent representative cells. A statistically 
significant difference (p<0.05) between Mam2-GFP and STE2-GFP is denoted by an asterisk. A: The 
mean individual pixel intensity at the membrane. B: The percentage membrane fluorescence of cells 
calculated from the total cell fluorescence. C: The average plasma membrane (PM) intensity and % 
membrane localization calculated from A and B.  
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4.3 Effects of Mutations in the SmallxxxSmall Motif on Cell 
Signalling 
4.3.1 SmallxxxSmall Motifs 
A motif of two small residues spaced one turn of the helix apart is implicated in the 
oligomerization of many membrane proteins (Lemmon, Flanagan et al. 1992; McClain, 
Iwamoto et al. 2003; Li, Gorelik et al. 2004; Jenei, Borthwick et al. 2009; King and Dixon 
2010). This is because small residues such as glycine, serine and alanine permit close 
contact between transmembrane helices to allow extensive van der Waals interactions 
(MacKenzie and Engelman 1998; Javadpour, Eilers et al. 1999). The importance of the 
smallxxxsmall motif in TM domains is reflected by its statistical over-representation in 
membrane proteins (Senes, Gerstein et al. 2000).  
4.3.2 STE2 and Mam2 Both Contain Motifs of Small Residues 
within Their First Transmembrane Domains 
The Sc. cerevisiae GPCR STE2 contain a GxxxG motif in its first transmembrane domain 
formed by residues G56 and G60 (Figure 4-6A). Previous studies have implied that this motif 
is involved in interactions between receptors and that disrupting this motif affects pheromone 
signalling and transport of the receptor to the plasma membrane (Overton, Chinault et al. 
2003). It has also been shown that the phenotype of a tailless GFP tagged version of the 
receptor, which is deficient in endocytosis, can be rescued by co-expression with the full-
length receptor, suggesting that interactions between receptors play a role in internalization 
(Overton and Blumer 2002). BRET experiments on whole cell lysate later confirmed the 
ability of full-length STE2 to form dimers (Gehret, Bajaj et al. 2006). To date there is no 
crystal structure of the receptor, meaning that the exact nature of interactions is not precisely 
characterized. A homology model presented in section 6.1.4 however shows that the GxxxG 
motif potentially maps to the lipid-facing side of the transmembrane domain (rather than 
being involved in intra-helical interactions within the protein), further supporting the theory 
that the motif could be involved in oligomerization of the receptor. 
There is evidence suggesting that Mam2 also forms oligomeric complexes (Ladds, Davis et 
al. 2005) although the reasons for oligomerization remains unknown. The sequence of 
Mam2 TM1 as predicted by the TMHMM algorithm (Krogh, Larsson et al. 2001) is shown in 
Figure 4-6B. Mam2 contain two putative smallxxxsmall motifs in its first transmembrane 
domain: G49xxxS53 and S53xxxA57. The residue G49 lies just outside of the region 
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predicted to be within the membrane, however, theoretically defined boundaries do not 
always agree with experimentally defined boundaries. Figure 4-6C shows an alignment 
between STE2 and Mam2 TM1 centred about the G56xxxG60 motif in STE2 and the 
putative smallxxxsmall motifs G49xxxS53 and S53xxxA57 in Mam2, with the log odds score 
of changing the amino acid in STE2 to the aligned amino acid in Mam2 shown underneath.  
The log odds score (Jones, Taylor et al. 1994), is a measure of how conserved specific 
mutations of residues found in the membrane are between homologous proteins. Negative 
log odds values indicate ‘disfavoured’ mutations and positive values mean that the mutation 
is ‘favoured’. In Figure 4-6C negative log odds scores are shown in blue, positive or neutral 
scores in yellow and residues that are unchanged are shown in green. With regards to the 
log odds score of changing amino acids in a transmembrane protein, it appears as though 
aligning the Mam2 residues S53xxxA57 to the STE2 G56xxxG60 motif conserves the 
sequence better than when aligning the Mam2 G49xxxS53 residues to STE2 G56xxxG60. If 
Mam2 functions similarly to STE2 then mutations to these residues might potentially have 
similar effects on cells when mutated. 
4.3.3 Mutations Investigated in this Chapter 
Two types of mutations were made in the smallxxxsmall motif of STE2 and Mam2 to 
investigate the effects to cell localization and cell signalling; conservative (changing a small 
residue to another small residue) and disfavoured (changing a small residue to a structurally 
larger residue). The log odds score penalty of conservative mutations is lower than for 
disfavoured mutations, for instance glycine to alanine is 1 or serine to alanine is 2. In 
contrast, the penalty of changing glycine to leucine is -4 and serine to leucine is -2. Although 
conservative mutations tend to have a smaller effect on proteins than disfavoured mutations, 
they can have detrimental effects. For instance, glycine to alanine mutations in the GxxxG 
motif found in the Heliobacter pylori toxin VacA abolishes protein function (McClain, Iwamoto 
et al. 2003).  
Three conservative mutations were investigated in the STE2 G56xxxG60 motif; G56A, G60A 
and the double mutant G56A,G60A. The same disfavoured mutations studied were the same 
residues mutated to leucine instead of alanine. Four conservative mutations were 
investigated in Mam2. These were G49A, S53A, A57G and the double mutant G49A,S53A. 
The disfavoured mutations investigated were G49L, S53L,A57L and the double mutant 
G49L,S53L.  
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Figure 4-6: Sequences of STE2 and Mam2 transmembrane domain 1 
A: Showing the amino acid sequence of STE2 TM1 as predicted by TMHMM. The two glycines G56 and G60 that form the smallxxxsmall motif in this domain 
are marked with residue numbers. B: Showing the amino acid sequence of Mam2 TM1 as predicted by TMHMM. C: Showing the log odds scores between 
Mam2 and STE2 TM1 with two different alignments, one centering S53xxxA57 in Mam2 and one centring G49xxxS53 in Mam2. A blue background 
represents negative log odds scores, yellow neutral or favoured. A green background indicates amino acids that are unchanged between the two proteins. 
Consequently the top alignment appears more conserved than the bottom alignment. 
0 10 20 30 40 50 60 70 80 90 100
STE2 Q51 A I M F G56 V R C G60 A A A L T L I V M W M T S73
Mam2 M50 T L S A Q L A L G V L T I L M W C L L S S S72
0 10 20 30 40 50 60 70 80 90 100
STE2 GxxxG V T Q A I M F G56 V R C G60 A A A L T L I V M W M T S
Mam2 SxxxA L L T G M T L S53 A Q L A57 L G V L T I L M W C L L S
Log odds score 0 -1 -2 1 1 0 1 1 0 6 -1 1 -2 1 0 3 3 1 1 1 2 1 1 -1 3
Mam2 GxxxS E R D R L L T G49 M T L S53 A Q L A L G V L T I L M W
Log odds score -2 -1 2 -1 1 1 -2 6 1 -1 -1 1 2 -2 -2 -2 -1 -4 2 0 0 -3 1 0 -3
A
B
C
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4.3.4 Conservative Mutations in the GxxxG motif of STE2 
Transmembrane Domain 1 Affects the Pheromone-response 
The pheromone response assay was performed to investigate the effects of conservative 
mutations in the STE2 GxxxG motif on signalling. JY1169 (sxa2>lacZ, mam2-) was 
transformed with pREP3x-STE2-GFP, pREP3x-STE2G56A-GFP, pREP3x-STE2G60A-GFP or 
pREP3x-STE2G56A,G60A-GFP. Cells were grown to mid log-phase and incubated with 0-10-5 M 
α-factor pheromone for 16 h.  Figure 4-7A show the transcriptional pheromone-response and  
Figure 4-7B the shmoo response of the different transformants.  Figure 4-7C shows the 
change in cell volume calculated as the increase above the median cell volume of 
unstimulated cells. The pEC50 and maximal signalling values calculated from the dose-
response in A and C are shown in  Figure 4-7D. For both the transcriptional response and 
the morphological response, the dose-response was observed to decrease at high 
pheromone concentrations, which may be attributable to down-regulation of the pheromone-
response.  
When exposed to pheromone, the mutants displayed characteristically different dose-
response patterns compared to STE2-GFP. The Ste2G56A-GFP mutant appeared slightly 
more sensitive to pheromone than STE2-GFP, and both Ste2G56A-GFP and STE2G60A-GFP 
mutants displayed slightly higher maximal signalling in the transcriptional response than 
STE2-GFP. These differences were however not statistically significant (calculated using an 
unpaired two-tailed t-test, p<0.05). In contrast, a 2-fold decrease in the maximal 
transcriptional and morphological dose-response was observed for the STE2G56A,G60A–GFP 
double mutant. This difference compared to wild-type GFP tagged receptor was statistically 
significant (calculated using an unpaired two-tailed t-test, p<0.05). 
The negative genetic interaction observed in the double-alanine mutant is interesting, 
especially as the signalling efficiency of each single alanine mutant was slightly elevated 
compared to wild-type. Although   the   structural   conformation   of   the   α-helix is largely 
determined by the symmetrical protein backbone, the amino acid side-chains can influence it 
to some extent thereby influencing the overall fold of the receptor. It seems unlikely however, 
that the fold of this double-mutant receptor is greatly affected as ligand-binding studies have 
demonstrated that it has  a  similar  affinity  to  α-factor as wild-type receptor (Overton, Chinault 
et al. 2003). Another possible explanation for the differences observed is that the double 
mutant, but not each single mutant, affects protein oligomerization which may affect 
signalling. 
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 Figure 4-7: Effect of conservative 
mutations in STE2 on the 
pheromone-response 
JY1169 (sxa2>lacZ, mam2-) was 
transformed with pREP3x–STE2-GFP, 
pREP3x-STE2G56A-GFP, pREP3x-
STE2G60A-GFP or pREP3x-
STE2G56A,G60A-GFP. Cells were cultured 
in AA to a density of ~5x106 cells/mL 
and incubated with 0 to 10-4 M α-factor. 
Results shown are means of triplicate 
independent determinations ±SE. A: 
The  β-galactosidase activity (OD420/106 
cells) of transformants to measure the 
transcriptional response. B: Median 
cell volumes of transformants to 
quantify the morphological response. 
C:  Change in cell volume calculated 
as the increase above the median cell 
volume of unstimulated cells. D: pEC50 
and maximal signalling values 
calculated from the dose-response 
curves in A and C. Statistically 
significant differences between STE2-
GFP and mutants are denoted by 
asterisks. The number of asterisks 
reflects the p-value such that * 
=p<0.05, **=p<0.01, ***=p<0.001. 
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4.3.5 Effects of Conservative Mutations in STE2-GFP on Receptor 
Localization 
The subcellular localization of STE2-GFP and the alanine STE2-GFP mutants was 
determined using confocal microscopy. JY1169 (sxa2>lacZ, mam2-) was transformed with 
pREP3x-STE2-GFP, pREP3x-STE2G56A-GFP, pREP3x-STE2G60A-GFP or pREP3x- 
STE2G56A,G60A-GFP. Cells were cultured in AA media lacking leucine to mid-exponential 
phase and examined using confocal microscopy. Figure 4-8 shows images of representative 
cells expressing each construct. An ImageJ/QuimP10 analysis was performed to quantify the 
amount of receptor on the membrane, as well as the ratio of receptor on the membrane to 
the interior of the cell (Figure 4-9A and B respectively). The average pixel intensity at the 
plasma membrane and the average percentage of fluorescence found at the plasma 
membrane compared to the interior of the cell is displayed in Figure 4-9C.  
Consistent with the functional analysis of the receptor, the subcellular localization of the 
STE2G56A-GFP and STE2G60A-GFP mutants resembled that of wild-type receptor, although 
the STE2G56A mutant appeared to display larger vacuoles (highlighted with a V in Figure 
4-8B). The STE2G56A,G60A-GFP double-mutant in contrast displayed a 2-fold reduction of 
receptor at the plasma membrane and this difference was found to be statistically significant 
(calculated by an unpaired two-tailed t-test, p<0.05), providing an explanation for the 
reduced signalling observed for this mutant in the pheromone response assay. The plasma 
membrane localization of this receptor is visibly reduced (compare Figure 4-8 A and D). It is 
not possible to determine the cause of the reduction in STE2G56A,G60A-GFP abundance but 
expression may be affected at any stage of the regulation of expression including 
transcription, translation, trafficking or receptor degradation. 
 Page 93 
 
 
Figure 4-8: Representative images showing the localization of the conservatively mutated 
STE2-GFP receptors in Sz. pombe  
JY1169 (sxa2>lacZ, mam2-) was transformed with A: pREP3x-STE2-GFP B: pREP3x-STE2G56A-GFP 
C: pREP3x-STE2G60A-GFP or D: pREP3x-STE2G56A,G60A-GFP. Cells were cultured in AA media 
lacking leucine to mid-exponential phase and examined using confocal microscopy.  Images were 
generated using a Personal DeltaVision (Applied Precision, Inc). Plasma membrane (PM) and 
vacuoles (V) are highlighted. 
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Figure 4-9: Measured fluorescence intensities at the cell membrane of STE2-GFP and the 
STE2-GFP constructs containing conservative mutations  
JY1169 (sxa2>lacZ, mam2-) was transformed with pREP3x-STE2-GFP, pREP3x-STE2G56A-GFP, 
pREP3x-STE2G60A-GFP or pREP3x-STE2G56A,G60A-GFP. Cells were cultured in AA media lacking 
leucine to mid-exponential phase and examined using confocal microscopy. Images were generated 
using a Personal DeltaVision (Applied Precision, Inc) and the intensity of cytoplasm and membrane 
fluorescence was determined using the software QuimP10. Values shown are means ±SEM of 30 
independent representative cells. A statistically significant difference (p<0.05) between wild-type and 
mutants is denoted by an asterisk. A: The mean individual pixel intensity at the membrane. B: The 
percentage membrane fluorescence of cells calculated from the total cell fluorescence. C: The 
average plasma membrane (PM) intensity and % membrane localization calculated from A and B.  
 Page 95 
 
4.3.6 Conservative Mutations in the First Transmembrane Domain 
of Mam2 Have Varying Effects on the Pheromone-response 
The effects of conservative mutations in the first transmembrane domain of Mam2 were also 
assessed using the pheromone response assay. JY1169 (sxa2>lacZ, mam2-) was 
transformed with pREP3x-Mam2-GFP, pREP3x-Mam2G49A-GFP, pREP3x-Mam2S53A-GFP, 
pREP3x-Mam2A57G-GFP or pREP3x-Mam2G49A,S53A-GFP. Cells were grown to mid log-phase 
and incubated with 0-10-4 M P-factor pheromone for 16 h. The results are shown in Figure 
4-10; Figure 4-10A show the transcriptional pheromone-response and Figure 4-10B the 
shmoo response of the different transformants. Figure 4-10C shows the change in cell 
volume calculated as the increase above the median cell volume of unstimulated cells. The 
pEC50 and maximal signalling values calculated from the dose-response in A and C are 
listed in Figure 4-10D.  
In the absence of pheromone, the transcriptional signalling activity was similar for wild-type 
Mam2 and the Mam2 mutants, however the base-line cell volumes fluctuated (Figure 4-10B). 
In the presence of pheromone the response of the mutants differed from the pheromone-
response in wild-type Mam2. The Mam2G49A-GFP mutant had a transcriptional response 
similar to wild-type Mam2 but displayed a two-fold reduction in maximal morphological 
response (Figure 4-10C). This difference was not found to be statistically significant 
however. The Mam2A57G-GFP and Mam2G49A,S53A-GFP mutants displayed the opposite trend 
with a reduced maximal transcriptional response but a similar maximal morphological 
response compared to wild-type Mam2 and this difference was statistically significant 
(calculated using an unpaired two-tailed t-test, p<0.01 for the A57G mutation and p<0.05 for 
the G49A,S53A mutation). Differences in the activation of the transcriptional and 
morphological response when expressing heterologous signalling components has 
previously been observed in Sz. pombe (Ladds, Goddard et al. 2007). This phenomenon 
cannot however be explained by the current model of the interactions between receptor and 
downstream signalling component. In the current model, Ras1 is activated downstream of 
the Gpa1 Gα-subunit, which interacts with the receptor. Ras1 then either interact via the 
GEF Efc25 to activate the morphological response, or Ste6 to activate the transcriptional 
response. The exact details of the protein-protein interactions and how one pathway but not 
the other can be activated are to date unknown. 
The Mam2S53A-GFP mutant displayed the strongest signalling phenotype with an apparent 
reduced response in both the transcriptional and the morphological pathway. A statistical 
analysis was performed (using an unpaired two-tailed t-test) and the differences observed in 
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the transcriptional response were significant (p<0.01), but not the morphological response. 
The dose-response was again observed to decrease towards higher concentrations of 
pheromone, indicative of down-regulation of signalling or cell death. 
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Figure 4-10: Effect of conservative 
mutations in Mam2 on the 
pheromone-response 
JY1169 (sxa2>lacZ, mam2-) was 
transformed with pREP3x-Mam2-GFP, 
pREP3x-Mam2G49A-GFP, pREP3x-
Mam2S53A-GFP, pREP3x-Mam2A57G-
GFP or pREP3x-Mam2G49A,S53A-GFP. 
Cells were grown in AA media to a 
density of ~5x106 cells/mL and incubated 
with 0-10-4 M P-factor. Results shown 
are means of triplicate independent 
determinations ±SE. A: The   β-
galactosidase activity (OD420/106 cells) of 
transformants to measure the 
transcriptional response. B: Median cell 
volumes of transformants to quantify the 
morphological response. C:  Change in 
cell volume calculated as the increase 
above the median cell volume of 
unstimulated cells. D: pEC50 and 
maximal signalling values calculated 
from the dose-response curves in A and 
C. Statistically significant differences 
between Mam2-GFP and mutants are 
denoted by asterisks. The number of 
asterisks reflects the p-value such that * 
=p<0.05, **=p<0.01, ***=p<0.001. 
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4.3.7 Effects of Conservative Mutations in Mam2-GFP on Receptor 
Localization 
The subcellular localization of Mam2-GFP and the alanine Mam2-GFP mutants was 
determined using confocal microscopy. JY1169 (sxa2>lacZ, mam2-) was transformed with 
pREP3x-Mam2-GFP, pREP3x-Mam2G49A-GFP, pREP3x-Mam2S53A-GFP, pREP3x-
Mam2A57G-GFP or pREP3x-Mam2G49A,S53A-GFP. Cells were cultured in AA media lacking 
leucine to mid-exponential phase and examined using confocal microscopy. Figure 4-11 
shows images of representative cells expressing each construct. An ImageJ/QuimP10 
analysis was performed to quantify the amount of receptor on the membrane, as well as the 
ratio of receptor on the membrane to the interior of the cell (Figure 4-12A and B 
respectively). The average pixel intensity at the plasma membrane and the average 
percentage of fluorescence found at the plasma membrane compared to the interior of the 
cell is displayed in Figure 4-12C.  
Surprisingly, despite their altered signalling behaviour, the conservative Mam2 mutants 
Mam2G49A-GFP, Mam2S53A-GFP, Mam2A57G-GFP and Mam2G49A,S53A-GFP all localized to the 
plasma membrane in higher quantities than wild-type Mam2 labelled with GFP. For all 
mutants, this difference was statistically significant (calculated using an unpaired two-tailed t-
test, p<0.05 for the single mutants and p<0.01 for the double-mutant). The ratio of receptor 
found at the cell cortex compared to intracellularly was also significantly higher for the 
mutants (Figure 4-12B), which may suggest that removal of receptor from the membrane is 
compromised. The increased amounts of receptor found at the cell cortex is interesting as it 
implies that the altered pheromone-response observed in these mutants cannot be attributed 
to the cellular localization of receptor, but instead the functionality of the receptors is 
somehow altered.    
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Figure 4-11: Representative images showing the localization of the conservatively mutated 
Mam2-GFP receptors in Sz. pombe 
JY1169 (sxa2>lacZ, mam2-) was transformed with A: pREP3x-Mam2-GFP, B: pREP3x-Mam2G49A-
GFP, C: pREP3x-Mam2S53A-GFP, D: pREP3x-Mam2A57G-GFP or E: pREP3x-Mam2G49A,S53A-GFP. 
Cells were cultured in AA media lacking leucine to mid-exponential phase and examined using 
confocal microscopy.  Images were generated using a Personal DeltaVision (Applied Precision, Inc).  
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Figure 4-12: Measured fluorescence intensities at the cell membrane of Mam2-GFP and the 
Mam2-GFP constructs containing conservative mutations  
JY1169 (sxa2>lacZ, mam2-) was transformed with pREP3x-Mam2-GFP, pREP3x-Mam2G49A-GFP, 
pREP3x-Mam2S53A-GFP or pREP3x-Mam2G49A,S53A-GFP. Cells were cultured in AA media lacking 
leucine to mid-exponential phase and examined using confocal microscopy. Images were generated 
using a Personal DeltaVision (Applied Precision, Inc) and the intensity of cytoplasm and membrane 
fluorescence was determined using the software QuimP10. Values shown are means ±SEM of 30 
independent representative cells. Statistically significant differences between Mam2-GFP and 
mutants are denoted by asterisks. The number of asterisks reflects the p-value such that * =p<0.05, 
**=p<0.01 and ***=p<0.001 A: The mean individual pixel intensity at the membrane. B: The 
percentage membrane fluorescence of cells calculated from the total cell fluorescence. C: The 
average plasma membrane (PM) intensity and % membrane localization calculated from A and B.  
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4.3.8 Disfavoured Mutations in the GxxxG motif of STE2 Have a 
Pronounced Effect on the Pheromone-response 
To investigate the effects of the non-conservative leucine mutations in the STE2 GxxxG 
motif, JY1169 (sxa2>lacZ, mam2-) was transformed with pREP3x-STE2-GFP, pREP3x-
STE2G56L-GFP, pREP3x-STE2G60L-GFP or pREP3x-STE2G56L,G60L-GFP. Cells were grown to 
mid log-phase and incubated with 0-10-5 M  α-factor pheromone for 16 h. Figure 4-13A show 
the transcriptional pheromone-response and Figure 4-13B the shmoo response of the 
different transformants. Figure 4-13C shows the change in cell volume calculated as the 
increase above the median cell volume of unstimulated cells. The pEC50 and maximal 
signalling values calculated from the dose-response in A and C are shown in Figure 4-13D. 
Mutating the GxxxG motif in the first transmembrane domain of STE2 to leucine had a much 
more pronounced effect than mutating residues to alanine (compare  Figure 4-7). A dose-
response curve could not be calculated for either of the mutants, although it appears as 
though there is a slight increase in signalling response towards the higher concentrations of 
pheromone for the STE2G56L-GFP mutant. This implies that the receptor binds pheromone 
with lower affinity, that coupling to downstream signalling effectors is affected, or that 
receptors are not efficiently localized to the plasma membrane, although the pheromone 
response assay cannot distinguish the cause. 
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Figure 4-13: Effect of 
disfavored mutations in STE2 
on the pheromone-response 
JY1169 (sxa2>lacZ, mam2-) was 
transformed with pREP3x–STE2-
GFP, pREP3x-STE2G56L-GFP, 
pREP3x-STE2G60L-GFP or 
pREP3x-STE2G56L,G60L-GFP. Cells 
were cultured in AA media to a 
density of ~5x106 cells/mL and 
incubated with 0-10-5 M α-factor. 
Results shown are means of 
triplicate independent 
determinations ±SE. A: The   β-
galactosidase activity (OD420/106 
cells) of transformants to 
measure the transcriptional 
response. B: Median cell 
volumes of transformants to 
quantify the morphological 
response. C:  Change in cell 
volume calculated as the 
increase above the median cell 
volume of unstimulated cells. D: 
pEC50 and maximal signalling 
values calculated from the dose-
response curves in A and C. 
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4.3.9 Effects of Disfavoured Mutations in STE2-GFP on Receptor 
Localization 
Confocal imaging was performed to determine whether the absence of a pheromone-
response in the STE2-GFP GxxxG leucine mutants was due to reduced expression of 
receptor at the plasma membrane, or may be attributable to another cause. JY1169 
(sxa2>lacZ, mam2-) was transformed with pREP3x-STE2-GFP, pREP3x-STE2G56L-GFP, 
pREP3x-STE2G60L-GFP or pREP3x- STE2G56L,G60L-GFP. Cells were cultured in AA media 
lacking leucine to mid-exponential phase and examined using confocal microscopy. Figure 
4-14 shows images of representative cells expressing each construct. An ImageJ/QuimP10 
analysis was performed to quantify the amount of receptor on the membrane, as well as the 
ratio of receptor on the membrane to the interior of the cell Figure 4-15A and B respectively). 
The average pixel intensity at the plasma membrane and the average percentage of 
fluorescence found at the plasma membrane compared to the interior of the cell is displayed 
in Figure 4-15C.  
The ImageJ/QuimP10 analysis of these images showed that the quantity of the leucine 
mutant receptors found at the cell cortex is reduced approximately three-fold compared to 
wild-type receptor (Figure 4-15A), a difference which is statistically significant (calculated 
using an unpaired two-tailed t-test, p<0.01). The ratio of receptor found at the cell membrane 
compared to the interior of the cell also differed between wild-type receptor and mutant 
receptor, with mutant receptors having increased amounts of internalized receptor. These 
appear to localize to vacuoles within the cells, highlighted by a V in Figure 4-15C. This 
difference was also found to be statistically significant (calculated using an unpaired two-
tailed t-test p<0.05 for the G56L mutation and p<0.01 for the G60L and G56L,G60L 
mutations). A previous study have shown that these leucine mutants cannot bind agonist 
(Overton, Chinault et al. 2003) which suggests that the receptor may be misfolded and 
consequently is internalized before reaching the plasma membrane. Studies on misfolded 
mutants of STE2 have shown that, in Sc. cerevisiae, errors in folding in the ER lead to 
transport of the receptor from the ER to vacuolar structures without the receptor reaching the 
plasma membrane (Jenness, Li et al. 1997) which could explain this phenomenon. 
Furthermore, the GFP derivative used is highly stable (Ladds, Davis et al. 2005), which may 
explain its accumulation in the vacuoles. 
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Figure 4-14: Representative images showing the localization of the STE2-GFP receptors 
containing the disfavored mutations in Sz. pombe  
JY1169 (sxa2>lacZ, mam2-) was transformed A: pREP3x-STE2-GFP B: pREP3x-STE2G56L-GFP C: 
pREP3x-STE2G60L-GFP or D: pREP3x-STE2G56L,G60L-GFP. Cells were cultured in AA media lacking 
leucine to mid-exponential phase and examined using confocal microscopy.  Images were generated 
using a Personal DeltaVision (Applied Precision, Inc). Plasma membrane (PM) and vacuoles (V) are 
highlighted. 
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Figure 4-15: Measured fluorescence intensities at the cell membrane of STE2-GFP and the 
STE2-GFP constructs containing the disfavored mutations 
JY1169 (sxa2>lacZ, mam2-) was transformed with pREP3x-STE2-GFP, pREP3x-STE2G56L-GFP, 
pREP3x-STE2G60L-GFP or pREP3x-STE2G56L,G60L-GFP. Cells were cultured in AA media lacking 
leucine to mid-exponential phase and examined using confocal microscopy. Images were generated 
using a Personal DeltaVision (Applied Precision, Inc) and the intensity of cytoplasm and membrane 
fluorescence was determined using the software QuimP10. Values shown are means ±SEM of 30 
independent representative cells. Statistically significant differences between STE2-GFP and mutants 
are denoted by asterisks. The number of asterisks reflects the p-value such that * =p<0.05 and 
**=p<0.01 A: The mean individual pixel intensity at the membrane. B: The percentage membrane 
fluorescence of cells calculated from the total cell fluorescence. C: The average plasma membrane 
(PM) intensity and % membrane localization calculated from A and B.   
 Page 106 
 
4.3.10 Effects of Disfavoured Mutations in Mam2-GFP on 
Pheromone Signalling 
Mutations of the GxxxG motif in STE2 to leucine had a dramatic effect on Sz. pombe 
pheromone signalling and localization of receptor intracellularly. It was therefore of interest 
to investigate whether similar trends would be observed in leucine mutants of Mam2. To 
investigate the effects of the non-conservative leucine mutations in the smallxxxsmall motif 
found in the first transmembrane domain of Mam2, JY1169 (sxa2>lacZ, mam2-) was 
transformed with pREP3x-Mam2-GFP, pREP3x-Mam2G59L-GFP, pREP3x-Mam2S53L-GFP, 
pREP3x-Mam2A57L-GFP or pREP3x-Mam2G49L,S53L-GFP. Cells were grown to mid log-phase 
and incubated with 0-10-5 M P-factor pheromone for 16 h. Figure 4-16A show the 
transcriptional pheromone-response and Figure 4-16B the shmoo response of the different 
transformants. Figure 4-16C shows the change in cell volume calculated as the increase 
above the median cell volume of unstimulated cells. The pEC50 and maximal signalling 
values calculated from the dose-response in A and C are shown in Figure 4-16D. 
When mutating the smallxxxsmall motif in Mam2 to leucine, cellular signalling was much 
more severely affected compared to when the motif was mutated to a small residue. This is 
similar to what was observed for the STE2 leucine mutants; however the Mam2 leucine 
mutations did not appear to be as detrimental to cellular signalling as the STE2 leucine 
mutations. The only mutation where both the morphological and transcriptional response 
was completely absent was for cells transformed with the Mam2G49L,S53L-GFP double mutant. 
All leucine mutants however were less sensitive to pheromone compared to wild-type 
receptor, and also exhibited lower maximal signalling. This difference was statistically 
significant, as calculated by an unpaired, two-tailed t-test (p<0.05-p<0.001) for all mutants.  
Cells transformed with the Mam2G59L-GFP construct were slightly more sensitive to 
pheromone compared to the other single residue mutants, and also had a slightly higher 
maximal signalling. If the face of the helix that these mutations map to is involved in receptor 
oligomerization, and if oligomerization is important for signalling, then this could imply that 
the S53 and A57 residues are more important than the G49 residue for close interactions of 
two receptors.   
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Figure 4-16: Effect of disfavored 
mutations in Mam2 on the 
pheromone-response 
JY1169 (sxa2>lacZ, mam2-) was 
transformed with pREP3x-Mam2-GFP, 
pREP3x-Mam2G49L-GFP, pREP3x-
Mam2S53L-GFP or pREP3x-
Mam2G49L,S53L-GFP. Cells were cultured 
in AA media to a density of ~5x106 
cells/mL and incubated 0 to 10-4 M P-
factor. Results shown are means of 
triplicate independent determinations 
±SE. A: The   β-galactosidase activity 
(OD420/106 cells) of transformants to 
measure the transcriptional response. 
B: Median cell volumes of 
transformants to quantify the 
morphological response. C:  Change in 
cell volume calculated as the increase 
above the median cell volume of 
unstimulated cells. D: pEC50 and 
maximal signalling values calculated 
from the dose-response curves in A and 
C. Statistically significant differences 
between Mam2-GFP and mutants are 
denoted by asterisks. The number of 
asterisks reflects the p-value such that * 
=p<0.05, **=p<0.01, ***=p<0.001. 
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4.3.11 The Mam2 Leucine Mutants are internalized to a Greater 
Extent than Wild-type Receptor  
To determine whether the altered signalling behaviour observed in the Mam2 leucine 
mutants was due to receptor mislocalization, cells were examined using confocal 
microscopy. JY1169 (sxa2>lacZ, mam2-) was transformed with pREP3x-Mam2-GFP, 
pREP3x-Mam2G49L-GFP, pREP3x-Mam2S53L-GFP, pREP3x-Mam2A57L-GFP or pREP3x-
Mam2G49L,S53L-GFP. Cells were cultured in AA media lacking leucine to mid-exponential 
phase and examined using confocal microscopy. Figure 4-17 shows images of 
representative cells expressing each construct. An ImageJ/QuimP10 analysis was 
performed to quantify the amount of receptor on the membrane, as well as the ratio of 
receptor on the membrane to the interior of the cell (Figure 4-17A and B respectively). The 
average pixel intensity at the plasma membrane and the average percentage of 
fluorescence found at the plasma membrane compared to the interior of the cell is displayed 
in Figure 4-17C.  
In contrast to the single alanine mutants that had remarkably clear plasma membrane 
localization; the leucine mutants appeared to predominantly localize intracellularly. Figure 
4-17A shows that the single leucine mutants had comparable levels of receptor at the 
plasma membrane to wild-type receptor, implying that the ER to plasma membrane transport 
was unaffected. When looking at the ratio of receptor found at the membrane compared to 
the interior of the cell however (Figure 4-17B), it is apparent that greater amounts of mutant 
receptors are internalized compared to wild-type receptor. For cells transformed with the 
pREP3x-Mam2S53L-GFP and pREP3x-Mam2A57L-GFP constructs this difference was 
statistically significant (calculated using an unpaired two-tailed t-test, p<0.05). The Mam2A57L 
mutant displayed both clear plasma membrane localization as well as a high degree of 
accumulation in vacuoles as highlighted in Figure 4-17D. Since these mutant receptors had 
comparable levels of receptor found at the cell surface compared to Mam2, but displayed 
reduced cellular signalling; receptor trafficking and degradation as well as localization may 
be affected by the mutations.  
In contrast, the Mam2G49L,S53L double-mutant localized almost exclusively to the interior of the 
cell, suggesting that the double-mutation had a stronger effect on localization. This is in 
accordance with the pheromone-response assay where this mutant displayed the most 
reduced response to pheromone, and this reduction is highly likely to be caused by an 
absence of receptor at the cell membrane.   
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Figure 4-17: Representative images showing the localization of the Mam2-GFP receptors 
containing the disfavored mutations in Sz. pombe 
JY1169 (sxa2>lacZ, mam2-) was transformed with A: Mam2-GFP or the disfavored Mam2 mutants B: 
Mam2G49L-GFP C: Mam2S53L-GFP D: Mam2A57L-GFP or E: Mam2G49L,S53L-GFP. Cells were cultured in 
AA media lacking leucine to mid-exponential phase and examined using confocal microscopy.  
Images were generated using a Personal DeltaVision (Applied Precision, Inc). Plasma membrane 
(PM) and vacuoles (V) are highlighted. 
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Figure 4-18: Measured fluorescence intensities at the cell membrane of Mam2-GFP and the 
Mam2-GFP constructs containing the disfavored mutations 
JY1169 (sxa2>lacZ, mam2-) was transformed with pREP3x-Mam2-GFP, pREP3x- Mam2G49L-GFP, 
pREP3x- Mam 2S53L-GFP or pREP3x- Mam2G49L,S53L-GFP. Cells were cultured in AA media lacking 
leucine to mid-exponential phase and examined using confocal microscopy. Images were generated 
using a Personal DeltaVision (Applied Precision, Inc) and the intensity of cytoplasm and membrane 
fluorescence was determined using the software QuimP10. Values shown are means ±SEM of 30 
independent representative cells. Statistically significant differences between Mam2-GFP and 
mutants are denoted by asterisks. The number of asterisks reflects the p-value such that * =p<0.05 
and ***=p<0.001. A: The mean individual pixel intensity at the membrane. B: The percentage 
membrane fluorescence of cells calculated from the total cell fluorescence. C: The average plasma 
membrane (PM) intensity and % membrane localization calculated from A and B.   
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4.4 High Concentrations of Pheromone is Toxic to 
Schizosaccharomyces pombe 
In the previous section, the transcriptional and morphological pheromone dose-response 
was observed to decrease towards the higher ends of the pheromone concentrations. This 
however did not seem as apparent for the signalling mutants displaying strong phenotypes. 
There are two possible reasons for the observed decrease in response. It could either reflect 
receptor desensitization to ligand, or toxicity of high concentrations of pheromone, or both. 
To test whether high concentrations of pheromone is toxic to Sz. pombe, cells were exposed 
to increasing concentrations of pheromone and assayed using a cell viability assay and flow 
cytometry.  
Sz. pombe was cultured to a density of 1x106 cells per mL and 1 mL of culture was 
incubated with 0, 10-7 M or 10-4 M P-factor for 16 h. Propidium iodide, which stain cells with 
damaged membranes and show in the PE-A channel, and SYTO9, which stain all cells and 
show in the FITC-A channel, were added to samples. SYTO9 fluoresce green whereas 
FRET between the two dyes result in red fluorescence; thus live cells can be distinguished 
from dead cells by the emission spectra. Flow cytometry was performed using an LSR II flow 
cytometer (BD Biosciences, Oxford, UK). Excitation of both dyes was achieved using a 488 
nm blue laser, and emission was detected using a 550 nm long pass filter with a 575/26 nm 
band pass filter for propidium iodide and a 505 nm long pass filter with a 530/30 nm band 
pass filter for SYTO® 9. Figure 4-19 shows the output from analysis of 100.000 cells in the 
PE-A channel (y-axis, propidium iodide) and FIT-C (x-axis, CYTO9) for cells treated with 0 M 
pheromone (A), 10-7 M pheromone (B) and 10-4 M pheromone (C). As shown in Figure 
4-19D, the number of dead cells in the populations is positively correlated with the amount of 
pheromone administered.  
The same phenomenon has previously been observed in Sc. cerevisiae where cell death in 
response to pheromone has been linked to the effector kinase STE20 and apoptosis; 
shmooing cells are committed to either mating or programmed cell death (Madeo, Fröhlich et 
al. 1997; Severin and Hyman 2002; Skulachev 2002). A homologous effector kinase to 
STE20 has however so far not been identified in Sz. pombe, although apoptosis has been 
observed. It is believed that the vacuoles, where internalized receptor is targeted, also play a 
role in apoptosis (Thompson and Parker 2009) although it is unclear what the link is. The 
occurrence of programmed cell death in unicellular organism is believed to improve the gene 
pool through the removal of infertile and damaged individuals and releasing nutrients back to 
the population (Severin and Hyman 2002). 
 Page 112 
 
 
Figure 4-19: Cell viability in response to pheromone  
JY1169 (sxa2>lacZ, mam2-) expressing pREP3x-Mam2-GFP was cultured in AA media lacking 
leucine to mid-exponential phase and exposed to 0, 10-7 M or 10-4 M P-factor and incubated on a 
rotating wheel for 16 h. Cells were then washed with PBS and stained with CYTO9 and propidium 
iodide before FACS analysis was performed. Propidium iodide exclusively stains cells with damaged 
membranes whereas SYTO9 stains all cells. SYTO9 fluoresce green whereas FRET between the two 
dyes result in emission in the red. Viable cells can therefore be distinguished from dead cells through 
the emission spectra. Flow cytometry was performed using an LSR II flow cytometer (BD Biosciences, 
Oxford, UK). Excitation of both dyes was achieved using a 488 nm blue laser, and emission was 
detected using a 550 nm long pass filter with a 575/26 nm band pass filter for propidium iodide and a 
505 nm long pass filter with a 530/30 nm band pass filter for SYTO® 9. 100.000 cells were analysed 
per sample A: shows the results from cells incubated with no P-factor B: shows the results from cells 
incubated with 10-7 M P-factor C: shows the results from cells incubated with 10-4 M P-factor and D: 
results shown are means of triplicate determinations of three independent isolates ±SEM.   
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4.5 Developing a Bioluminescence Resonance Energy Transfer 
Assay to Measure Oligomerization 
Mutating the smallxxxsmall motif in both Mam2 and STE2 altered cell localization as well as 
functionality of receptors. To see whether this is a possible effect of altering the 
oligomerization of receptors, in addition to cell localization, fusions of receptors to the Renilla 
reniformis luciferase Rluc were generated for live cell real-time BRET assays in Sz. pombe. 
To date, there are no publications discussing the use of BRET in Sz. pombe receptor 
oligomerization studies. In Sc. cerevisiae however energy transfer assays have successfully 
been utilized to monitor STE2 oligomerization including FRET (Overton, Chinault et al. 2003) 
or BRET in lysed cells (Gehret, Bajaj et al. 2006).   
The main disadvantage of using FRET for investigating energy transfer between G protein-
coupled receptors is that the tail of the receptor is too large to allow successful coupling 
between fluorophores. The tail must therefore be removed, which also removes the 
internalization signal in the receptor with an accumulation of receptor at the plasma 
membrane as a result. This has three possible outcomes on the result of assays. Firstly, 
aggregates of receptor on the membrane could result in false positive results. Secondly 
because receptor is not removed from the cell surface in response to pheromone, then any 
effects that the down-regulation of the pheromone-response may have on oligomerization 
cannot be monitored. Thirdly, in Sz. pombe removal of the C-terminal domain has a dramatic 
effect on receptor activity, because it contains the Rgs1 binding-site (McCann 2010). The 
use of a bioluminescent chromophore however removes this problem because it allows a 
longer distance between donor and acceptor for successful energy transfer.   
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4.5.1 The Effect of Rluc-Receptor Fusions on Cellular Signalling  
To perform BRET assays, Mam2-Rluc and STE2-Rluc receptor fusions were constructed to 
act as the donor in the assay. These constructs were assayed for reporter activity in 
response to pheromone in order to determine whether labelling receptors with Rluc has any 
adverse effects on cellular signalling.  
4.5.1.1 A STE2-Rluc Fusion Has No Effect on Pheromone Signalling 
To determine whether an Rluc label has an effect on cellular signalling via STE2, the 
pheromone dose-response of JY1169 (sxa2>lacZ, mam2-) transformed with pREP3x-STE2-
Rluc was compared the pheromone dose-response of JY1169 transformed with pREP3x-
STE2 and pREP3x-STE2-GFP. Cells were grown to mid log-phase and incubated with 0-10-4 
M  α-factor pheromone for 16 h. Figure 4-20A show the transcriptional pheromone-response 
and Figure 4-20B the shmoo response of the different transformants. Figure 4-20C shows 
the change in cell volume calculated as the increase above the median cell volume of 
unstimulated cells. The pEC50 and maximal signalling values calculated from the dose-
response in A and C are shown in Figure 4-20D. 
The signalling activity of cells transformed with the STE2-Rluc was statistically comparable 
to those transformed with STE2-GFP and STE2, calculated by an unpaired two-tailed t-test. 
This suggests that the Rluc label has no effect on signalling via STE2. The decrease in 
signalling response due to cell death in cells expressing STE2-GFP exposed to higher 
concentrations of pheromone was also observed in cells expressing the STE2-Rluc fusions.   
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Figure 4-20: Effect of Rluc and 
GFP tags on the activity of 
STE2  
JY1169 (sxa2>lacZ, mam2-) was 
transformed with pREP3x-STE2-
GFP and  pREP3x-STE2-Rluc 
and cells were cultured in AA 
media to a density of ~5x106 
cells/mL and incubated with 
concentrations   of   α-factor 
ranging from 0 to 10-4 M. Results 
shown are means of triplicate 
independent determinations 
±SE. A: The   β-galactosidase 
activity (OD420/106 cells) of 
transformants to measure the 
transcriptional response. B: 
Median cell volumes of 
transformants to quantify the 
morphological response. C:  
Change in cell volume calculated 
as the increase above the 
median cell volume of 
unstimulated cells. D: pEC50 and 
maximal signalling values 
calculated from the dose-
response curves in A and C. 
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4.5.1.2 A Mam2-Rluc Fusion Has No Effect on Pheromone Signalling 
To determine whether labelling receptors with Rluc has an effect on cellular signalling via 
Mam2, the pheromone dose-response of JY1169 (sxa2>lacZ, mam2-) transformed with 
pREP3x-Mam2-Rluc was compared the pheromone dose-response of JY1169 transformed 
with pREP3x-Mam2-GFP. Cells were grown to mid log-phase and incubated with 0-10-4 M P-
factor pheromone for 16 h. Figure 4-21A show the transcriptional pheromone-response and 
Figure 4-21B the shmoo response of the different transformants. Figure 4-21C shows the 
change in cell volume calculated as the increase above the median cell volume of 
unstimulated cells. The pEC50 and maximal signalling values calculated from the dose-
response in A and C are shown in Figure 4-21D. 
The signalling activity of cells transformed with the pREP3x-Mam2-Rluc was comparable to 
those transformed with pREP3x-Mam2-GFP, although cells expressing the Rluc tag 
appeared slightly more sensitive to pheromone. The Rluc tag does not appear to affect 
signalling via Mam2 significantly however. 
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Figure 4-21: Effect of Rluc 
and GFP tags on the activity 
of Mam2  
JY1169 (sxa2>lacZ, mam2-) 
was transformed with pREP3x-
Mam2-GFP and  pREP3x-
Mam2-Rluc and cells were 
cultured in AA media to a 
density of ~5x106 cells/mL and 
incubated with concentrations of 
P-factor ranging from 0 to 10-5 
M. Results shown are means of 
triplicate independent 
determinations ±SE. A: The   β-
galactosidase activity 
(OD420/106 cells) of 
transformants to measure the 
transcriptional response. B: 
Median cell volumes of 
transformants to quantify the 
morphological response. C:  
Change in cell volume 
calculated as the increase 
above the median cell volume 
of unstimulated cells. D: pEC50 
and maximal signalling values 
calculated from the dose-
response curves in A and C.   
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4.5.2 Receptor-Rluc Fusions Luminesce in Live cells  
To determine whether a luminescence signal could be detected from receptor-Rluc fusions 
Sz. pombe JY1169 (sxa2>lacZ, mam2-) was transformed with pREP3x-STE2-Rluc or 
pREP3x-Mam2-Rluc. Cultures were grown to 1x107 cells per mL and diluted to 1x106 cells 
per mL or concentrated to 1x108 cells per mL with  the  addition  of  60  μM  of  the  Rluc  substrate  
EnduRen. Samples were incubated on a rotating wheel for 2 h before assaying in a Berthold 
Mithras LB940 BRET multimode microplate reader. The luminescence output from the cells 
transformed with the receptor-Rluc fusions was measured and results are shown in Figure 
4-22. The luminescence intensity shows a linear increase with population size and is 
detectable for all population sizes. Further characterization of expressing Rluc in Sz. pombe 
is discussed in Chapter 7. 
 
Figure 4-22: Luminescence intensity of cells expressing STE2-Rluc and Mam2-Rluc 
JY1169 (sxa2>lacZ, mam2-) was transformed with pREP3x-STE2-Rluc or pREP3x-Mam2-Rluc. 
Cultures were grown to 107 cells and diluted to concentrations of 1x106, 1x107 or 1x108 cells per 
sample. 60 μM EnduRen was added to samples followed by 2 h incubation on a rotating wheel. Cells 
were then assayed for luminescence in a Berthold Mithras LB940 BRET multimode microplate reader 
(Berthold Technologies, UK). Values shown are the means ±SEM of triplicate repeats and have been 
corrected for background signal. 
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4.5.3 Energetic Coupling between Receptor-Rluc and Receptor-
GFP Fusions cannot be Detected 
As outlined in the background, both STE2 and Mam2 have previously been shown to form 
receptor oligomers (Ladds, Davis et al. 2005), and in STE2 mutations to the GxxxG motif in 
transmembrane domain 1 reduce oligomerization. Experiments performed in this chapter 
demonstrated that mutations to the smallxxxsmall motif in the first transmembrane domain of 
Mam2 resulted in a reduction in the pheromone response, possibly caused by receptor 
mislocalization, similar to what was observed for the STE2 mutants. BRET technology was 
therefore utilized to investigate whether this is an effect of hindering receptor 
oligomerization. 
An Rluc-GFP fusion expressed from the pREP3x vector acted as a positive control and the 
STE2, Mam2, Mam2G49A, Mam2G49S,S53A and Mam2G49L,S53L receptors labelled with GFP and 
Rluc were chosen for initial analysis. STE2 acted as an additional positive control as BRET 
assays using this receptor has previously been performed successfully in Sc. cerevisiae. 
The mutants were chosen for their signalling and localization phenotypes.  Mam2G49A 
signalled comparable to wild-type receptor, but was found at higher concentrations at the 
plasma membrane. Mam2G49S,S53A displayed reduced signalling activity but was not 
mislocalized and Mam2G49L,S53L did not signal because it did not localize to the plasma 
membrane. The mutant receptors were fused to Rluc in the pREP3x vector. The receptors 
were also fused to GFP in the pREP4x vector. The pREP4x vector contains the selectable 
ura4 marker from Sz. pombe and will be maintained in the JY1169 strain as this strain has a 
nutritional requirement for the gene product when grown in the absence of uracil. Rluc and 
GFP expressed without fused receptors were included as a negative control. The BRET 
donor and acceptor pairs that were used listed in Table 4-1.  
BRET Donor BRET Acceptor 
pREP3x-Rluc-GFP pREP3x-Rluc-GFP 
pREP3-Rluc pREP4x- GFP 
pREP3x-STE2-Rluc pREP4x-STE2-GFP 
pREP3x-Mam2-Rluc pREP4x-Mam2-GFP 
pREP3x-Mam2G49A-Rluc pREP4x-Mam2G49A-GFP 
pREP3x-Mam2G49S,S53A-Rluc  pREP4x-Mam2G49S,S53A-GFP  
pREP3x-Mam2G49L,S53L-Rluc  pREP4x-Mam2G49L,S53L-GFP  
 Table 4-1: BRET donor and acceptor pairs  
Showing the BRET donor and acceptor pairs co-expressed in JY1169 (sxa2>lacZ, mam2-). The left 
column lists the donors expressed from the pREP3x vector. The right column lists the acceptors 
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which were expressed from the pREP4x vector, with the exception of the pREP3x-Rluc-GFP fusion 
which acted as a positive control. 
The BRET donor and acceptor pairs were co-expressed in JY1169 (sxa2>lacZ, mam2-).  
1x106, 1x107 or 1x108 cells were used per sample and incubated for 2 h together with 60  μM  
of the Rluc substrate EnduRen prior to assaying in a micro-plate reader (see Chapter 7 for a 
discussion of optimization of Rluc detection). No energy transfer could be detected between 
any of the constructs (data not shown). This could be due to a number of reasons. The 
donor and acceptor may be too far apart for coupling. This seems unlikely however because 
resonance energy transfer has previously been reported for STE2 BRET donor and acceptor 
fusions (Gehret, Bajaj et al. 2006). In case the signal is too low to be detected using 108 cells 
the using more cells could lead to the detection of signal. It would be challenging however to 
increase the amount of cells in the sample. Lastly, GFP from Aequorea victoria was used, 
and this version may not excite at the wavelength emitted from Rluc whereby using other 
versions of the fluorescent protein might lead to coupling, alternative versions of Rluc also 
exist.  
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4.6 Summary 
The Sc. cerevisiae and Sz. pombe pheromone receptors STE2 and Mam2 were expressed 
in Sz. pombe and assessed for their ability to activate the pheromone-response. Signalling 
activity of Mam2 from the pREP3x plasmid was not significantly different from signalling 
activity of endogenously expressed Mam2. Likewise, adding a GFP tag to either Mam2 or 
STE2 did not hinder signalling activity. The sensitivity of the pheromone dose-response of 
cells transformed with STE2 was similar to cells transformed with Mam2, but maximal 
signalling was reduced. This could possibly be attributable to an inability of STE2 to correctly 
couple to the Sz. pombe cellular machinery, for instance the inability to bind Rgs1. A novel 
method of quantifying cellular protein localization was employed, which indicated that STE2 
might not be processed as efficiently as Mam2 in the Sz. pombe protein degradation 
pathways. This may again be due to an inability of STE2 to efficiently couple to Sz. pombe 
processes. 
Mutations mapping to a motif of two small residues in the first transmembrane domain of the 
receptors influenced both the sensitivity and maximal response to pheromone in cells.  In 
some cases, such as the G60A mutation in STE2, pheromone signalling was unaffected 
despite reduced expression at the plasma membrane. For STE2 mutants where pheromone 
signalling was affected however, this seemed to correlate with reduced plasma membrane 
expression. In Mam2, mutations to another small residue at residues S53 and A57 seemed 
to have a greater effect than when mutating residue G49, suggesting that these residues are 
pivotal to the correct functioning of the receptor.  
The response in the morphological pathway often, but not always, correlated with the 
response in the transcriptional pathway. For instance the Mam2G49A mutant displayed a 
transcriptional pheromone-response comparable to wild-type Mam2 but the morphological 
response was halved. In most cases a reduction in signalling activity correlated with reduced 
expression of the receptor at the plasma membrane. This was not always the case however, 
for instance the Mam2A57G mutant was expressed at the cell cortex in higher amounts than 
wild-type Mam2, but had reduced signalling activity. When mutating the residues to the 
structurally much larger residue leucine signalling activity was decreased for all constructs. 
For the STE2 leucine mutants the pheromone-response was completely abolished. For the 
Mam2 leucine mutants there was a two-fold reduction in the pheromone-response for each 
single leucine mutant, and an absence of response in the double-mutant.  
C-terminal fusions of Rluc to receptor were made and these successfully activated the 
pheromone-response in Sz. pombe. Luminescence intensity was shown to increase linearly 
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with increasing population size. Bioluminescence resonance energy transfer assays of cells 
co-transformed with receptor-Rluc and receptor-GFP fusions, or an Rluc-GFP construct 
failed to detect an energy transfer between Rluc and GFP however, suggesting that the two 
isoforms are not compatible donor and acceptor pairs.  
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5 CHARACTERIZING THE SELF-ASSOCIATION OF 
INDIVIDUAL TRANSMEMBRANE DOMAINS IN 
STE2 AND MAM2 
5.1.1 Background 
It might be possible to study the oligomerization of polytopic proteins through the study of 
their individual TM domains, utilizing the notion that separate TM domains first form 
individual stable units before inter-molecular contacts are formed. The aim of this chapter 
was to explore this possibility. To do this the TOXCAT assay was used which measure the 
self-association of TM domains in an in vivo environment. In addition to the TOXCAT assay, 
molecular modelling using the software suite CHI was also performed to predict specific TM-
TM interactions. Sections 5.1.2 and 5.1.3 demonstrate the assays employed on the well-
characterized dimerizing protein GpA and its dimerization impaired mutant G83I as proof of 
concept of the methods, before characterizing the oligomerization of the STE2 and Mam2 
TM domains.  
5.1.2 The TOXCAT Assay and Controls 
The TOXCAT assay (detailed in section 2.2.9) was used to measure the propensity of 
individual TM domains to oligomerize. This assay measures the strength of TM-TM 
interactions by means of the reporter protein CAT. The TM domain of GpA, which is known 
to strongly dimerize, and its dimerization-impaired mutant (G83I), were used as positive and 
negative controls respectively, and their sequences are shown in Figure 5-1A. A Western 
blot was performed in order to quantify the expression level of each construct (Figure 5-1B), 
because the expression level of the chimera is linearly related to reporter activity. Through 
adjusting the TOXCAT signal to the expression level the relative strength of oligomerization 
of the TM domains under investigation can be normalized to GpA.  
The TM domains of the two controls were expressed as MBP-TM-ToxR fusion chimera and 
the red arrow in the Western blot shown in Figure 5-1 points to the full-length ~66 kDa 
chimera. The chimera may get proteolytically cleaved however, as indicated by the presence 
of a second lower molecular weight band, marked with a red star at ~43 kDa and 
corresponds to the mass of MBP.  
MBP-TM-ToxR chimeras were expressed in the E. coli NT326 strain, which is a malE 
deficient mutant. The malE gene encodes endogenous maltose binding protein, which is 
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needed for transport of maltose to the cytoplasm. The correct insertion and orientation of 
chimera can therefore be checked by the malE complementation assay where cells are 
grown on media where maltose is the sole carbon source. Only cells containing the correctly 
inserted and oriented MBP-TM-ToxR chimera will grow and form colonies (Figure 5-1C, left) 
because the expression of malE in the chimera compensates for the lack of MalE in the 
genome. In some instances, chimera fail to grow on the maltose plates, and the spheroplast 
assay can be performed instead (Figure 5-1C right). In the spheroplast assay, cell cultures 
are separated into fractions containing periplasm (PF), spheroplasts (SF) and spheroplasts 
treated with proteinase K (SPF). Since MBP is bound to the membrane it should not be 
detectable in the PF but appear in the membrane-containing SF (highlighted with a blue 
arrow). In the SPF this band disappears because MBP is liberated from the TM-ToxR 
domains, and is instead detectable as a lower molecular weight band, marked with a blue 
star. This lower molecular weight band correlates with the proteolytically cleaved chimera. If 
the 66 kDa band is not present in the spheroplast fraction this indicates that the chimera is 
not inserted into the membrane.  
In the TOXCAT assay (Figure 5-1D), levels of CAT activity are normalized to the expression 
level relative to GpA, meaning that strengths of interactions are all relative to the strength of 
the GpA dimer. CAT activity of the dimerization-impaired GpA G83I mutant is ~10% of GpA 
and other TM domains may display interactions stronger than GpA, weaker than G83I, or in 
between the two (Jenei, Borthwick et al. 2009; Lawrie, Sulistijo et al. 2010). The assay 
cannot discriminate between different oligomeric states however, meaning that CAT activity 
detected could be due to dimer formation, or formation of higher order oligomers.  
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Figure 5-1: Expression, insertion and orientation checks for the TOXCAT controls  
All assays were performed in the E. coli NT326 strain (malE-) A: Showing the transmembrane domain 
sequence of the positive control GpA and its dimerization deficient G83I mutant, which acted as the 
negative control. The bold residues highlight the GxxxG motif, and the red residue marks the mutation 
rendering the TM domain dimerization deficient. These were inserted into the pccKan vector in order 
to express MBP-TM-ToxR chimera. B: Expression check of the positive and negative control shown 
on the left. The arrow indicates the full MBP-TM-ToxR chimera. The star indicates MBP proteolytically 
separated from the TM-ToxR chimera. C: MalE complementation assay of the positive and negative 
control (left) and spheroplast assay of the positive and negative control to further test its insertion and 
orientation in the membrane (right). E: CAT activity of the positive and negative control determined by 
the TOXCAT assay to measure the degree of homo-oligomerization. Results shown are means of 
triplicate determinations of three independent isolates ±S.E.M.   
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5.1.2.1 Molecular Modelling of GpA Dimerization 
Molecular models of the dimerization of GpA were built using the CHI (CNS (Crystallography 
and NMR Searching) of Helix Interactions) suite described in detail in Section 2.2.13.2. 
Briefly, CHI builds   two  α-helices from the primary sequence of the TM domain of interest. 
The helices are then iteratively rotated about their long axis relative to each other. Each 
rotation is followed by simulated annealing and energy minimization in which the rotational 
angle phi and crossing angle omega is free to vary. Four trials are carried out in each 
search, each using varying starting velocities in the simulated annealing process meaning 
that each CHI run generate different structures. The backbone root-mean-square deviation 
(RMSD) is then calculated and compared between structures, and structures where the 
backbone RMSD differs by 1.0 Å or less are placed into a cluster. A minimum of 10 
structures of similar geometry were set as a cut-off point to form a cluster, and within each 
cluster the structure was averaged. For each structure modelled, five rounds of CHI 
searches were run and compared. Results were plotted on an (x,y) coordinate graph with the 
frequency domain on the z-axis. The x and y axes correspond to the phi angles, i.e. the 
relative rotation of helix1 (phi1) to helix2 (phi2) in each cluster. Dimers containing 
symmetrical interaction interfaces are located on a diagonal line running between (0,0) and 
(360,360).  
Figure 5-2A shows the clusters of structures generated via the CHI searches of GpA. Only 
right-handed helices are shown for all models because GpA is known to form right-handed 
dimers (MacKenzie, Prestegard et al. 1997), however the program does find both left and 
right handed solutions. The phi angles plotted on the x and y-axes represent the rotation of 
the helices relative to each other, and consequently clusters of structures coinciding with the 
red line drawn between vertices (0,360) are symmetrical structures. When modelling homo-
dimers, symmetrical structures are often assumed, however the formation of higher order 
oligomers may involve interactions that are not symmetrical. The z-axis represents the 
number of clusters found in each search for each relative rotation, and clusters found in 
individual repeats are represented by separate colours (red, green, black, purple and blue). 
The data shows that in three of the repeats, a symmetrical structure is found coinciding with 
a rotation of the helices from the starting structure of ~70° (encircled in black). This structure 
has   an   average   crossing   angle   (Ω)   of   ~45°   and   slight shift along the long helical axes 
relative to each other, which would be assumed in a symmetrical dimer. In this model the 
centre of the helices are separated by a minimum of ~6.3 Å. The structure of the 
symmetrical GpA dimer found in the CHI searches is shown in Figure 5-2A. The close 
association of the glycine residues (shown in blue) allows close packing of the helices of the 
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dimer, and optimal packing of the  β-branched ‘ridge’ residues (represented by spheres). The 
GxxxG motif is often found adjacent to the large aliphatic residues isoleucine, valine, and to 
a lesser extent leucine (Russ and Engelman 2000; Senes, Gerstein et al. 2000). Isoleucine 
and  valine  are  both  β-branched residues, meaning that they have two carbons attached to 
their   β-carbon as opposed to one, which is the case in most other amino acids. As a 
consequence there is a lot of bulkiness near the protein backbone in the α-helical 
conformation restricting the possible conformations of the protein. It is believed that the 
restricted side-chain motion of these residues minimize the loss of entropy upon dimerization 
via GxxxG motifs (Liu, Crocker et al. 2003). The NMR structure of glycophorin A reveal that 
the groove formed by the GxxxG motif, and the ridge of the neighbouring valine residues 
(GVxxGV) form a large ridges-into-grooves contact surface for dimer formation (MacKenzie, 
Prestegard et al. 1997).  
When mutating G83 to isoleucine, the symmetrical structure involving close packing of the 
GxxxG motif, found at phi angle 70°, disappear as indicated by the blue arrow in Figure 
5-2B. Instead a new symmetrical structure appears which is formed by packing of I77, M81 
and I85 at the interface. This helix however contained a large shift, 3.7 Å, along the long 
helical axes of the helices relative to each other and the distance between helices increased 
to 8.8 Å. This is much further than the 6.3 Å observed in the wild-type dimer. 
This indicates that CHI can, with interpretation and in conjunction with experimental data, be 
used to predict the formation of TM helix dimer formation. Since data from different searches 
cannot easily be assembled and because CHI exports data in a format compatible with the 
UNIX platform, a script was written to extract data from multiple CHI searches and to make 
the data windows compatible. 
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Figure 5-2: Structure of the GpA dimer 
The phi plots on the left show the distribution of clusters from global searches as a function of their 
orientation, represented by the angle phi. Four MD repeats using random starting velocities were 
performed in each run and five separate searches were performed. When >10 separate structures 
with  Cα  RMSD  values  within  <1  Å  were  found, their structure was averaged to generate  a  “cluster”.  
Different colors of clusters indicate solutions found in separate repeats and symmetrical structures 
found in several repeats are encircled in black. Structural models of such clusters are shown on the 
right. A: The clusters of structural solutions found for the GpA dimer B: The clusters of structural 
solutions found for the dimerization deficient G83I mutant. The arrow indicates the absence of the 
cluster comprising of dimers associating via the GxxxG motif. 
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5.2 Homo-Oligomerization of the STE2 Transmembrane Domains 
5.2.1 Oligomerization of Transmembrane Domains 1-7 from STE2 
An initial screen of all seven transmembrane domains in STE2 was performed to test the 
propensity of each domain to self-associate in the TOXCAT assay. Seven different MBP-TM-
ToxR chimeras were cloned into the pccKan vector containing sequences corresponding to 
the predicted TM domains 1-7 in STE2. The intracellular TM boundaries have been 
characterized (Choi and Konopka 2006) and the extracellular boundaries were predicted 
using the TM prediction software TMHMM (Krogh, Larsson et al. 2001). The sequences of 
each transmembrane insert are shown in Figure 5-3A.  An expression check was performed 
because concentration differences affect the relative CAT activities found in the TOXCAT 
assay, and thus the strength of oligomerization. Figure 5-3B shows the western blot of whole 
cells to check the expression of each transmembrane insert. Two bands are present in the 
blot; a heavier band at ~66 kDa corresponding to the full MBP-TM-ToxR chimeras (red 
arrow) and a higher mobility band at ~43 kDa (red star). The presence of the lower 
molecular weight band, as previously discussed, has been reported in literature and 
corresponds to proteolytically cleaved MBP (Russ and Engelman 1999). The expression 
level of each transmembrane insert relative to GpA was calculated using ImageJ (Abramoff, 
Magalhaes et al. 2004) to allow normalization of oligomerization data, shown underneath the 
blot.  
The malE complementation assay (Figure 5-3C) showed that all transmembrane domains 
with the exception of TM3 grow on maltose, indicating correct insertion and orientation of 
these chimeras. The spheroplast assay was performed on TM3 (Figure 5-3C) to further 
analyse its insertion into the membrane. The PF did not contain MBP as expected. The SF in 
contrast contained a band corresponding to the MBP-TM-ToxR chimera (blue arrow). When 
treated with proteinase K this band disappeared as shown in the SPF and only the band 
corresponding to proteolytically cleaved MBP remained (blue star). These checks confirm 
that all the individual TM domains from STE2 are expressed at comparable levels to GpA 
and insert into the membrane with the correct topology.    
The propensity of TM domains 1-7 from STE2 to self-associate was measured using the 
quantitative CAT assay, described in detail in section 2.2.9, and results were normalized to 
expression levels relative to GpA. Surprisingly, despite BRET and FRET data indicating that 
STE2 homo-oligomerizes via a GxxxG motif in its first TM domain (Overton, Chinault et al. 
2003; Gehret, Bajaj et al. 2006) and the implications of this motif for cell localization and 
function of STE2, presented in chapter 4, TM1 did not self-associate in the TOXCAT assay 
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(Figure 5-3D). Similarly, the TM3 insert did not oligomerize and resulted in the lowest CAT 
activity; yielding only 1% of the GpA CAT activity. 
Interestingly, TM2 self-associated with measured reporter CAT activity close to the positive 
control; ~87% of GpA. Previously published FRET experiments using receptor fragments 
have shown that TM1 alone cannot self-associate, however TM1-TM2 receptor fragments 
self-associate with near wild-type affinity (Overton and Blumer 2002). The FRET 
experiments did not investigate oligomerization of TM2 alone however, and the high 
TOXCAT signal observed for TM2 is therefore of interest.  
TM5 also exhibited high reporter activity with a mean CAT activity of 81% of GpA. In the 
FRET experiments on receptor fragments this domain also self-associated when expressed 
with TM6 and TM7, however these interactions were believed to be due to aggregation 
because fragments did not interact with wild-type receptor (Overton and Blumer 2002).  
Expressing the TM4 and TM7 inserts resulted in only 14% and 12% CAT activity 
respectively, compared to GpA. This was unexpected, as TM4 has been implicated in a 
second oligomerization interface. This interface is believed to be separate from the TM1 
motif and serve to allow the formation of higher order oligomers (Wang and Konopka 2009). 
TM7 has also been implied in the oligomerization of STE2 in the absence of ligand, together 
with TM1 (Kim, Lee et al. 2009). Expressing TM6 inserts in contrast resulted in slightly 
higher CAT activity; 45% of GpA.  
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Figure 5-3: Expression, insertion, orientation and oligomerization of the STE2 TM domains 1-7 
TOXCAT Chimeras 
All assays were performed in the E. coli NT326 strain (malE-) A: Showing the sequence of the seven 
different transmembrane inserts corresponding to STE2 transmembrane domain 1-7. These were 
inserted into the pccKan vector in order to express MBP-TM-ToxR chimera. B: Expression check of 
the constructs used in this study. The arrow indicates the full MBP-TM-ToxR chimera. The star 
indicates MBP proteolytically separated from the TM-ToxR chimera. C: MalE complementation assay 
of the constructs used in this study (left). The construct incorporating TM3 did not grow on maltose 
and therefore the spheroplast assay was performed on this construct (right) D: CAT activity of the TM 
chimeras determined by the TOXCAT assay to measure the degree of homo-oligomerization. The 
asterisks denote ranges of mean CAT activity normalized to GpA where *=26-50%, **=51%-75%, 
***=76%-100%, ****=101%-125% and *****=>126%. Results shown are means of triplicate 
determinations of three independent isolates ±S.E.M.   
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5.2.2 Further Characterization of the Homo-oligomerization of 
Transmembrane Domain 1 from STE2  
5.2.2.1 Length Optimization of Transmembrane Domain 1 in STE2 
Due to previous reports suggesting that the Sc. cerevisiae GPCR STE2 oligomerizes via a 
GxxxG motif in its first TM domain (Overton, Chinault et al. 2003; Gehret, Bajaj et al. 2006) it 
was surprising that the domain did not self-associate in the TOXCAT assay. Studies have 
shown that the strength of reporter activity in the TOXCAT assay is dependent on the 
positioning of the ToxR domains relative to each other, which is influenced by the length of 
the TM insert (Langosch, Brosig et al. 1996; Li, Gorelik et al. 2004; Jenei, Borthwick et al. 
2009). It has also been shown that the positioning of the GxxxG motif in the membrane 
influences the signal (Johnson, Rath et al. 2006). Since reporter activity is influenced by the 
insert, and because of the number of studies suggesting that STE2 self-associates via TM1-
TM1 interactions, different lengths and frames of the predicted TM1 domain were inserted 
into the TOXCAT chimera to see if CAT activity could be improved.   
Figure 5-4A shows the seven different sequences of TM1 inserted into the TOXCAT MBP-
TM-ToxR chimera. Both the length and the frame of the TM domain was considerably varied 
in order to determine whether the absence of CAT activity was an artefact due to the length 
and frame of the construct assayed initially. The expression check (Figure 5-4B) shows that 
the 19 and 20 amino acid long TM domains were not expressed at very high levels - only 8-
9% of the level of GpA expression respectively, meaning that their TOXCAT signals would 
need to be increased ~12.5 fold during the normalization procedure. The other constructs 
were expressed at levels comparable to GpA. All constructs, with the exception of the 16 
amino acid-long insert, grew on maltose and it was therefore concluded that these chimeras 
were correctly inserted and orientated across the inner membrane (Figure 5-4C, left). The 16 
amino acid-long construct was further investigated using the spheroplast assay, and it was 
found that the construct was correctly inserted and oriented across the membrane as 
indicated by the 66 kDa band present in the spheroplast fraction (Figure 5-4C, right). 
All constructs had very low TOXCAT signals prior to normalization to GpA. After 
normalization however, the signal from the 19 amino acid long construct increased 
dramatically. A noticeable increase was also seen in the 20 amino acid long construct and 
the signal from the 25 amino acid long construct was also somewhat increased. All these 
constructs, however, had a much lower relative expression when compared to GpA meaning 
that the TOXCAT signal from the 19 amino acid long construct was increased ~12.5 fold, 
that of the 20 amino acid long construct increased ~11-fold, and the signal from the 25 
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amino acid long construct more than doubled. Due to the heavy cleavage of these constructs 
however, the results cannot be reliably interpreted and are likely to be artefacts of the 
normalization procedure. These results therefore indicate that STE2 TM1 when expressed in 
isolation, does not self-associate. 
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Figure 5-4: Length optimization of transmembrane domain 1 from STE2 
All assays were performed in the E. coli NT326 strain (malE-) A: Showing the sequence of the 
different lengths and frames of TM domain 1 from STE2 inserted into the pccKan vector to test if the 
TOXCAT signal could be improved. B: Expression check of the constructs used in this study. The 
arrow indicates the full MBP-TM-ToxR chimera. The star indicates MBP proteolytically separated from 
the TM-ToxR chimera. C: MalE complementation assay of the constructs used in this study (left). The 
construct incorporating the 16 amino acid long construct did not grow on maltose and therefore the 
spheroplast assay was performed on this construct (right) D: CAT activity of the TM chimeras 
determined by the TOXCAT assay to measure the degree of homo-oligomerization. The asterisks 
denote ranges of mean CAT activity normalized to GpA where *=26-50%, **=51%-75%, ***=76%-
100%, ****=101%-125% and *****=>126%. Results shown are means of triplicate determinations of 
three independent isolates ±S.E.M.   
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5.2.2.2 Molecular Modelling of STE2 Transmembrane Domain 1 
Dimerization 
Although TM1 from STE2 did not appear to oligomerize in the TOXCAT assay, because of 
the effects of mutating this motif to leucine in the full-length protein (discussed in Chapter 4), 
the structure of a dimer was modelled. CHI modelling of the 19 amino acid long TM1 
construct revealed two symmetrical right-handed structures that were present in three 
independent repeats respectively (Figure 5-5A) and one symmetrical left-handed dimer 
(Figure 5-5B) none of which involved close-packing via the GxxxG motif. In the right-handed 
dimer found at a relative phi angle of 100°, the centre of the helices were packed relatively 
close with a minimum distance of 6.9 Å between the helical axes. The close packing of the 
helices was achieved via interactions between opposite A52 and G56 residues (blue 
spheres), thereby unexpectedly implying a different smallxxxsmall motif from the previously 
reported G56xxxG60 motif (Overton, Chinault et al. 2003). The left-handed solution shown in 
Figure 5-5B was very similar structurally, and residues G60 were not involved in dimer 
formation as illustrated in the structure.  In these two models, C59 (shown as spheres 
coloured by elements in Figure 5-5A) achieved close packing in the dimer interface through 
packing against the G60 residues of the opposite helix. This seems improbable in the full-
length protein because C59 is involved in ligand binding and faces the TM bundle (Tantry, 
Ding et al. 2010). R58, in contrast, which is also involved in ligand binding, was pointing 
away from the dimer interface, as would be expected. Taken together, this structural model 
is not supported by experimental evidence, as both glycines 56 and 60 are implicated in 
oligomerization, and because of the positioning of the cysteine residue.  
A second right-handed symmetrical dimer was found at a relative rotational angle of 227° 
(Figure 5-5A, left panel). In this model, the distance between the helical axes was much 
larger than found in the first model (8.9 Å) and the helices appeared to pack via the C59 and 
R58 residues introducing a bend in the TM domain. Bends do occur in TM helices, and have 
been observed in GPCRs, however not in the case of STE2 TM1 and this model therefore 
appears unlikely (Yeagle, Bennett et al. 2007). 
In conclusion, the TOXCAT data and the structural modelling do not predict that STE2 TM1 
oligomerizes via the GxxxG motif. These data therefore support the finding in the FRET 
studies on TM receptor fragments that STE2 TM1 cannot oligomerize on its own (Overton 
and Blumer 2002). 
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Figure 5-5: Molecular modeling of STE2 TM domain 1 dimers 
The phi plot on the left show the distribution of clusters from global searches of the STE2 TM1 dimers 
as a function of helix orientation represented by the angle phi. Four MD repeats using random starting 
velocities were performed in each run and five separate searches were performed. When >10 
separate   structures  with  Cα  RMSD   values  within   <1  Å  were   found   their   structure  was  averaged   to  
generate   a   “cluster”.   Different   colors   of   clusters   indicate   solutions   found   in   separate   repeats   and  
symmetrical structures found in several repeats are encircled in black. A: Right-handed solutions. B: 
Left-handed solutions. 
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5.2.3 Characterization of the Homo-oligomerization of 
Transmembrane Domain 2 from STE2  
5.2.3.1 Transmembrane Domain 2 Contains Several Polar Residues 
The TOXCAT data presented here as well as the published FRET study on receptor TM 
fragments (Overton and Blumer 2002) show that TM1 cannot self-associate on its own; and 
the FRET study suggested that TM2 is required in order to stabilize interactions. The initial 
TOXCAT study of the seven transmembrane domains in STE2 further implicated that TM2 
self-associate strongly. Due to the functional effects of mutating the GxxxG motif in TM1 (as 
discussed in chapter 4) but its inability to form dimers in the TOXCAT assay and modelling, it 
might be possible that STE2 dimers interact via contacts formed between the TM2 domains 
to the other receptor, and close proximity of receptors may be achieved via close packing of 
TM1 domains.  
TM2 contains several polar residues, including asparagine, glutamine, serine and histidine 
which, when plotted on a helical wheel diagram, appear to be distributed over approximately 
two-thirds of the helix (Figure 5-6A). Slightly polar amino acids such as serine, threonine and 
tyrosine have been shown to have a moderate effect on oligomerization of transmembrane 
domains (Gratkowski, Lear et al. 2001; Zhou, Merianos et al. 2001). More strongly polar 
amino acids however, have been shown to have a much greater effect on transmembrane 
domain oligomerization. These include, among others, asparagine and histidine (Choma, 
Gratkowski et al. 2000; Zhou, Cocco et al. 2000; Zhou, Merianos et al. 2001) which are 
present in the STE2 TM2 domain. The sequence context of the polar amino acids is, 
however, important. For example, the membrane protein BNIP3 dimerizes strongly via 
hydrogen bonding of histidine residues on separate helices, however BNIP3 also contains a 
GxxxG motif on the same face as the histidine residue. Mutations of the GxxxG motif 
disrupts dimerization by not allowing the two monomers to come into close enough proximity 
for histidine to hydrogen bond (Sulistijo, Jaszewski et al. 2003; Lawrie, Sulistijo et al. 2010). 
The abundance of polar residues in the TM2 domain may suggest that the GxxxG motif in 
TM1 merely allow two TM2 domains to come into close proximity, thus allowing hydrogen 
bond formation between polar residues in two separate TM2 domains. This would probably 
involve an asymmetric interaction, either between the TM1 and TM4 domains or between the 
TM2 and TM7 domains. The TM7 domain has previously been implicated in oligomerization 
of STE2 (Kim, Lee et al. 2009) and this domain also contains a smallxxxsmall motif of two 
alanine residues. The TM4 domain has also been implicated in a second oligomerization 
motif although it is not know what interactions mediate oligomer formation. This motif does 
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contain a smallxxxsmall motif; TxxxA, which aligns to the same motif in rhodopsin in the 
homology models presented later in Chapter 6. This motif is however found packing against 
the TM3 domain meaning that it is unlikely to be involved in oligomer formation.  
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5.2.3.2 Structural Models of the Positioning of Polar Residues in 
Transmembrane Domain 2 
Figure 5-6B shows a homology model of STE2 (discussed in detail in Chapter 6) and polar 
residues found in TM2 are highlighted. The asparagine residue N84 (shown in blue) is 
located on the lipid-facing side of TM2 and would be accessible for interactions with another 
receptor. The other polar residues present in TM2 appear less accessible, with H94 (shown 
in purple) facing the TM bundle and hydrogen bonding with Y98, which in turn also hydrogen 
bond to R58 in TM1. In this model both glycines from the GxxxG motif in TM1 are accessible 
on the lipid facing side of the protein (red spheres), which is likely if they mediate receptor-
receptor interactions, together with N84 in TM2.  
There is an NMR structure available in the protein databank of STE2 TM1-TM2 (PDB ID 
2K9P), shown in Figure 5-6C (Neumoin, Cohen et al. 2009). In this model however, N84 
projects in a direction where it would possibly pack against TM3 and/or TM4. The GxxxG 
motif is also inaccessible and packs together with A63 against the large hydrophobic 
residues in TM2; V86, L90 and L93. H94 is not H-bonding to Y98, but both residues are 
instead pointing into the lipid moiety in the direction that the TM3 and TM4 domains would 
be expected to reside.  
The positioning and interactions of H94, Y98 and R58 are relevant because it is known that 
R58   interacts   with   the   α-factor peptide through cation-π   interactions   (Tantry, Ding et al. 
2010) and a Y98H mutation results in constitutive activity of the receptor (Parrish, Eilers et 
al. 2002). Moreover, these residues are highly conserved in the yeast receptors (Eilers, 
Hornak et al. 2005). A close-up view of the hydrogen bonding network in the homology 
model of STE2 is shown in Figure 5-6D.  From this model, it seems possible that Y98 could 
interact with R58 to keep the receptor in its inactive state, an interaction stabilized by H94. 
Upon ligand binding, R58 might instead interact with the ligand, thus breaking the bond to 
Y98, which would relax TM1-TM2 interactions and may lead to other conformational 
changes in the protein. The Y98H mutant is likely to be unable to form this hydrogen bonding 
network, because if it is charged it may not be able to interact with the positively charged 
arginine residue and the histidine residue. This could explain the constitutive activity of the 
Y98H mutant.   
The homology model thus predicts a very different structure from the NMR structure. In the 
former, N84 should be accessible for homo-dimer formation whereas in the latter H94 would 
be accessible for homo-dimer formation in the full-length protein. Both models however have 
their draw-backs. Membrane protein homology modelling is not at a stage where it is 
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considered highly accurate, due to a lack of protein structures on which to base predictions. 
This is further hindered by low sequence similarity between the yeast and class A GPCRs. 
Similarly; the NMR structure was determined using detergent micelles, which do not provide 
an environment in which protein structure prediction is considered highly accurate. Detergent 
micelles can destabilize helix-helix interactions, via competing interactions between amino 
acids and the polar head-groups of the detergent, thereby allowing increased side-chain 
flexibility in the amino acid chain or disrupting inter-helical bonds (Langosch, Brosig et al. 
1996; MacKenzie 2006). To see if either structural model agrees with the TOXCAT data, the 
N84 and H94 residues were both mutated to alanine, to see if the mutations would disrupt 
oligomerization. 
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Figure 5-6: STE2 TM domain 2 in the context of the full-length protein 
A: A helical wheel of STE2 TM domain 2. The colour coding corresponds to colours used in B-D. B: 
Homology model of the positioning of polar residues in STE2 TM domain 2. The GxxxG motif and R58 
in TM domain 1 are also highlighted. A detailed description of the homology models can be found in 
Chapter 6. C: NMR structure of TM domain 1 and 2 resolved in micelles (Neumoin, Cohen et al. 
2009), PDB ID 2K9P. D: Interactions between TM1 and TM2 as predicted by homology modelling.  
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5.2.3.3 Molecular Modelling of STE2 Transmembrane Domain 2 
Dimerization  
CHI modelling of the STE2 TM2 domain revealed two sets of symmetrical right-handed 
dimers shown in the left panel of Figure 5-7A and encircled in black, and two sets of left-
handed dimers shown in the left panel of Figure 5-7B. Of the right handed dimers, one was 
found in four separate searches and all contained hydrogen bonds between the side-chain 
amide of N84 and hydroxyl group of S87 on opposite helices, as well as a hydrogen bond 
between the hydroxyl group of the S95 residues, as shown in the left-most structural model 
in Figure 5-7A. In the second symmetrical right-handed dimer, the side chain of H94 was 
found to hydrogen bond to a backbone carbonyl of the opposite helix, and there was also a 
hydrogen bond between the hydroxyl groups of opposite S87 residues (Figure 5-7A, right-
most model). In this model, N84 is found pointing away from the interface. The left-handed 
models also implied residues N84, S87 or H94 in dimer formation. In the first dimer (middle 
panel, Figure 5-7B) the side chain amide of N84 H-bonds to the side-chain carbonyl of the 
opposite N84 residue, as well as to the protein backbone. There is also an H-bond between 
the hydroxyl group on the side-chain of S87 and the Q85 side-chain amide. The second 
symmetrical left-handed dimer contains an H-bond between the side-chain imidazoles of the 
H94 residues (Figure 5-7A, right-most panel).  
Due to the biological importance of H94, suggesting that it is likely to face the TM bundle in 
the full-length protein, and the putative positioning of N84 on the opposite side of the helix, 
as well as their individual involvement in each of the two symmetrical dimers modelled, it 
was of interest to model dimer formation when these residues were mutated.   
When changing N84 to alanine, three right-handed symmetrical dimers were found (Figure 
5-8A). The dimer found at 43° was stabilized by a hydrogen bond between the imidazole ring 
of H94 and the hydroxyl group on S95, as shown in the middle panel. The structures found 
at 235° involved a polar contact between the two helices formed by Q85 hydrogen bonding 
to the main chain of the opposite helix via its side-chain amide (right-most structural model in 
Figure 5-8A). The third dimer involved interactions between the free N-termini of the 
peptides, which is an artefact due to the method of modelling free peptide termini and not 
physiologically   relevant  and   therefore  won’t  be discussed further. No H-bonds were found 
between the two left-handed dimers (Figure 5-7B) but interactions appeared to be stabilized 
by other forces. In one dimer residues V86, F89 and L93 were found at the interface and in 
the other S87 and H94 were found at the interface.  
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When H94 was changed to alanine, a right-handed dimer similar to that observed for wild-
type TM2 was observed (Figure 5-9A, middle panel). This dimer was stabilized by a H-bond 
between the hydroxyl groups of S95, and additional H-bonding between the side-chain N84 
amide with the hydroxyl group of S87 on the opposite helix (stabilized by interactions 
between N84 and S87 and S95-S95) was present at 25° (Figure 5-9A). There are also a 
number of dimers present at 10° that contained the interactions between residues N84 and 
S87, but not S95. The second right-handed symmetrical dimer identified in this search 
resembled the second symmetrical dimer found in the wild-type search, and is stabilized by 
a hydrogen bond between the hydroxyl groups of S87, but obviously without the H-bond 
formed by H94 in the wild-type dimer (shown in Figure 5-9A, right panel). Only one left-
handed symmetrical dimer was identified, shown in Figure 5-9B. This dimer formed a 
hydrogen bonding network between the N84 side-chain amide to the Q85 side-chain 
carbonyl and the N84 side-chain amide to the opposite N84 side-chain carbonyl. It also 
contained a hydrogen bond between the hydroxyl groups on the side-chain of S95.   
It is not straight-forward to draw any conclusions from this data. It appears as though a N84A 
mutation will disrupt oligomerization resulting from either N84A-N84A interactions or 
H94/S87-S87 interactions in the left-handed models, but only N84A-N84A interactions in the 
right-handed models. In contrast, a H94A mutation does not disrupt oligomerization resulting 
from N84-N84 interactions in either the left-handed or right-handed models.   
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Figure 5-7: Structural models of wild-type STE2 TM domain 2 dimers 
The phi plots on the left show the distribution of clusters from global searches as a function of their 
orientation, represented by the angle phi. Four MD repeats using random starting velocities were 
performed in each run and five separate searches were performed. When >10 separate structures 
with  Cα  RMSD  values  within  <1  Å  were   found   their  structure  was  averaged   to  generate  a  “cluster”.  
Different colors of clusters indicate solutions found in separate repeats and symmetrical structures 
found in several repeats are encircled in black. Structural models of such clusters are shown on the 
right. Yellow dashed lines indicate a predicted H-bond A: The clusters of right-handed structural 
solutions B: The clusters of left-handed structural solutions. 
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Figure 5-8: Structural dimeric models of STE2 TM domain 2 N84A mutants 
The phi plots on the left show the distribution of clusters from global searches as a function of their 
orientation, represented by the angle phi. Four MD repeats using random starting velocities were 
performed in each run and five separate searches were performed. When >10 separate structures 
with  Cα  RMSD  values  within  <1  Å  were   found   their  structure  was  averaged   to  generate  a  “cluster”.  
Different colors of clusters indicate solutions found in separate repeats and symmetrical structures 
found in several repeats are encircled in black. Structural models of such clusters are shown on the 
right. Yellow dashed lines indicate a predicted H-bond A: The clusters of right-handed structural 
solutions B: The clusters of left-handed structural solutions. 
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Figure 5-9: Structural dimeric models of STE2 TM domain 2 H94A mutants 
The phi plots on the left show the distribution of clusters from global searches as a function of their 
orientation, represented by the angle phi. Four MD repeats using random starting velocities were 
performed in each run and five separate searches were performed. When >10 separate structures 
with  Cα  RMSD  values  within  <1  Å  were   found   their  structure  was  averaged   to  generate  a  “cluster”.  
Different colors of clusters indicate solutions found in separate repeats and symmetrical structures 
found in several repeats are encircled in black. Structural models of such clusters are shown on the 
right. Yellow dashed lines indicate a predicted H-bond A: The clusters of right-handed structural 
solutions B: The clusters of left-handed structural solutions. 
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5.2.3.4 Mutations of N84 and H94 Affect the In Vivo Oligomerization of 
Transmembrane Domain 2  
To test if either N84 or H94 is involved in the self-association of STE2 TM2, each residue 
was mutated to alanine and inserted into the TOXCAT MBP-TM-ToxR expression vector. 
The sequences are shown in Figure 5-10A with the relevant amino acids shown in bold. Both 
chimeras containing mutated TM2 domains had a ~2-fold increased expression level 
compared to GpA (Figure 5-10B) and little proteolytically cleaved chimera was found, as 
indicated by the much larger ratio of the 66 kDa band compared to the 43 kDa band. Both 
chimeras were inserted and oriented correctly across the E. coli plasma membrane as 
indicated by the MalE complementation assay (Figure 5-10C).   
Figure 5-10D shows the CAT activities for the TM2 domains containing the N84A and H94A 
mutations, normalized to expression levels, with wild-type TM2 shown for comparison. Both 
mutations reduced self-association of the domain. The N84A mutation greatly reduced the 
ability of TM2 to self-associate, yielding a 20-fold decrease in CAT activity compared to wild-
type TM2 levels.  The H94A mutation also reduced reporter activity, but to a lesser degree 
than the N84A mutation, yielding a ~5-fold decrease in CAT activity. Assuming a 
symmetrical interaction between TM domains, from the predictions made by the structural 
modelling of these dimers, this may implicate that STE2 TM2 oligomerization involved 
residues H94 and S87.  
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Figure 5-10: Mutations affecting STE2 TM domain 2 dimerization  
All assays were performed in the E. coli NT326 strain (malE-) A: Showing the sequence of STE2 TM2 
and highlighting in black the two mutations tested for their affects on TM2 dimerization; N84A and 
H94A (sequences shown underneath and highlighted in red), that were investigated in the TOXCAT 
assay B: Expression check of the constructs used in this study. The arrow indicates the full MBP-TM-
ToxR chimera. The star indicates MBP proteolytically separated from the TM-ToxR chimera. C: MalE 
complementation assay of the constructs used in this study D: CAT activity of the TM chimeras 
determined by the TOXCAT assay to measure the degree of homo-oligomerization. The asterisks 
denote ranges of mean CAT activity normalized to GpA where *=26-50%, **=51%-75%, ***=76%-
100%, ****=101%-125% and *****=>126%. Results shown are means of triplicate determinations of 
three independent isolates ±S.E.M.    
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5.3 Homo-oligomerization of the Mam2 Transmembrane Domains 
5.3.1 Oligomerization of Transmembrane Domains 1-7 from Mam2 
An initial screen of all seven transmembrane domains in Mam2 was performed to investigate 
the propensity of each domain to self-associate and to identify similarities and differences 
between Mam2 and STE2. Seven different MBP-TM-ToxR chimeras were cloned into the 
pccKan vector containing sequences corresponding to TM 1-7 in Mam2. The sequences of 
each transmembrane insert are shown in Figure 5-11A.  An expression check was 
performed to measure the relative levels of chimera expression and allow normalization to 
GpA expression levels, shown in Figure 5-11B. The blot shows both bands described 
previously; the heavier band at ~66 kDa corresponding to the full MBP-TM-ToxR chimeras 
(red arrow) and the higher mobility band at ~43 kDa (red star) corresponding to 
proteolytically cleaved chimeras. The expression level of each TM insert relative to GpA is 
shown underneath the blot.  
The malE complementation assay (Figure 5-11C) showed that all TM domains with the 
exception of TM5 grew on maltose, indicating correct insertion and orientation of these 
chimeras. The spheroplast assay was performed on TM5 (Figure 5-11C) to further analyse 
its insertion into the membrane. The PF did not contain MBP as was expected. The SF in 
contrast contained a band corresponding to the MBP-TM5-ToxR chimera (blue arrow). When 
treated with proteinase K this band disappeared as shown in the SPF and only the band 
corresponding to proteolytically cleaved MBP remained (blue star). These checks confirm 
that the individual transmembrane domains from Mam2 are expressed at comparable levels 
to GpA and insert into the membrane with the correct topology.    
Figure 5-11D shows the TOXCAT data for Mam2 TM domains 1-7 normalized to expression 
levels relative to GpA. Interestingly, TM1 in Mam2 displayed relatively high levels of self-
association, in contrast to what was observed for STE2 TM1. The mean CAT activity for 
Mam2 TM1 was 60% of GpA compared to 7% for the STE2 TM1 domain. Similar to STE2 
however, the Mam2 TM2 domain was observed to self-associate strongly. The interaction 
between Mam2 TM2 domains (112% CAT activity of GpA) was stronger than that observed 
for STE2 TM2 (87% CAT activity of GpA).  
TM5 from Mam2 also self-associated, although the reporter activity observed for Mam2 was 
somewhat lower than for the corresponding domain in STE2; 59% of GpA compared to 81%. 
Like STE2, Mam2 TM3 and TM4 did not strongly self-associate and TM6 and TM7 self-
associated moderately stronger than the oligomerization deficient GpA G83I mutant.  
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Figure 5-11: Expression, insertion, orientation and oligomerization of the Mam2 TM domains 1-
7 TOXCAT Chimeras 
All assays were performed in the E. coli NT326 strain (malE-) A: Showing the sequence of the seven 
different transmembrane inserts corresponding to Mam2 transmembrane domain 1-7. These were 
inserted into the pccKan vector in order to express MBP-TM-ToxR chimera. B: Expression check of 
the constructs used in this study. The arrow indicates the full MBP-TM-ToxR chimera. The star 
indicates MBP proteolytically separated from the TM-ToxR chimera. C: MalE complementation assay 
of the constructs used in this study (left). The construct incorporating TM5 did not grow on maltose 
and therefore the spheroplast assay was performed on this construct (right) D: CAT activity of the TM 
chimeras determined by the TOXCAT assay to measure the degree of homo-oligomerization. The 
asterisks denote ranges of mean CAT activity normalized to GpA where *=26-50%, **=51%-75%, 
***=76%-100%, ****=101%-125% and *****=>126%. Results shown are means of triplicate 
determinations of three independent isolates ±S.E.M.   
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5.3.2 Further Characterization of the Homo-Oligomerization of 
Transmembrane Domain 1 from Mam2  
5.3.2.1 Length-Optimization of Transmembrane Domain 1  
Length optimization of the Mam2 TM1 domain was performed to investigate whether CAT 
activity could be further increased. It was also of interest to centre the two different putative 
smallxxxsmall motifs discussed in Chapter 4; G49xxxS53 and S53xxxA57 to explore 
whether centralizing either motif within the TM domain of the chimera would result in higher 
reporter activity.   
Figure 5-12A shows the five different frames and lengths of the predicted Mam2 TM1 
inserted into the TOXCAT chimera. All constructs were expressed at levels comparable to 
GpA (Figure 5-12B) and the western blot displays both bands characteristic of expression of 
TOXCAT constructs; the full-length chimera and the proteolytically cleaved chimera. All 
constructs grew on maltose in the malE complementation assay, indicating correct 
orientation and insertion of chimera (Figure 5-12C). The 18 amino acid-long construct was 
investigated in the initial screen and therefore the expression and insertion of this construct 
is not shown in this section however its CAT activity is shown in Figure 5-12D for 
comparison. 
The 13 amino acid-long  constructs   “13”  and   “13A”  centre   the  S53xxxA57  and  G49xxxS53  
motifs respectively (Figure 5-12A). As discussed in Chapter 4, when mutating the S53 and 
A57 residues to glycine in the full-length   protein,   the   β-galactosidase reporter activity is 
reduced ~2-fold. In contrast, when G49 is mutated to alanine, reporter activity is 
indistinguishable from wild-type Mam2. If this decrease in signalling is due to a reduction in 
oligomeric state, then it seems likely that the construct centering the SxxxA motif would 
oligomerize more strongly in the TOXCAT assay than the construct centring GxxxS. Indeed, 
construct   “13”,   centring the S53xxxA57 motif, displayed a significantly stronger degree of 
self-association   compared   to   construct   “13A”   that   centred   the   G49xxxS53   motif. (Figure 
5-12D). The reporter activity for the construct centring the SxxxA motif was 42% of GpA and 
that of the construct centring the GxxxS motif was 10%. This may indicate that 
oligomerization of Mam2 is achieved via packing of the S53xxxA57 motif in TM1.  
The highest degree of self-association was observed for the 16 amino acid-long construct, 
with 75% CAT activity compared to GpA. This construct also centred the SxxxA motif in the 
TM domain, but was slightly longer than the 13 amino acid-long construct. The longer length 
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of this construct might allow the domain to traverse the membrane in a more relaxed 
configuration, which may lead to the stronger interaction observed.  
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Figure 5-12: Length optimization of transmembrane domain 1 from Mam2 
All assays were performed in the E. coli NT326 strain (malE-) A: The sequence of the different lengths 
and frames of TM domain 1 from Mam2 inserted into the pccKan vector to test if the TOXCAT signal 
could be improved. Note that the two 13 amino acid long constructs each centre a different putative 
smallxxxsmall motif; SxxxA and GxxxS B: Expression check of the constructs used in this study. The 
arrow indicates the full MBP-TM-ToxR chimera, the star indicates MBP proteolytically separated from 
the TM-ToxR chimera. C: MalE complementation assay of the constructs used in this study, all 
constructs grew on maltose indicating correct insertion and orientation of chimera.  D: CAT activity of 
the TM chimeras determined by the TOXCAT assay to measure the degree of homo-oligomerization. 
The asterisks denote ranges of mean CAT activity normalized to GpA where *=26-50%, **=51%-75%, 
***=76%-100%, ****=101%-125% and *****=>126%. Results shown are means of triplicate 
determinations of three independent isolates ±S.E.M.   
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5.3.2.2 Molecular Modelling of Mam2 Transmembrane Domain 1 
Dimerization suggests that Interactions are mediated by the 
S53xxxA57 motif 
CHI modelling of the 16 amino acid-long Mam2 TM1 construct revealed two symmetrical 
right-handed structures that were present in three and five independent repeats respectively, 
shown in Figure 5-13A. The first symmetrical structure was found at a relative rotational 
angle of 90° and involved hydrogen bonding between the side-chain amide of Q55 to a 
backbone carbonyl on the opposite helix (either Q55 or L52) as shown in the middle panel of 
Figure 5-13A. Interestingly, the second symmetrical structure, which was found in all five 
independent runs and at a relative rotational angle of 290°, involved interactions between 
the S53xxxA57 motifs. In this model dimer formation occurred via close packing of the motif 
and hydrophobic interactions rather than hydrogen bonding. This model is shown on the 
right in Figure 5-13A. The helices in this model were separated by a shorter interhelical 
distance than observed in the Q55 model on the left, with the centre of the helices separated 
by ~7.8 Å compared to ~8.6 Å in the Q55 model. One symmetrical left-handed dimer was 
predicted, shown in Figure 5-13B. This dimer was only found in three repeats and the 
clusters only contained 10 structures each. This dimer associated through packing via a 
L52xxxL56 motif resulting in a relatively large inter-helical distance of ~9 Å.  
The most abundantly found model for a Mam2 TM1 dimer interacted via an SxxxA motif. As 
discussed in Chapter 4, mutations of these two residues in the full-length protein resulted in 
strong signalling-defective phenotypes in vivo. These single mutants expressed comparable 
amounts of receptor at the cell membrane, suggesting that the functionality of the receptor 
was affected, rather than its localization. Models were therefore built to investigate whether 
mutations of this motif to the structurally larger residue leucine would remove interactions 
between this face of the helices. Only right-handed models were considered since the motif 
was not involved in dimerization of the left-handed dimers. As shown in Figure 5-14B, 
leucine mutations to this motif completely abolish dimer formation at the S53xxxA57 
interface (indicated by the arrow).  
Dimerization via Q55 was also implicated in the right-handed structures. Q55 is located on 
the opposite face of the helix compared to the S53xxxA57motif. This residue was also 
mutated to leucine to see what effects this would have on dimer formation in the models. 
Interestingly, in the right-handed models, a Q55L mutation resulted in the loss of 
dimerization via S53xxxA57, shown in Figure 5-14C.  
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The structural models of these mutants therefore predict that if Q55 is involved in the 
oligomerization of Mam2 TM1, then a Q55L mutation would disrupt this interaction. Mutating 
the S53xxxA57 motif to leucine in contrast will most likely not have an effect on 
oligomerization because Q55 can still hydrogen bond to the opposite helix.  
If instead the S53xxxA57motif is responsible for the interactions between TM1 helices, then 
mutating this motif to leucine will disrupt oligomerization. A Q55L mutation is however also 
likely to disrupt oligomerization via the S53xxxA57motif, because interactions via the 
S53xxxA57motif disappeared when mutating Q55L in the models. 
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Figure 5-13: Structural models of Mam2 TM domain 1 dimers 
The phi plots on the left show the distribution of clusters from global searches as a function of their 
orientation, represented by the angle phi. Four MD repeats using random starting velocities were 
performed in each run and five separate searches were performed. When >10 separate structures 
with  Cα  RMSD  values  within  <1  Å  were   found   their  structure  was  averaged   to generate  a  “cluster”.  
Different colors of clusters indicate solutions found in separate repeats and symmetrical structures 
found in several repeats are encircled in black. Structural models of such clusters are shown on the 
right. A: Right-handed solutions B: Left-handed solutions. 
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Figure 5-14: Mutations affecting wild-type Mam2 TM domain 1 dimer formation 
A: The SxxxA motif is implied in the dimerization of wild-type TM1 when modeling helix interactions 
using CHI, dimers associating via this motif are marked with a blue arrow in the phi plot. B: When 
mutating the SxxxA motif to leucine, interactions via this face of the helix is diminished, as marked by 
the blue star. Compare to A. C: When mutating Q55 to leucine, interactions via SxxxA are also 
diminished.   
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5.3.2.3 Mutations Affecting the Oligomerization of Mam2 
Transmembrane Domain 1  
The structural models presented in the previous section predicted that symmetrical dimers of 
Mam2 TM domain 1 are formed either by hydrogen bonding of the side-chain amide in Q55 
the main chain L52 or Q55 on the opposite helix or by close packing of the S53xxxA57 motif. 
Mutations to the S53 and A57 residues furthermore had a strong effect on pheromone 
signalling. It was therefore of interest to mutate these residues in the TOXCAT chimera to 
see if either of these mutations would reduce the strength of oligomerization. The 16 amino 
acid long construct was used because this chimera displayed the highest CAT activity in the 
TOXCAT length optimization assay.  
The sequence of the 16 amino acid long Mam2 TM1 construct is shown in Figure 5-15A. The 
two mutants tested (S53L, A57L and Q55L) are shown underneath with the respective 
mutations highlighted. Figure 5-15B shows the expression check of these two mutants; the 
constructs containing each mutant TM domain were expressed at levels comparable to GpA. 
The MalE complementation assay shown in Figure 5-15C indicate that both constructs are 
inserted and orientated correctly across the plasma membrane, meaning that any reduction 
in CAT activity is due to a reduction in oligomerization of the TM domain.  
Interestingly, both mutations reduced oligomerization of Mam2 TM 1, shown in Figure 5-15D. 
Wild-type TM1 reporter activity is shown for comparison. Reporter activity was slightly higher 
for the S53L,A57L double mutant compared to the Q55L mutant, with mean activity of 21% 
compared to 9% of GpA. The structural models predicted that the S53L,A57L double mutant 
would not affect oligomerization via Q55 but the Q55L mutation could reduce oligomerization 
via the S53xxxA57 motif. Since oligomerization was reduced in both mutants in the TOXCAT 
assay, it is therefore plausible that Mam2 TM1 dimerizes via the S53xxxA57 motif, if a 
symmetrical interaction between helices is assumed.  
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Figure 5-15: Mutations affecting Mam2 TM domain 1 dimerization  
All assays were performed in the E. coli NT326 strain (malE-) A: Showing the sequence of Mam2 TM1 
with the predicted smallxxxsmall motif highlighted in black. The sequence of the two TM1 mutants 
assayed; S53L,A57L and Q55L, are shown underneath with their respective mutations highlighted in 
red. B: Expression check of the constructs used in this study. The arrow indicates the full MBP-TM-
ToxR chimera. The star indicates MBP proteolytically separated from the TM-ToxR chimera. C: MalE 
complementation assay of the constructs used in this study, all constructs grew on maltose indicating 
correct insertion and orientation of chimera.  D: CAT activity of the TM chimeras determined by the 
TOXCAT assay to measure the degree of homo-oligomerization. The asterisks denote ranges of 
mean CAT activity normalized to GpA where *=26-50%, **=51%-75%, ***=76%-100%, ****=101%-
125% and *****=>126%. Results shown are means of triplicate determinations of three independent 
isolates ±S.E.M.   
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5.3.3 Further Characterization of the Homo-Oligomerization of 
Transmembrane Domain 2 from Mam2  
5.3.3.1 Mam2 Transmembrane Domain 2 Contains Polar Residues at 
Similar Positions to STE2 Transmembrane Domain 2 
The N84A and H94A mutations each reduced oligomerization of the STE2 TM2 domain. A 
sequence alignment of TM2 in Mam2 and STE2 predicts that N84 and H94 in STE2 align to 
N83 and R93 in Mam2, as shown in Table 5-1. It is interesting that H94 aligns to an arginine 
residue in Mam2 because, as previously discussed, H94 may be involved in keeping the 
receptor in its inactive state in the absence of ligand through interactions with Y98 and R58. 
Upon  ligand  binding,  R58  could  instead  interact  with  the  α-factor peptide (Tantry, Ding et al. 
2010) and the loss of these contacts may relax TM1-TM2 interactions and lead to structural 
changes in the protein required for activation. In Mam2, Q58 in TM1 aligns to R58 (see 
Figure 4-6), and in TM2 N97 align to Y98. The similarity of these residues to the aligned 
residues in STE2 indicates the possibility that TM1-TM2 interactions and P-factor binding in 
Mam2 are mediated by interactions between R93 and N97 and Q58 respectively. Although 
the distribution of polar residues in the two TM domains appears very similar, there are 
differences; Mam2 does not contain a polar residue aligning to S95 in STE2 but does 
contain a polar residue at position 91, which is non-existent in STE2. 
 
 
Table 5-1: Sequence alignment of STE2 and Mam2 TM2  
Sequence alignment between TM2 of the Sc. cerevisiae receptor STE2 and TM2 of the Sz. pombe 
pheromone receptor Mam2. The two residues that reduced oligomerization of STE2 TM2 when 
mutated to alanine are highlighted in black. The corresponding residues in Mam2 are also highlighted.  
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5.3.3.2 Effects of Mutations in Mam2 Transmembrane Domain 2  
Since an N84A and a H94A mutation in STE2 TM2 each reduced oligomerization of this 
domain in the TOXCAT assay, and because of the sequence similarity between Mam2 and 
STE2, it was of interest to mutate the corresponding residues N83 and R93 in Mam2 TM2 to 
see if the same effects would be observed for this domain. Residue N83 is furthermore of 
interest because mutations at this position have been linked to constitutive activity of the 
receptor (Goddard, Ladds et al. 2005).  
Figure 5-16A shows the sequence of Mam2 TM2 with each mutation tested highlighted in 
bold. All chimeras were expressed at levels similar to expression of the GpA control (Figure 
5-16B) and the full-length 66 kDa chimera was the predominant species present (only low 
levels of the 43 kDa proteolytically cleaved chimera were observed). The malE 
complementation assay indicated that all chimeras were correctly inserted and oriented 
across the E. coli inner membrane (Figure 5-16C).  
The results from the TOXCAT assay (Figure 5-16D) of the N83A and R93A mutants were 
surprising. When mutating the residues that align to N83 and R93 in STE2, oligomerization 
was reduced, and the same was expected for Mam2. In Mam2 however, each mutation 
slightly increased reporter activity relative to GpA, indicating that interactions are stronger 
than for wild-type TM domain 2. In the N83A mutant, mean reporter activity was 131% of 
GpA and for the H93A mutant CAT activity was 133% of GpA, compared to the 112% CAT 
activity observed for wild type TM2. 
Since the N83A and R93A mutations did not reduce CAT activity, C91; a residue which is 
positioned on the opposite face of the helix (shown in the helical wheel projection in Figure 
5-16E), was mutated to alanine to investigate whether this would have an effect on CAT 
activity. In this mutant, CAT activity was reduced to 68% of GpA, indicating that the 
oligomerization interface may involve this face of the helix.  
A second possibility is that the TM domain aggregate, and that aggregation mediated by the 
N83 and R93 residues does not result in ToxR dimerization, whereas dimerization through 
another face of the helices does. Consequently when changing the N83 and R93 residues to 
alanine, the TOXCAT signal is increased, although overall oligomerization may not be 
increased.   
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Figure 5-16: TOXCAT assay and controls for Mam2 TM domain 2 mutants  
All assays were performed in the E. coli NT326 strain (malE-) A: Showing the sequence of Mam2 TM 
domain 2 and three mutations tested for their effect on dimerization; N83A, C91A and R93A, that 
were investigated in the TOXCAT assay. Residues mutated are highlighted in black in the wild-type 
sequence and respective mutations are shown in red in each mutant. B: Expression check of the 
constructs used in this study. The arrow indicates the full MBP-TM-ToxR chimera. The star indicates 
MBP proteolytically separated from the TM-ToxR chimera. C: MalE complementation assay of the 
constructs used in this study, all constructs grew on maltose indicating correct insertion and 
orientation of chimera. D: CAT activity of the TM chimeras determined by the TOXCAT assay to 
measure the degree of homo-oligomerization. The asterisks denote ranges of mean CAT activity 
normalized to GpA where *=26-50%, **=51%-75%, ***=76%-100%, ****=101%-125% and 
*****=>126%. Results shown are means of triplicate determinations of three independent isolates 
±S.E.M. E: Helical wheel projection of Mam2 TM2 with polar residues highlighted.  
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5.3.3.3 Molecular Modelling of Mam2 Transmembrane Domain 2 
Dimerization 
CHI modelling of the Mam2 TM 2 domain revealed a cluster of right-handed symmetrical 
dimers in Figure 5-17A found at 100°. This structure contained H-bonds between the side-
chain hydroxyl groups of opposite S84 residues as well as a hydrogen bond between the 
side-chain hydroxyl group of S83 on one helix and the side-chain hydroxyl group of N84 on 
the other helix, as shown in the structural model, and was found in four of five independent 
CHI searches. One symmetrical left-handed interaction was found V88, L92, I95 and V99, 
shown in Figure 5-17B.  
The residues that aligned to STE2 N98 and H94 in Mam2, N83 and R93, were then changed 
to alanine in Mam2. When changing N83 to alanine, the cluster at phi = 100° disappeared 
and instead a structure at 335° appeared. This was found in two of the five CHI searches as 
shown in Figure 5-18B. The modelling of the wild-type TM2 domain suggests that N83 is 
involved in dimer formation. If this is the case then another contact must compensate when 
N83 is mutated to alanine, because the N83A mutant interacted strongly in the TOXCAT 
assay. The structure found in the search of the N83A mutant contained hydrogen bonds 
between the side chain amine of R93 to the side-chain carbonyl of N97 and between the 
side-chain hydroxyl group of S86 to the side-chain amine of R93 on each respective helix, 
which could act as the compensating contacts as shown in the structural model in Figure 
5-18.  
When mutating R93 to alanine, again only one symmetrical right-handed dimer was found in 
the CHI searches, shown in the phi plot in Figure 5-19A. This dimer contained a hydrogen 
bond between the side-chain hydroxyl groups of adjacent S95 residues as shown in the 
structural model in the right panel of Figure 5-19A. Two symmetrical left-handed dimers were 
found. One appeared similar in structure to the left-handed dimer found for the N83A mutant 
and interacted via a L92xxL95 motif (Figure 5-19B, middle panel). The second dimer 
interacted via interactions between the side-chain carbonyl of N84 and the hydroxyl group on 
the S85 side-chain (Figure 5-19B, right panel).   
In the predicted wild-type dimer, C91 does not appear to be involved in any direct polar or 
non-polar interactions. It is therefore surprising that the C91 mutant was the only mutant 
shown to reduce oligomerization. Structural modelling of the C91A mutant revealed four 
symmetrical right-handed clusters. These all interacted via N83 and S84, however due to the 
variability in their relative rotation the nature of these interactions varied. No symmetrical left-
handed dimer was generated during the CHI searches of the C91A mutant.  
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Figure 5-17: Structural models of Mam2 TM domain 2  
The phi plots on the left show the distribution of clusters from global searches as a function of their 
orientation, represented by the angle phi. Four MD repeats using random starting velocities were 
performed in each run and five separate searches were performed. When >10 separate structures 
with  Cα  RMSD  values  within  <1  Å  were   found   their  structure  was  averaged   to  generate  a  “cluster”.  
Different colors of clusters indicate solutions found in separate repeats and symmetrical structures 
found in several repeats are encircled in black. Structural models of such clusters are shown on the 
right. A: Right-handed solutions B: Left-handed solutions. 
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Figure 5-18: Structural dimeric models of Mam2 TM domain 2 incorporating a N83A mutation 
The phi plots on the left show the distribution of clusters from global searches as a function of their 
orientation, represented by the angle phi. Four MD repeats using random starting velocities were 
performed in each run and five separate searches were performed. When >10 separate structures 
with  Cα  RMSD  values  within  <1  Å  were   found   their  structure  was  averaged   to  generate  a  “cluster”.  
Different colors of clusters indicate solutions found in separate repeats and symmetrical structures 
found in several repeats are encircled in black. Structural models of such clusters are shown on the 
right. Yellow dashed lines indicate a predicted H-bond A: The clusters of right-handed structural 
solutions B: The clusters of left-handed structural solutions. 
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Figure 5-19: Structural dimeric models of Mam2 TM domain 2 incorporating a R93A mutation 
The phi plots on the left show the distribution of clusters from global searches as a function of their 
orientation, represented by the angle phi. Four MD repeats using random starting velocities were 
performed in each run and five separate searches were performed. When >10 separate structures 
with  Cα  RMSD  values  within  <1  Å  were   found   their  structure  was  averaged   to  generate  a  “cluster”.  
Different colors of clusters indicate solutions found in separate repeats and symmetrical structures 
found in several repeats are encircled in black. Structural models of such clusters are shown on the 
right. Yellow dashed lines indicate a predicted H-bond A: The clusters of right-handed structural 
solutions B: The clusters of left-handed structural solutions. 
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Figure 5-20: Structural modeling of Mam2 TM domain 2 incorporating a C91A mutation 
The phi plots on the left show the distribution of clusters from global searches as a function of their 
orientation, represented by the angle phi. Four MD repeats using random starting velocities were 
performed in each run and five separate searches were performed. When >10 separate structures 
with  Cα  RMSD  values  within  <1  Å  were   found   their  structure  was  averaged   to  generate  a  “cluster”.  
Different colors of clusters indicate solutions found in separate repeats and symmetrical structures 
found in several repeats are encircled in black. A: The clusters of right-handed structural solutions B: 
The clusters of left-handed structural solutions. 
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5.4 Summary 
The oligomerization of the individual transmembrane domains from the STE2 and Mam2 
receptors was investigated using the TOXCAT assay and CHI searches. It was found that 
TM1 from STE2 did not oligomerize in the TOXCAT assay, and structural modelling did not 
predict dimerization via the GxxxG motif, which has previously been implied in 
oligomerization of the receptor (Overton, Chinault et al. 2003). This was however in 
agreement with studies suggesting that STE2 TM1 requires the presence of additional 
domains in order to oligomerize (Overton and Blumer 2002). In contrast, TM1 from the 
Mam2 receptor was found to self-associate strongly in the TOXCAT assay and modelling 
predicted that oligomerization was driven by a SxxxA motif present in the domain. 
Experimental data where residues S53 and A57 were mutated to leucine confirmed that this 
motif is involved in the self-association of this domain. This is interesting because, as 
discussed in Chapter 4, even seemingly conservative mutations of these residues affect 
pheromone signalling activity in Sz. pombe, and larger mutations such as the leucine 
mutation further affects the receptor localization.  
TM2 was found to oligomerize strongly in both receptors. In STE2, a N84A and a H94A 
mutation were found to reduce oligomerization. Molecular dynamics simulations suggested 
that interactions might occur via the histidine residue, because when changing both N84 and 
H94 to alanine this interaction was weakened. In contrast, mutating the residues N83 and 
R93 in Mam2, which align to N84 and H94 in STE2 TM2, resulted in increased 
oligomerization of TM domains. Homology modelling of STE2 to rhodopsin suggests that the 
H94 residue faces the TM bundle and oligomerization via this residue implies that separate 
TM domains from polytopic proteins may not be stable individually, particularly not the more 
polar TM domains. This was further suggested by the sheer amount of structures of 
dissimilar conformations found for the Mam2 R93A mutant in the CHI searches. 
TM5 from both receptors was also found to self-associate strongly. Fragments of this domain 
from STE2 have previously been shown to non-specifically aggregate (Overton and Blumer 
2002) and it was therefore not pursued further. In the light of recent models of the CXCR4 
receptor this is however interesting, as high-resolution crystal structures have demonstrated 
homo-dimerization of CXCR4 via TM5 (Wu, Chien et al. 2010). In contrast, TM3 from both 
receptors exhibited the lowest level of oligomerization measured for all TM domains. Low to 
medium CAT activity was measured from TM6, a domain that was additionally shown to be 
involved in CXCR4 dimerization (Wu, Chien et al. 2010). TM4 and TM7 also did not appear 
to self-associate in the TOXCAT assay. This was somewhat unexpected because both these 
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domains have previously been implied in the oligomerization of the STE2 receptor (Kim, Lee 
et al. 2009; Wang and Konopka 2009). It cannot be ruled out however that reporter activity 
would not have improved for TM domains exhibiting low CAT activity if length optimization 
had been performed.    
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6 MOLECULAR MODELS OF THE STE2 AND MAM2 
G PROTEIN-COUPLED RECEPTORS  
6.1 Homology Models of STE2  
Homology modelling is the process by which a protein sequence of interest (the query) is 
aligned to a protein sequence of known structure (the template), and the structure of the 
query is predicted on the basis of the template. Protein structure tends to be more highly 
conserved than protein sequence; however mutations, deletions and insertions in the 
sequence all result in changes in the 3D structure of the protein. Therefore higher sequence 
similarity between query and template produce better models. To date there are no 
experimentally solved structures of the class D fungal mating pheromone receptors, and 
predictions must therefore be made based on alignments to the class A receptors. The low 
sequence similarities between the classes are likely to make models less reliable, however 
the overall functional and structural similarity between receptors of different classes makes 
modelling   efforts   worthwhile   nevertheless.   For   instance,   human   Gα   subunits   have   been  
shown to couple to both STE2 (Crowe, Perry et al. 2000) and Mam2 (Ladds, Davis et al. 
2003) and yeast GPCRs are activated and desensitised similarly to the class A receptors 
(Chen, Lin et al. 2002; Lin, Duell et al. 2004) suggesting some degree of structural similarity 
between the receptors.  
This chapter presents structural homology models of STE2 based on the structure of bovine 
rhodopsin and the human β2-adrenergic receptor. These models were compared to a 
previously published structural model of the STE2 receptor (Eilers, Hornak et al. 2005). To 
evaluate the quality of the models produced the positioning of residues important to the 
functioning  of  rhodopsin  and  the  β2-adrenergic receptors were compared to aligned residues 
in STE2. These models were then used to predict whether the GxxxG motif in the first 
transmembrane domain of STE2 is accessible as an oligomerization interface. This chapter 
also continued the work presented in Chapter 5 of modelling separate transmembrane 
domains as individual stable units. Individual TM domains from rhodopsin and the β2-
adrenergic receptor were modelled to see whether intra-protein TM domain interactions 
could be predicted using CHI. Individual TM domains from STE2 were also modelled to see 
whether the interactions found in the homology models could be reproduced. STE2 was 
modelled rather than Mam2 due to the low sequence similarity of Mam2 to template 
receptors; 20% similarity is regarded as a minimum standard (Clothia and Lesk 1986) and 
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even for STE2 similarity to class A receptors is only ~10%-14% for the TM spanning 
domains. 
6.1.1 Alignment of a Previously Published Model of STE2 to Two 
Class A Receptors  
A homology model of STE2 based on the class A receptors has previously been published, 
its alignment to rhodopsin   and   the   β2-adrenergic receptors shown in Figure 6-1 (Eilers, 
Hornak et al. 2005). In the alignment it is notable that the TM domains in STE2 all are 
predicted to be shorter than the TM domains  in  rhodopsin  and  the  β2-adrenergic receptor. A 
comparison of the number of amino acids in each helix is shown in Table 6-1. To date there 
appear to be no reports suggesting that the thickness of the yeast plasma membrane is 
different to mammalian plasma membranes however considering that on average the STE2 
transmembrane  domains  are  5.71  residues  shorter  than  the  class  A  receptor’s  and  that  each  
residue result in a 0.15 nm rise of the helix, assuming that the tilt angles of the helices are 
similar then the yeast plasma membrane could possibly be ~0.86 nm thinner than 
mammalian plasma membrane. Moreover, the hydrophobic core of a typical cell membrane 
is estimated to 0.2-0.3 nm making it likely that TM helices are ~15-20 amino acids long 
(Beevers and Dixon 2010).  
The tilt angles of the rhodopsin transmembrane domains have been estimated to be 28.4° 
for TM1, 27.2° for TM2, 29.6° for TM3, 3.8° for TM4, 22.7° for TM5, 7.4° for TM6 and 13.4° 
for TM7 (Unger, Hargrave et al. 1997). Of the least tilted domains; TM4, TM6 and TM7, TM4 
and TM7 have the shortest amino sequences of all transmembrane domains. If the length of 
the transmembrane domain relate to its tilt then this would be expected as these domains do 
not need to span the same distance across the membrane as the more tilted domains. TM6 
in contrast is longer which could be to accommodate the outward tilt of the helix during 
activation as opsin is tilted 6-7 Å outwards compared to dark state rhodopsin (Scheerer, 
Park et al. 2008). However, considering at the lengths of the STE2 transmembrane domains 
it is unlikely that the length of the domains relate clearly to their tilt angles, as the same 
trends are not as prominent for STE2. In STE2, although TM4 and TM7 are among the 
shortest domains, TM6 is the shortest. STE2 TM6 contain the characteristic proline present 
in 90% of GPCRs believed to enable movement of the helix upon activation (EIling, Frimurer 
et al. 2005) and when mutated incur constitutive activity of the yeast receptors (Konopka, 
Margarit et al. 1996; Ladds, Davis et al. 2005). Surprisingly in the alignment presented by 
Eilish and co-workers, the proline present in TM6 of STE2 does not align to the proline in 
TM6 of rhodopsin or the β2-adrenergic receptor. 
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Table 6-1: Comparison of TM domain lengths 
Showing a comparison of the number of residues found in TM domains 1-7 from bovine rhodopsin, 
human β2-adrenergic receptor and STE2.   
 
TM domain Rhodopsin Β2-adrenergic STE2 
1 30 30 23 
2 29 29 20 
3 29 29 24 
4 25 25 21 
5 26 26 24 
6 28 28 19 
7 24 24 20 
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Figure 6-1: Sequence alignment of the rhodopsin, β2-adrenergic and STE2 receptors (Eilers, Hornak et al. 2005) 
Alignment based on previously published models of STE2 (Eilers, Hornak et al. 2005).  Row  1  shows  the  sequence  of  rhodopsin,  row  2  the  β2-
adrenergic receptor and row 3 the STE2 receptor. Red arrows denote cuts in the sequence (i.e. the N-termini, extracellular loop 1 and 2 and 
the C-termini). TM1 is shown in light blue, TM2 in orange, TM3 in green, TM4 in purple, TM5 in dark blue, TM6 in red and TM7 in grey. 
Sequences displayed in black represent extra-membrane sequences and the residue number of rhodopsin in shown above the sequences. 
Gaps are represented by dots 
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6.1.2 Sequence Alignments Demonstrate Low Sequence Similarity 
between STE2 and Class A Receptors 
Despite being aligned to similar criteria, the alignment presented in this chapter is 
considerably different to the model proposed by Eilers and co-workers (Eilers, Hornak et al. 
2005) which may reflect the sequence divergence of the query and templates, and the 
resulting challenge in making predictions. Despite the alignments being different, the 
transmembrane boundaries are identical and are both in agreement with previously 
described experimentally defined intracellular boundaries (Choi and Konopka 2006) and very 
similar to predictions calculated with the TMHMM (TransMembrane prediction using Hidden 
Markov Models) algorithm (Krogh, Larsson et al. 2001). A comparison of the predicted TM 
spanning boundaries is shown in Table 6-2.  
The alignment and models presented here were produced in collaboration with Dr. Stefano 
Costanzi from the National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) at 
the National Institutes of Health (NIH). Two models were built; one based on the structure of 
the human β2-adrenergic receptor PDB ID 2RH1 (Cherezov, Rosenbaum et al. 2007) and 
one based on the structure of bovine rhodopsin PDB ID 1GZM (Li, Edwards et al. 2004). The 
alignment is shown in Figure 6-2. Due to low sequence similarity between the template and 
STE2  query;;  10%  for  rhodopsin  and  14%  for  the  β2-adrenergic receptor, the N-termini and 
C-termini and the extracellular loop 1 and 2 were excluded in order to produce more 
meaningful alignments. Furthermore, multiple alignments were built with evolutionary related 
receptors. Transmembrane boundaries were defined by maximising the distribution of 
charged residues to serve as anchors to the polar heads of the lipid bilayer. 
In comparison to the previously published alignment (Eilers, Hornak et al. 2005), TM1 of 
STE2 is shifted four residues towards the N-termini   of   rhodopsin   and   the   β2-adrenergic 
receptor. There are 3.6 residues per turn of a helix, and therefore this shift will result in an 
upward translation of the helix, rather than dramatically changing the side of the helix 
interacting with other helices. TM2 in the previously published alignment of STE2 is shifted 5 
residues, TM3 is shifted 2 residues and TM4 is shifted 1 residue closer to the N-termini of 
rhodopsin  and  the  β2-adrenergic receptor. The biggest difference is seen in TM5 where the 
alignment proposed by Eilers and co-workers push the helix 7 residues along the length of 
TM5  in  rhodopsin  and  the  β2-adrenergic receptor. In TM6 however, the previously published 
alignment positions the start of the helix two residues upstream from the new alignment. In 
TM7 there is a shift of 3 residues towards the C-terminus of the previously published 
alignment compared to the new alignment.   
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Table 6-2: Comparison of STE2 TM boundaries 
A comparison between the TM boundaries of STE2 defined by TMHMM (TransMembrane prediction 
using Hidden Markov Models), criteria set to produce the new alignment, the previously published 
model (Eilers, Hornak et al. 2005) and experimental data defining the intracellular boundaries (Choi 
and Konopka 2006). The TMHMM algorithm was accessed via the TMHMM server 
(http://www.cbs.dtu.dk/services/TMHMM/).  
 
 
 
Helix TMHMM New 
alignment 
Eilers et  al’s 
alignment 
Experimentally defined 
intracellular boundary 
1 51-73 51-73 51-73 73 
2 80-102 83-102 83-102 83 
3 133-155 133-156 133-156 156 
4 162-184 164-184 164-184 164 
5 209-231 209-232 209-232 232 
6 244-266 248-266 248-266 248 
7 276-298 276-295 276-295 295 
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Figure 6-2: Sequence alignment of the rhodopsin, β2-adrenergic and STE2 receptors 
Row  1  shows  the  sequence  of  rhodopsin,  row  2  the  β2-adrenergic receptor and row 3 the STE2 receptor. Red arrows denote where cuts have been made in 
the sequence in order to increase the percent similarity i.e. the N-termini, extracellular loop 1 and 2 and the C-termini. TM1 is shown in light blue, TM2 in 
orange, TM3 in green, TM4 in purple, TM5 in dark blue, TM6 in red and TM7 in grey. Sequences displayed in black represent extra-membrane sequences 
and the residue number of rhodopsin in shown above the sequences. Gaps are represented by dots. The alignment was made in collaboration with Dr. 
Stefano Costanzi from the National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) at the National Institutes of Health (NIH). 
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6.1.3 The Differences in Alignments Result in Different Models 
The homology models of STE2 based on the previously published sequence alignment and 
the   new   alignment   appear   quite   different   from   the   structures   of   rhodopsin   and   the   β2-
adrenergic receptor, which they were modelled on. To demonstrate differences and 
similarities, the homology models were compared to conserved features in the class A 
receptors.  
6.1.3.1 Close Packing of Transmembrane Domains 1 and 7 
Residue G51 in TM1 of rhodopsin is important for close packing to V300 in TM7, and 
substitution of G51 for the structurally larger residue leucine results in misfolding of the 
protein and retinitis pigmentosa - an eye condition ultimately leading to blindness (Sung, 
Davenport et al. 1993; Hwa, Garriga et al. 1997). Close packing between helix 1 and 7 is 
crucial as it facilitates an H-bond between the side-chain amide of N55 to the backbone 
carbonyl of A299 (Figure 6-3A). In the new alignment rhodopsin G51 aligns to STE2 A62; 
both of which  are  small  residues.  The  Cα  distance  between  the  residues  in  the  STE2  model  
compared to rhodopsin are similar, with 5.1 Å in STE2 and 5.2 Å in rhodopsin. In STE2 a 
hydrogen bond forms between the side-chain of R58 and the backbone carbonyl of L283 
(Figure 6-3B) although the bond forms on the side near the extracellular side of the 
membrane rather than the side near the intracellular end of the membrane as in rhodopsin. 
In the previously published alignment (Eilers, Hornak et al. 2005) G51 is aligned to C49, a 
residue which has a considerably larger side-chain than both alanine and glycine. The 
aligned residue in TM7 is also large – L287, and as a result of two residues with bulky side-
chains  the  two  helices  are  spaced  much  further  apart  with  a  Cα  distance  of  6.0  Å  between  
residues, and there are no polar contacts between helices (Figure 6-3C). It also appears as 
though helix 7 is a lot straighter compared to rhodopsin TM7, which is not apparent in the 
new homology model of STE2 based on rhodopsin.  
The β2-adrenergic receptor also contains a small residue packing against a larger residue, 
although for this receptor TM7 contains the small residue (G320) and TM1 contains the 
larger residue (I47) as shown in Figure 6-3D. This brings the two TM domains tightly 
together with a resulting Cα  distance  of  4.3  Å between the two residues and allows an H-
bond to form between the side-chain amide of N51 and the backbone carbonyl of S319 
(Figure 6-3D). Both homology models of STE2  based  on  the  β2-adrenergic receptor have a 
Cα  distance  of 4.6 Å between the residues aligning to I47 and G320 which is slightly more 
distal compared to the template receptor (Figure 6-3E&F for the model proposed in this 
thesis compared to the model proposed by Eilers and co-workers respectively). Neither of 
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the homology models based on the   β2-adrenergic receptor facilitates a polar contact 
between TM1 and TM7  in  contrast  to  what  is  observed  in  the  β2-adrenergic receptor.  
Neither of the homology models exposes residues T278, A285 and L285 in TM7 to the lipid 
bilayer. These residues have previously been implicated in oligomerization of STE2 (Kim, 
Lee et al. 2009) suggesting that they might face the lipid bilayer.  
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Figure 6-3: Homology models of STE2 TM1 and 
TM7 on bovine rhodopsin and the human β2-
adrenergic receptor  
Homology models of STE2 TM1 and TM7 based 
on bovine rhodopsin and the human β2-adrenergic 
receptor. TM1 and TM7 are shown in yellow and 
blue respectively. Spheres mark the residues 
important for close packing of TM1 and TM7 in the 
two class A receptors. The corresponding 
residues in STE2 are shown as spheres. The 
distance  between  the  Cα  atoms  in  these  residues  
is shown by the red dotted line. The yellow dotted 
line shows the hydrogen bonds between helices 
and interacting residues are represented as stick 
models. All models were built using the full 
alignments but TM2, TM3, TM4, TM5 and TM6 are 
not shown for clarity. A: Structure of bovine 
rhodopsin (Li, Edwards et al. 2004). B: Homology 
model of STE2 to bovine rhodopsin based on the 
new alignment. C: Homology model of STE2 to 
rhodopsin based on the previously published 
alignment (Eilers, Hornak et al. 2005). D: 
Structure of the human β2-adrenergic receptor 
(Cherezov, Rosenbaum et al. 2007). E: Homology 
model   of   STE2   to   the   β2-adrenergic receptor 
based on the new alignment. F: Homology model 
of   STE2   to   the   β2-adrenergic receptor based on 
the alignment made by Eilers and co-workers. 
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6.1.3.2 Interactions between Transmembrane Domains 2, 3 and 4 
In the new alignment, TM2 does not span the portion of rhodopsin TM2 containing the highly 
conserved residue N78 whose side-chain hydrogen bonds to the indole nitrogen of W161, 
conserved in 97% of class A receptors, shown in Figure 6-4A (Li, Edwards et al. 2004). In 
rhodopsin, W161 spans the gap between TM4 and TM2 and is responsible for effectively 
locking TM3 in place. In the new alignment this residue is replaced by L173, however in 
STE2 the side-chain appears to point into the lipid bilayer rather than   providing   a   ‘lock’  
effect, as shown in Figure 6-4B. In the alignment proposed by Eilers and co-workers (2005) 
W161 aligns to G174, a much smaller residue. The model based on this alignment also 
contains an extensive hydrogen bonding network between TM2, TM3 and TM4 (Figure 6-4C) 
like in rhodopsin, although they appear dissimilar.   
TM2, TM3 and TM4  in  the  β2-adrenergic receptor also contain a network of polar contacts 
(shown in Figure 6-4D) (Rasmussen, Choi et al. 2007). This appears to have a similar effect 
to the network found in bovine rhodopsin in that TM3 is locked into position by a tryptophan 
in TM4; residue W158 for the β2-adrenergic receptor, which H-bond to the side-chain 
hydroxyl group on S74 in TM2. Neither model of STE2 based on the β2-adrenergic receptor 
contains this interaction between TM2 and TM4 as shown in Figure 6-4E and F for the model 
presented here and Eilers and co-worker’s (2005) model respectively.  
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Figure 6-4: Homology models of STE2 
TM2, TM3 and TM4 on rhodopsin and 
β2-adrenergic receptor 
Homology models of STE2 TM2, TM3 and 
TM4 based on bovine rhodopsin and 
human β2-adrenergic receptor. TM2 is 
shown in purple, TM3 in cyan and TM4 in 
green. Hydrogen bonds between helices 
are shown by the yellow dotted line and 
interacting residues are represented as 
stick models. All models were built using 
the full alignments but TM1, TM5, TM6 and 
TM7 are not shown for clarity. A: Structure 
of bovine rhodopsin (Li, Edwards et al. 
2004). B: Homology model of STE2 to 
bovine rhodopsin based on the new 
alignment. C: Homology model of STE2 to 
bovine rhodopsin based on the previously 
published alignment (Eilers, Hornak et al. 
2005). D: Structure of human β2-
adrenergic receptor (Cherezov, 
Rosenbaum et al. 2007). E: Homology 
model   of   STE2   to   the   β2-adrenergic 
receptor based on the new alignment.  
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6.1.3.3 Presence of the Ionic Lock in the Homology Models 
Class A GPCRs in the inactive state are believed to contain an ‘Ionic lock’ formed between a 
highly conserved E/DRY motif located on the intracellular side of TM3 and acidic residues in 
TM6. The presence of an ionic lock has been demonstrated in inactive bovine rhodopsin (Li, 
Edwards et al. 2004) and human dopamine D3 receptor (Chien, Liu et al. 2010). In the 
crystal structure of the β2-adrenergic receptor the ionic lock was absent, however it was 
argued that the presence of T4 lysozyme may have disrupted the interaction (Rasmussen, 
Choi et al. 2007; Rosenbaum, Rasmussen et al. 2009) and its presence is important to 
stabilize the inactive conformation as its disruption results in constitutive activity of the 
receptor (Ballesteros, Jensen et al. 2001). In the crystal structure of activated rhodopsin the 
ionic lock is disrupted (Scheerer, Park et al. 2008) and these residues are also observed to 
move apart in the crystal structure of activated adenosine A2A receptor (Xu, Wu et al. 2011).  
In rhodopsin the ionic lock is formed via a hydrogen bond between the side-chain guanidium 
group of R135 in TM3 and the side-chain carboxylate group of E247 in TM6 (shown in 
Figure 6-5A) (Li, Edwards et al. 2004). The fungal GPCRs in contrast do not contain an 
E/DRY motif in TM3. In the alignment of STE2 to bovine rhodopsin and human β2-
adrenergic receptor the E/DRY motif align to residues V152IF in the alignment presented in 
this thesis (see Figure 6-2) and I150KV in the previously published alignment (Eilers, Hornak 
et al. 2005) (see Figure 6-1). In TM6, E247 in rhodopsin align to L238 in the alignment 
presented in this thesis and Q240 in the previously published alignment (Eilers, Hornak et al. 
2005).  
In the homology model of STE2 based on the previously published alignment (Eilers, Hornak 
et al. 2005) to rhodopsin and the β2-adrenergic receptor there was no hydrogen bond 
formed between TM3 and TM6. In contrast, both homology models presented in this thesis 
based on the alignment to rhodopsin and the β2-adrenergic receptor contained a hydrogen 
bond between Q149 in TM3 and H245 in TM6 (shown in Figure 6-5B and Figure 6-5C 
respectively). The models of STE2 presented in this thesis therefore contain a putative ionic 
lock in contrast to the previously published homology model of STE2.   
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Figure 6-5: Presence of a putative ionic lock in the homology models of STE2 
Intracellular view of the ionic lock present in A: Rhodopsin PDB ID: 1GZM (Li, Edwards et al. 2004). 
B: STE2 based on the structure of bovine rhodopsin (PDB ID: 1GZM (Li, Edwards et al. 2004)) and 
the alignment presented in this thesis. C: STE2 based on the structure of human β2-adrenergic 
receptor (PDB ID: 2RH1 (Cherezov, Rosenbaum et al. 2007)) and the alignment presented in this 
thesis. The ionic lock is circled in red and interacting residues are shown as stick models.   
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6.1.3.4 Presence of Proline Residues in the Receptors 
Proline is unique among the amino acids because its amino nitrogen is cyclised with the 
terminal carbon of the propyl side-chain. Proline therefore cannot occupy many main-chain 
conformations easily occupied by other amino acids and consequently proline distorts 
secondary  structures  by  introducing  a  kink  in  α-helices  or  melting  β-sheets (Nilsson and von 
Heijne 1998). Proline residues are consequently most commonly   found   at   the   start   of   α-
helices   and   β-sheets, or within loops, turns or unordered structures of proteins (Reiersen 
and Rees 2001) with the notable exception of transmembrane helices where proline 
residues are often found in the middle of the helix (Barlow and Thornton 1988). Figure 6-6A 
shows hydrogen bonding within the main-chain  of  a  canonical  α-helix containing no proline 
residues. As illustrated by the yellow dotted lines, the backbone N-H group of residue i 
hydrogen bonds the backbone C=O group of the residue found four residues preceding i.  
Proline residues introduce kinks in helices because its cyclic side-chain prevents hydrogen 
bonding of the backbone amine i to the i-4 backbone carbonyl causing a steric clash and 
bending of the helix as a consequence. This bend further prevents hydrogen bonding of the 
i+1 backbone amine to the i-3 carbonyl. Remarkably, proline residues are present at 60% of 
transmembrane  helix  deformation  sites  and  it’s  been  proposed  that  in  cases  where  proline  is  
not present, the proline could have been lost with time as the kink got stabilized by other 
molecular forces (Yohannan, Faham et al. 2003). Mutations of transmembrane proline 
residues have been shown to have an effect on both ligand binding and activation of GPCRs 
(Ladds, Davis et al. 2005; Reis, Santos et al. 2007; Mazna, Grycova et al. 2008) 
demonstrating their importance. With the exception of TM6 and TM7, proline is absent from 
the TM domains in STE2 (see Figure 6-2). This is in contrast to bovine rhodopsin and human 
β2-adrenergic receptor that contain prolines in all TM domains except TM3. The proline 
containing TM domains TM6 and TM7 are highly conserved between Mam2 and STE2 as 
illustrated in the alignment shown in Table 6-3. The proline present in TM6 (Table 6-3A) is 
conserved in both the class A receptors and the fungal receptors and plays a pivotal role in 
GPCR activation (Ladds, Davis et al. 2005; Schwartz, Frimurer et al. 2006). Prolines are 
believed to reduce the stability and rigidity of TM helices due to the loss of the NH...O=C 
bond   thereby   allowing   a   “global   toggle   switch”   upon   activation through motion flexibility 
(EIling, Frimurer et al. 2005; Schwartz, Frimurer et al. 2006).  
As illustrated in the left panel of Figure 6-6B and C, the conserved proline residue (shown in 
green) in TM6 introduce a kink in the TM domain of both bovine rhodopsin and human β2-
adrenergic receptor. Consequently there is an absence of two hydrogen bonds between the 
N-H group of P267 and the C=O group of I263 (red dots) and the N-H group of Y268 and 
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C=O group of C264 (black dots) in rhodopsin (Figure 6-6B left panel). H-bonds present 
within the main-chain are illustrated by yellow dots. Similarly  for  the  β2-adrenergic receptor 
(Figure 6-6C left panel) there is an absence of a hydrogen bond between the N-H group of 
P288 and the C=O group of L284 (red dots) and the N-H group of F289 and the C=O group 
of C285 (black dots).  
The models presented in this thesis align the STE2 TM6 proline with the homologous 
residues in rhodopsin and the  β2-adrenergic receptor and as a result the main-chain of the 
homology models of STE2 look very similar to the class A receptors (shown in Figure 6-6B 
and   C,   middle   panel,   for   the   model   based   on   rhodopsin   and   the   β2-adrenergic receptor 
respectively). Hydrogen bonds present within the main-chain are illustrated by yellow dots. 
The models contain no hydrogen bond between the N-H group of P258 and the C=O group 
of S254 (red dots) and the N-H group of S259 and the C=O group of L255 (black dots) in 
STE2, denoting a loss of the i-4 to i and i+1 to i-3 hydrogen bonds.    
Interestingly in contrast, the previously published model of STE2 (Eilers, Hornak et al. 2005) 
did not align to the proline residue in TM6 of STE2 to the proline residue in TM6 of the class 
A GPCRs (see Figure 6-1). Consequently the main-chain of the STE2 homology model is 
structurally considerable different to the main-chain of the class A GPCRs and contain an 
additional helix deformation site. The model of STE2 based on rhodopsin is shown in the 
right panel of Figure 6-6B. This model lacks the proline to proline-4 hydrogen bond (cyan 
dots in the right panel of Figure 6-6B) as expected (the H-bond between the N-H group of 
P258 to the C=O group of S254). It does not however lack the proline+1 to proline-3 
hydrogen bond (and as it is present this bond is represented by yellow dots). The break in 
the helix imposed by structural alignment to rhodopsin are represented by red and black dots 
and occur between the N-H groups of I260 and I261 to the C=O groups of L256 and V258 
respectively. In this model there is also a loss of an additional H-bond between the N-H 
group of L264 and the C=O group of S259 (represented by purple dots in the right panel of 
Figure 6-6B). The  model  of  STE2  to  the  β2-adrenergic receptor based on the alignment by 
Eilers and co-workers (2005) does contain a H-bond between the N-H group of L264 and the 
C=O group of S259 (therefore shown as yellow dots) but besides this bond there is an 
absence of the same H-bonds as the model based on the crystal structure of rhodopsin 
(Figure 6-6C, right panel).  
The alignment presented in this thesis therefore appear to produce models that more closely 
resemble the class A GPCRs on which they are modelled compared to the previously 
published model (Eilers, Hornak et al. 2005). This may suggest that the alignment presented 
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in this thesis is based on more relevant criteria and consequently may have produced more 
accurate models.  
 
A 
                    TM6 
                    Rhodopsin M V I A F L I C W L P Y A G V A F 
   β2-adrenergic 
receptor I M G T F T L C W L P F F I V N I 
   STE2 L I M S C Q S L L V P S I I F I L 
   Mam2 L V I S C Q C L I V P A T F T I I 
                                             
B 
                    TM7 
                    Rhodopsin I F M T I P A F F A K T S A V Y N P V I 
β2-adrenergic 
receptor E V Y I L L N W I G Y V N S G F N P L I 
STE2 V L T T V A T L L A V L S L P L S S M W 
Mam2 G F S S M T Q C L L I I S L P L S S L W 
                     Table 6-3: Alignment of core residues in TM6 and TM7 of rhodopsin, β2-adrenergic receptor, 
STE2 and Mam2 
Showing the alignment of core TM residues in TM6 and TM7 of the budding yeast STE2 GPCR and 
fission yeast Mam2 GPCR and aligned residues in bovine rhodopsin and human   β2-adrenergic 
receptor. Proline residues in the two TM domains are highlighted in red. A: Aligned residues in TM6 
spanning M257-F273 in rhodopsin, I278-I294 in  the  β2-adrenergic receptor, L248-L264 in STE2 and 
L251-I267 in Mam2. B: Aligned residues in TM7 spanning I286-I305 in rhodopsin, E306-I325 in the 
β2-adrenergic receptor, V276-W295 in STE2 and G276-W295 in Mam2. 
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Figure 6-6: Effect of a conserved proline residue on hydrogen-bonding in the main-chain of 
TM6 of GPCRs 
Illustrating the disruptive effects of a proline residue on intra-main-chain hydrogen-bonding in TM6 of 
GPCRs. All GPCR models (B-C) were produced by modeling the full-length protein but only TM6 is 
shown for clarity. Yellow dots represent existing hydrogen-bonds within the models. Bonds 
represented by other colors denote the absence of a bond that would be present in a canonical  α-
helix. A: Side-view of the main-chain   of   a   canonical   α-helix. Note that the N-H group of residue i 
hydrogen bonds to the C=O group of the i-4 residue. B: Crystal structure of rhodopsin PDB ID: 1GZM 
(Li, Edwards et al. 2004) (left panel), model of STE2 based on 1GZM and the alignment presented in 
this thesis (middle panel), model of STE2 based on 1GZM and the previously published alignment 
(Eilers, Hornak et al. 2005) (right panel). C: Crystal  structure  of   the  β2-adrenergic receptor PDB ID: 
2RH1 (Cherezov, Rosenbaum et al. 2007) (left panel), model of STE2 based on 1GZM and the 
alignment presented in this thesis (middle panel), model of STE2 based on 1GZM and the previously 
published alignment (Eilers, Hornak et al. 2005) (right panel). 
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6.1.4 The New Models of STE2 Renders the GxxxG Motif 
Accessible for Interactions unlike the Previously Published 
Model  
Several studies have suggested that the GxxxG motif in the first TM domain of STE2 is 
pivotal to oligomerization of the receptor (Overton and Blumer 2002; Overton, Chinault et al. 
2003; Gehret, Bajaj et al. 2006). Work presented in Chapter 4 of this thesis showed that 
mutations to the GxxxG motif cause mis-localization of the receptor, and decreased cellular 
signalling in response to pheromone, although the work presented in Chapter 5 implied that 
TM1 is not sufficient alone to induce oligomerization.  
If the GxxxG motif is involved in directly mediating receptor-receptor interactions then the 
motif would be expected to be available at the lipid interface, as opposed to being buried in 
the TM bundle. In both models of STE2 presented in this thesis the GxxxG motif is located at 
the lipid interface (shown in Figure 6-7A for the model based on the structure of bovine 
rhodopsin and Figure 6-7C for the model based on the structure of the human β2-adrenergic 
receptor). This is in contrast to the previously published model of STE2 (Eilers, Hornak et al. 
2005) where the GxxxG motif is not readily accessible at the protein-lipid interface (shown in 
Figure 6-7B for the model based on the structure of bovine rhodopsin and Figure 6-7D for 
the model based on the structure of the human   β2-adrenergic receptor). This further 
suggests that the models presented in this thesis represent more meaningful structures than 
the previously published models.  
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Figure 6-7: The GxxxG motif is accessible for interactions in the new models 
Showing the homology models of STE2. TM1 is shown in yellow, TM2 in purple and the GxxxG motif 
in TM is shown in red. A: Modeled on rhodopsin based on the new alignment B: Modeled on 
rhodopsin based on the alignment by Eilers and coworkers (Eilers, Hornak et al. 2005). C: Modeled 
on  the  β2-adrenergic receptor based on the new alignment D: Modeled on  the  β2-adrenergic receptor 
based on the alignment by Eilers and coworkers (Eilers, Hornak et al. 2005). 
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6.2 Molecular Modelling of Interactions in Individual 
Transmembrane Domains 
The software suite CHI has previously been used to successfully predict oligomerization of 
several TM-spanning proteins (Adams, Arkin et al. 1995; Brunger, Adams et al. 1998; Jenei, 
Borthwick et al. 2009; Pang, Savva et al. 2009; King, Oates et al. 2011) but not interactions 
within TM domains of large polytopic proteins such as GPCRs. As discussed in the 
introduction, the two-stage model of membrane protein folding postulates that individual TM 
domains in polytopic proteins can be regarded as individual stable domains (Popot and 
Engelman 1990; Engelman, Chen et al. 2003). To further explore this possibility, 
oligomerization of TM1 and TM2 from bovine rhodopsin was modelled using CHI and 
compared to the crystal structure of the receptor (Li, Edwards et al. 2004). TM1 and TM2 
were chosen because they do not appear to undergo extensive rotation upon activation 
(Scheerer, Park et al. 2008) and do not contain inter-helical hydrogen-bonds, a property 
which was considered desirable due to the modelling of non-polar TM1-TM1 interactions in 
Chapter 5 of this thesis. Since data from different searches cannot easily be assembled and 
because CHI exports data in a format compatible with the UNIX platform, a script was written 
to extract data from multiple CHI searches and to make the data windows compatible. This 
script was similar to the one written for Chapter 5 but handles data from hetero-oligomers.  
Figure 6-8A shows TM1 (yellow) and TM2 (purple) from the crystal structure of bovine 
rhodopsin (Li, Edwards et al. 2004). Residues I48 in TM1 and V87 in TM2 are located at the 
interface of the two TM domains and are shown as van der Waals spheres. These two 
residues were highlighted in the CHI models to identify models containing a similar geometry 
to the crystal structure. Figure 6-8B shows the right-handed solutions to CHI modelling of 
oligomerization of bovine rhodopsin TM1 and TM2. None of the structures appearing in more 
than one CHI search display similar packing to the crystal structure. Figure 6-8C shows the 
left-handed solutions. Like when modelling homo-oligomerization of GPCR TM domains (see 
Chapter 5), fewer left-handed solutions were found compared to right-handed solutions. 
Again, structures appearing in more than one run did not resemble the crystal structure. 
These results suggest that TM domains in complex polytopic proteins cannot be modelled as 
individual domains and therefore this was not explored further.  
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Figure 6-8: CHI models of interactions between TM1 and TM2 in bovine rhodopsin 
Using CHI modeling to predict the interactions between bovine rhodopsin TM1 and TM2. Four MD 
repeats using random starting velocities were performed in five separate searches. When >10 
separate   structures  with  Cα  RMSD   values  within   <1  Å  were   found   their   structure  was  averaged   to  
generate  a  “cluster”, indicated by different colours in the phi plots. Structural models of clusters found 
in >1 search are indicated by the arrows projecting from the phi plots. A: Showing the relative 
orientation of TM1 (yellow) and TM2 (purple) of bovine rhodopsin as determined by X-ray 
crystallography (Li, Edwards et al. 2004). Residues I48 and V87 are located at the helix-helix interface 
and are highlighted as van der Waals spheres. B: Right-handed solutions from the CHI modeling. C: 
Left-handed solutions from the CHI modeling.  
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6.3 Summary 
This chapter compared and contrasted new homology models of the fungal STE2 GPCR to a 
previously published model of the receptor (Eilers, Hornak et al. 2005). These models were 
based on alignments to solved structures of the class A GPCRs bovine rhodopsin (Li, 
Edwards et al. 2004) and the human β2-adrenergic receptor (Rasmussen, Choi et al. 2007). 
Alignments of these receptors are challenging to produce due to the low sequence similarity 
between the fungal GPCRs and class A GPCRs and therefore structural features were 
compared and contrasted between the homology models and the template receptors.  
The homology models presented in this thesis appear to represent more relevant and 
accurate structural models than the model proposed by Eilers and co-workers (2005) for 
several reasons. Firstly, the GxxxG motif implied as an oligomerization motif of the receptor 
is located at the protein-lipid interface in the models presented in this thesis. Secondly, the 
conserved proline in TM6 is located at the helix deformation site and thirdly, TM3 and TM6 
interact via a hydrogen bond which may represent an ionic lock important for stabilizing the 
inactive state of class A receptors. In contrast, in the previously published model of STE2 the 
GxxxG motif is buried into the TM bundle, the conserved proline in TM6 forms a second helix 
deformation site and there is no hydrogen bond between TM3 and TM6.  
This chapter also sought to validate the methods used in Chapter 5 where oligomerization of 
the receptor was modelled based on interactions between single TM domains. This was 
done by modelling the interactions between TM1 and TM2 in bovine rhodopsin to see if the 
crystal structure of this portion of the GPCR could be reproduced. This was unsuccessful 
however through using CHI modelling. This raises questions as to how useful CHI modelling 
is to predict TM-TM interactions and also how physiologically relevant it is to study 
interactions in polytopic proteins via single TM domains.   
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7 THE DEVELOPMENT OF A LUMINESCENT 
REPORTER SYSTEM FOR THE 
SCHIZOSACCHAROMYCES POMBE 
PHEROMONE-RESPONSE PATHWAY 
7.1 Background 
7.1.1 Reporter Systems 
It is often desirable to study changes in genetic activity in signalling pathways. Traditionally 
used techniques to study gene expression, such as northern blots, are however often time-
consuming and therefore costly. Instead, gene reporter systems are today commonly used 
to quantify the transcription of genes under the control of a promoter of interest. The reporter 
should be easily quantified and ideally have sufficiently low mRNA stability and protein half-
life to accurately reflect changes in transcriptional activity. The use of bacterial reporters to 
probe eukaryotic gene regulation was commenced in the 1980’s using the genes cat 
(Gorman, Moffat et al. 1982) and lacZ (Sambrook, Fritsch et al. 1989). The bacterial protein 
CAT catalyzes the transfer of acetyl groups from acetyl CoA to chloramphenicol, which 
detoxifies the antibiotic. The acetylation reaction of CAT was traditionally measured using 
radiolabels although nowadays there are fluorescent alternatives available. The lacZ gene 
encodes  β-galactosidase which has traditionally been a popular reporter because it can be 
monitored both quantitatively and qualitatively (Serebriiskii and Golemis 2000).   β-
galactosidase hydrolyzes a range of substrates including the synthetic substrate o-
nitrophenol β-D-galactopyranosidase to form a yellow product. This product can readily be 
quantified using a spectrophotometer; however assays tends to be time-consuming, low-
throughput, performed in lysed cells and it is also possible to measure endogenous cellular 
activity.  
The development of luminescent reporters marked a key advance in using reporter assays 
to monitor changes in transcriptional events. Luminescent reporters are proteins that 
catalyze a reaction to produce light, which can be quantified. The development of assays 
involving the expression of the bioluminescent protein luciferase in heterologous systems, 
derived from organisms such as click beetle luciferase and firefly luciferase, resulted in 
highly sensitive assays. Click beetle luciferase however require the use of cofactors which 
are typically not available in vivo in sufficiently high amounts, and firefly luciferase require an 
 Page 194 
 
exogenously added substrate for luminescence which is not membrane permeable, meaning 
that cells must be lysed (Naylor 1999). The development of the GFP reporter removed the 
requirement for an exogenously added substrate and quantification could be done in vivo 
rather than on cell lysate (Kain, Adams et al. 1995). Both fluorescence and bioluminescence 
produce photons upon transition from excited state molecular orbitals to lower energy 
orbitals. Fluorescence and bioluminescence differ however in how the excited states are 
achieved; fluorescent molecules are excited by light whereas bioluminescent molecules 
catalyze chemical reactions producing photons.  Bioluminescence has the advantage over 
fluorescence in that no influx of light is required, thereby reducing background noise. The 
GFP reporter however allows automated assays using intact cells, resulting in high-
throughput data. The development of the Renilla reniformis luciferase Rluc as a reporter 
removed the requirement of using cell lysate in luciferase assays because its substrate 
coelenterazine can cross cell membranes. Assays can therefore be performed in vivo similar 
to the GFP reporter but without the high background noise. The half-life of coelenterazine is 
short, ~17 minutes, and result in a high degree of auto-luminescence in cells (Promega 
2009). The development of the stable coelenterazine derivative EnduRen (Promega 
Corporation, Southampton, UK) instead allow stable luminescence measurements over long 
periods of time with low auto-luminescence making the reporter suitable for high-throughput 
experiments over time.  
7.1.2 Existing Schizosaccharomyces pombe Reporter Systems 
Several methods currently exist for the quantification of the Sz. pombe pheromone response 
including   the  β-galactosidase and GFP-based reporter assays. As outlined in section 1.4.3 
however, these reporter assays may be insensitive, low-throughput, or rely on lysed cells 
and it is therefore desirable to develop and characterize alternative reporter assays. The 
luminescent reporter Rluc is regarded as a more sensitive reporter than GFP because of low 
background noise in assays. The enzyme also does not require any post-translational 
modifications unlike β-galactosidase or GFP thereby reducing maturation time, and it has a 
short half-life of only 0.5-1 h (Loening, Fenn et al. 2006). The Rluc reporter may therefore 
provide a more sensitive reporter able to detect the pheromone-response earlier than GFP-
based assays, whilst maintaining the advantage of allowing continuous high-throughput 
assays to be performed. The work presented in section 4.5 demonstrated that Rluc, when 
expressed as a receptor fusion under the control of the nmt1 promoter, functioned in Sz. 
pombe but did not couple energetically to GFP. It was therefore of interest to optimize the 
conditions under which the activity of Rluc is assayed. This chapter discusses the 
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development and characterization of a bioluminescence based reporter system for the Sz. 
pombe pheromone-response pathway using the Renilla reniformis luciferase Rluc.   
7.1.3 The GFP and β-Galactosidase Reporters Do Not Appear To 
Accurately Reflect the Transcription of the Pheromone-
response Genes 
Reporter assays measure the total accumulated reporter protein within the cell population to 
determine rate of transcription. The accumulation of reporter is therefore a problem because 
a build-up of transcriptional activity is measured rather than the transcriptional rate at a 
specific point in time. Accumulation is influenced by the stability of the reporter protein and 
its mRNA. Certain   versions   of   β-galactosidase and GFP are not ideal reporters of cell 
signalling for this reason because the half-lives of these reporters can be up to 48 h (Park 
and Oh 2010). The  β-galactosidase and GFP reporters also continue to signal in samples 
after the point of cell death (Miller 1972; Guthrie and Fink 2002) further adding to 
accumulation of reporter. 
The  GFP  reporter  system  and  the  β-galactosidase reporter both appear to accumulate when 
used as quantifiers of the transcriptional pheromone-response in Sz. pombe. Measurements 
of the activity of a GFP reporter over time is shown in Figure 7-1A (Smith 2009). In this 
graph, the pheromone-response appears to increase almost linearly with time with no 
indication of down-regulation of the pheromone-response. This is not an accurate depiction 
of pheromone signalling as the pheromone-response is down-regulated via several 
mechanisms. These include among others; degradation of extracellular pheromone via 
Sxa2, although down-regulation will occur in the presence of pheromone (Imai and 
Yamamoto 1992; Ladds, Rasmussen et al. 1996; Ladds and Davey 2000), regulation of 
signalling via RGS proteins (Pereira and Jones 2001; Smith, Hill et al. 2009), 
dephosphorylation of the MAP kinase (Didmon, Davis et al. 2002) and down-regulation of 
receptor (Hicke and Riezman 1996; Hicke, Sanolari et al. 1998). The stable increase in 
fluorescence may be caused by an accumulation of reporter, due to protein and/or mRNA 
stability, or reflect other problems with the assay. 
The  use  of  the  β-galactosidase reporter provides a better indication of the down-regulation of 
the pheromone-response over time, shown in Figure 7-1B. Briefly, JY544 cells (sxa2>lacZ) 
were cultured in AA media to a density of ~5x106 cells/mL. Cells were incubated with 
concentrations of pheromone ranging from 0 to 10-4 M for 0-16 h and   the  β-galactosidase 
activity was measured at 2 h intervals. An   increase   in   β-galactosidase production is 
observed after 2-4 h and a plateau is reached after 12-14 h in cells incubated with 10-7 M or 
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higher concentrations of pheromone. At lower concentrations of pheromone only a slight 
increase   of   β-galactosidase production is observed. After 14 h, there is a decrease   in   β-
galactosidase production indicative of down-regulation of the pheromone-response. It is 
however unlikely that there is a 2-4 h lag before the pheromone-response is initiated. The 
observed lag is likely to be due to the sensitivity of the assay i.e. the minimum amounts of  β-
galactosidase that can be detected by the instrumentation and background noise. The rate 
of protein folding and maturation may also have an impact on the lag phase. The rate of 
formation  of  functional  units  of  β-galactosidase is limited by protein quantity and it has been 
observed that a two-fold increase in protein concentration lead to a two-fold increase in 
correctly  folded  β-galactosidase units (Nichtl, Buchner et al. 1998). 
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Figure 7-1: Activity  of  the  GFP  and  β-galactosidase reporters 
A: Fluorescence intensity over time in a sxa2>GFP Sz. pombe reporter strain subjected to varying 
concentrations of pheromone. Adapted from (Smith 2009). B: β-galactosidase activity (OD420/106 
cells) over time in the JY544 (sxa2>lacZ) reporter strain. Cells were cultured in DMM to a density of 
~5x106 cells/mL. Cells were incubated with concentrations of pheromone ranging from 0 to 10-4 M for 
0-16 h on  a  rotating  wheel  and  the  β-galactosidase activity was measured at 2 h intervals. 
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7.2 Development of a Luminescent Schizosaccharomyces pombe 
Reporter Strain 
Two luminescent reporter strains for the Sz. pombe pheromone-response pathway were 
developed to test whether a more sensitive assay could be produced utilizing luminescence. 
One strain incorporated the Renilla reniformis luciferase Rluc (modified to remove an internal 
BamHI site) and the other incorporated Rluc8 which is a mutated version of Rluc containing  
eight mutations in the protein sequence (A55T, C124A, S130A, K136R, A143M, M185V, 
M253L and S287L) (Loening, Fenn et al. 2006). Rluc8 when expressed in mammalian cell 
lines provide brighter luminescence readings compared to Rluc making it easier to detect. 
Rluc8 is however also reported to be a more stable derivative, meaning that the dynamics of 
gene activation and suppression may be more difficult to infer when using the protein as a 
reporter of transcription. Both Rluc and Rluc8 were therefore tested to assess their suitability 
as reporters of the Sz. pombe pheromone-response. 
The JD3649 and JD3647 constructs (created as detailed in section 3.4) were digested with 
SpeI and BamHI and transformed into a yeast strain containing the  5’  and  3’  UTR  of  sxa2 
with the ORF (open reading frame) disrupted by the ura4 cassette (JY522; Mat1-M, 
Δmat2/3::LEU2-, leu1-, ade6-M216, ura4-D18, cyr1-D51, sxa2::ura4+) a strategy described 
previously (Didmon, Davis et al. 2002) and illustrated in Figure 7-2. Potentially successful 
transformants, those which had replaced sxa2::ura4 with sxa2::Rluc or sxa2::Rluc8, were 
plated onto 5-fluoro-orotic-acid (FOA) plates. Orotidine 5'-monophosphate decarboxylase, 
encoded by ura4, converts FOA to a toxic compound (fluoro-uracil), and therefore only cells 
lacking the cassette are expected to grow on FOA plates (Grimm, Kohli et al. 1988). These 
colonies were picked and grown to mid-log phase in AA growth media.  
Having selected for cells no longer containing the ura4 cassette, flanked by the sxa2 5'- and 
3'-UTRs, it remained to select those which had successfully integrated sxa2>Rluc and 
sxa2>Rluc8 in place of ura4. To do this, genomic DNA from resultant colonies were 
prepared and subjected to PCR screening using primers JO2681 and JO2628 for Rluc and 
JO2690 and JO2691 for Rluc8 (sequences specified above). This amplified the reporters to 
demonstrate their genome integration, and strains that had successfully integrated the 
reporters yielded bands ~1 kb in size, as shown in Figure 7-3A for strains that had 
incorporated Rluc and Figure 7-3B for strains that had incorporated Rluc8 (top gel in each 
image). A second PCR screen was performed to demonstrate that the reporters had 
integrated into the correct chromosomal site using the forward primers JO2681 for Rluc and 
JO2691 for Rluc8 together  with  JO1934  (TAGCCAACGCTAAGGAAC).  JO1934  binds  the  3’  
 Page 199 
 
UTR of sxa2 (position 2222-2205 relative to the sxa2 ATG) and this screen therefore yields a 
larger DNA fragment ~1600 bp in size.   
The absence of amplified PCR product indicates that the reporter has not integrated into the 
genome (illustrated by the green arrows in Figure 7-3). If only the PCR using the reporter 
specific primers yields a band, then the reporter has incorporated at the wrong locus in the 
chromosome (illustrated by the blue arrows in Figure 7-3). If both screens yield an amplified 
PCR product then the reporter has incorporated into the chromosome at the correct locus 
(illustrated by the purple arrows in Figure 7-3). For strains transformed with Rluc colonies 3-
11 and 13-16 appeared to have incorporated Rluc successfully and for Rluc8 colonies 5 and 
7-10 appeared to have incorporated the reporter successfully (Figure 7-3A and B 
respectively, bottom gel). The strain created incorporating sxa2::Rluc was named JY1552 
and the strain created incorporating sxa2::Rluc8 was named JY1553.  
 
 
 
Figure 7-2: Creation of the sxa2::Rluc and sxa2::Rluc8 strains 
The SpeI/BamHI fragments from JD3649 (sxa2>Rluc) and JD3647 (sxa2>Rluc8) were used to 
transform JY522 (sxa2::ura4+) and strains were selected by growth in the presence of FOA. Growth 
in the presence of FOA indicates loss of the ura4 cassette as the ura4 product Orotidine 5'-
monophosphate decarboxylase converts FOA into the toxic compound fluoro-uracil.  
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Figure 7-3: Integration of Rluc or Rluc8 into the Sz. pombe genome 
Homologous recombination between   the   5’   and   3’ UTRs contained in JD3649 or JD3647 and in 
JY522 replaced the ura4 cassette with either Rluc (A) or Rluc8 (B). PCR reactions of genomic 
extracts from potential integrants were performed to show that the reporters had integrated into the 
genome (top gels in both A and B) using primers JO2681/JO2628 for Rluc and JO2690/JO2691 for 
Rluc8. A second PCR reaction was performed to show that the reporters were incorporated at the 
correct loci (bottom gels in both A and B) using primers JO2681/JO1934 for Rluc and 
JO2691/JO1934 for Rluc8.   Bands present in both the top and bottom gels represent strains that 
have successfully integrated the reporter gene (3-11 and 13-16 for Rluc and 5 and 7-10 for Rluc8) as 
illustrated by the purple arrows. The green arrows indicate that homologous recombination was not 
successful. The blue arrow indicates that the reporters had integrated into the genome at the wrong 
locus. Agarose gel was documented with G:Box gel documentation system. This created the strains 
JY1552 (sxa2::Rluc) and JY1326 (sxa2::Rluc8). 
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7.3 Signal:Noise Optimization 
7.3.1 Intrinsic Noise Levels to the System 
Initial luminescence measurements on cells expressing the Rluc and the brighter Rluc8 
reporters revealed large amounts of noise generated from the micro-plates (Figure 7-4A). 
Subsequent investigations revealed that due to a manufacturing error the Berthold Mithras 
LB940 BRET multimode microplate reader (Berthold Technologies, UK) lacked an infrared 
filter to block out autoluminescence due to excitation of the plates in the far red, a previously 
unknown issue with these instruments. After the installation of an infrared filter the signal to 
noise ratio improved (Figure 7-4B), note the difference in scales between the two graphs. 
Excitation of the plate could still be detected up to two min after commencing 
measurements. A 2 min delay was therefore incorporated before luminescence readings 
were taken, unless otherwise stated. 
 
 
 
 
Figure 7-4: Time-dependent decay of luminescence  
Measurements were taken on a single well containing AA media using a Berthold Mithras LB940 
BRET multimode microplate reader (Berthold Technologies, UK). A: Time-dependent auto-
luminescence decay before the infrared filter was installed. B: Time-dependent auto-luminescence 
decay after the infrared filter was installed. Note the difference in scales. 
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7.3.2 Noise Levels Vary With the Type of Micro-Well Plate Used  
When measuring reporter activity a high signal to noise ratio is desirable in order to obtain 
accurate readings. Therefore a trial of five different 96 micro-well plates was performed to 
identify the plate with the lowest background noise levels. White plates are believed to 
provide better luminescence readings because they reflect light and thereby amplify the 
signal. Using a plate with a clear bottom however has the advantage of enabling cell density 
measurements via OD600 readings. Black plates are often used in fluorescence assays 
where white plates often lead to cross-talk and high background levels (Promega 2011). 
Figure 7-5 shows the different micro-well plates that were tested. They were A: white plate 
with grey wells B: white plate with white wells C: black plate with white wells D: black plate 
with clear bottomed wells and E: black plate with black wells. All plates were manufactured 
by Berthold (Berthold Technologies, UK).  
Figure 7-6A shows the pheromone-response of 106 JY1552 (sxa2>Rluc) cells incubated with 
0-10-4 M concentrations of pheromone for 16 h on a rotating  wheel  with   60  μM  EnduRen  
added 2 h prior to measurements. A 5 min delay was incorporated before luminescence 
readings in the plate-reader due to the signal decay time-frame (Figure 7-6C). 
Luminescence could not be measured from the black plates, however other experiments 
have shown that a luminescent signal can be measured from these plates when using in the 
excess of 107 cells in the assay. A luminescent signal was detected from the three plates 
containing white wells. The plate shown in Figure 7-5C exhibited the highest noise levels, 
which is likely to be due to high intrinsic noise levels on this plate even after a 5 minute delay 
(Figure 7-6C). The dose-response for the plates shown in Figure 7-5A and C appear very 
similar. When comparing their best-fit values however for the dose-response curve (Figure 
7-6B) it appears as though the plate shown in Figure 7-5C give more consistent readings, 
because the standard error of the mean is much smaller across all values describing the 
curve. These results indicate that the plate shown in Figure 7-5C provide the most 
reproducible results, and that a delay of at least 100 seconds need to be incorporated in the 
assays prior to luminescence readings. 
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Figure 7-5: The different micro-well plates tested 
Five different plates (Berthold Technologies, UK), were compared for their relative luminescence 
intensities. A: white plate with grey wells B: white plate C: black plate with white wells D: black plate 
with clear bottom E: black plate with black backdrop.  
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Figure 7-6: The effects of using different micro-well plates on the luminescent signal 
A: JY1552 (sxa2>Rluc) was cultured to a density of 106 cells per mL and pheromone was added to 
cells at concentrations ranging from 0 to 10-4. Cells were incubated for 14 h on a rotating wheel and 
60  μM  EnduRen  was  added   followed   by   further   two  h incubation. Luminescence from the different 
samples was then measured using the different plates in succession using a Berthold Mithras LB940 
BRET multimode microplate reader (Berthold Technologies, UK). A five minute delay was 
incorporated prior to readings. Results shown are means of at least triplicate repeats ±S.E.M B: The 
best-fit alues of the dose-response curve shown in A. C: Time-dependent decay of auto-
luminescence of the different plates.  
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7.4 Characterization of the Rluc and Rluc8 Reporters 
7.4.1 Cells Expressing Rluc8 Provide Higher Luminescent 
Readings in Response to Pheromone Compared to Cells 
Expressing Rluc  
The dynamics of Rluc and Rluc8 reporter activity were measured and compared to assess 
which reporter provides a better approximation of the Sz. pombe transcriptional pheromone-
response. JY1552 (sxa2>Rluc) and JY1553 (sxa2>Rluc8) were grown to a density of 106 
cells and exposed to 0 to10-4 M pheromone for 16 h on a rotating wheel. Luminescence 
measurements were then taken using a Berthold Mithras LB940 BRET multimode microplate 
reader (Berthold Technologies, UK).   
Figure 7-7A shows the pheromone dose-response of Sz. pombe incorporating the reporter 
genes Rluc or Rluc8 in its genome. A ~2 fold increase in maximal signalling is observed 
when expressing the Rluc8 reporter compared to the Rluc reporter. The pEC50 value is 
slightly lower for Rluc8 than for Rluc, which might reflect the increased brightness of the 
mutated version of Rluc so that it is detected at lower levels (Figure 7-7B). In contrast, the 
morphological response of the two strains was very similar (Figure 7-7C) indicating that the 
differences seen in the measured transcriptional activity is due to differential dynamics of the 
two reporters rather than any other cellular events. Interestingly, the pheromone-response 
decrease in the morphological response at the highest concentration of pheromone in 
accordance  with  what  was  observed  when  using  β-galactosidase as a reporter (see chapter 
3.4) but not the transcriptional response.   
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Figure 7-7: A comparison of the Rluc and Rluc8 Reporters 
JY1552 (sxa2>Rluc) and JY1553 (sxa2>Rluc8) were cultured in AA media to a density of 106 cells. 
Cells were exposed to pheromone and placed on a rotating wheel for 16 h.   60   μM  EnduRen  was  
added 2 h prior to measuring the luminescence signal and cell density. Cells were assayed for 
luminescence intensity using a Berthold Mithras LB940 BRET multimode microplate reader (Berthold 
Technologies, UK). Results shown are means of triplicate results ±S.E.M and normalized to 106 cells. 
A: The luminescence intensity per 106 cells of the two reporters. B: The morphological response of 
cells expressing the two different reporters C: The pEC50 values of the transcriptional and 
morphological response in cells expressing the two different reporters. 
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7.4.2 Only Viable Cells Signal 
Both the transcriptional response and the morphological response measured in strains 
expressing the   β-galactosidase reporter decrease at the higher concentrations of 
pheromone (~10-5 M and 10-4 M) compared to the medium concentrations (~10-7 M and 10-6 
M). It was demonstrated (see chapter 4) that exposing cells to high concentrations of 
pheromone increase the amount of inviable cells in samples compared to treating cells to no 
or medium concentrations of pheromone, in addition to cells arresting in G1 (Davey and 
Nielsen 1994). In contrast, when using Rluc and Rluc8 as a reporter, the transcriptional 
response was not observed to decrease at the higher pheromone concentrations although 
the morphological response did (see section 7.4.1). The toxicity of high concentrations of 
pheromone, coupled to the long half-life  of   the  enzyme  β-galactosidase and assaying cell 
lysate may bias measurements of the pheromone-response when  using  the  β-galactosidase 
assay. The Rluc enzyme catalyzes the oxygenation of the substrate coelenterazine to 
produce luminescence. The EnduRen substrate has protective groups added to the site of 
oxygenation to make the substrate more stable in aqueous environments. This protective 
group must be removed by esterases found in live cells before Rluc can oxygenate the 
substrate and produce light (Promega 2009). Therefore, the addition of EnduRen to dead 
cells should not result in luminescence. Since the transcriptional response does not appear 
to decrease in cells expressing Rluc and Rluc8, it was of interest to investigate whether 
these strains also have increased cell death at increasing concentrations of pheromone and 
to see whether a pheromone-response could be measured from dead cells. 
Flow cytometry was used to quantify the amount of dead cells in strains JY1552 (sxa2>Rluc) 
and JY1553 (sxa2>Rluc8) exposed to low, medium and high concentrations of pheromone 
(Figure 7-8A). Cell viability decreased in response to pheromone when expressing the Rluc 
reporter, demonstrating that this phenomenon is not confined to cells expressing the lacZ 
reporter. To test whether these dead cells contribute to luminescence readings cells were 
exposed to pheromone and incubated on a rotating wheel for 16 h. At 16 h cells were lysed 
and  60  μM  EnduRen  was  added  to  the  samples.  After  a  2 h incubation period luminescence 
was measured. In the unlysed control EnduRen was added at the 14 h time-point rather than 
the 16 h time-point. Figure 7-8B shows that although the live cells signal normally, no signal 
is detected from the lysed cells. This suggests that dead cells are unlikely to contribute to the 
luminescence readings and the absence of a decrease in pheromone-response in cells 
exposed to high concentrations of pheromone may be due to accumulation of reporter. Due 
to the toxic effects of high concentrations of pheromone it was further decided to exclude the 
high concentrations of pheromone from further experiments. 
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Figure 7-8: The number of dead cells increases in response to pheromone but do not signal 
A: Flow cytometry to determine the amount of dead JY1552 (sxa2>Rluc) cells in the sample following 
incubation on a rotating wheel for 16 h with 0, 10-7 M and 10-4 M pheromone. Cells were then washed 
with PBS and stained with cyto-9 and propidium iodine before FACS analysis was performed. Results 
shown are means of triplicate determinations of three independent isolates ±SEM. Results are 
normalized to the number of dead cells in the population of cells not exposed to pheromone. B: The 
transcriptional pheromone-response of live or lysed cells. JY1552 (sxa2>Rluc) was cultured in AA 
media to a density of 106 cells per mL, exposed to pheromone concentrations ranging from 0-10-4 M 
and incubated on a rotating wheel for 16 h. At 16 h cells  were  lysed  and  60  μM  EnduRen  was  added  
to the samples and after a two h incubation period luminescence was measured. In the unlysed 
control EnduRen was added at the 14 h time-point rather than the 16 h time-point and luminescence 
was measured at 16 h. 
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7.4.3 The Use of Different Media Does Not Appear To Influence 
Luminescence Output Significantly 
The stability of Rluc and Rluc8 is affected by the type of media that the reporters are 
expressed in, with Rluc8 being more stable (Loening, Fenn et al. 2006). To see if a 
difference could be measured using different media typically used when studying the Sz. 
pombe pheromone-response, cells were cultured in two different media; DMM minimal 
media and the richer media AA. The strains JY1552 and JY1553 (sxa2>Rluc and 
sxa2>Rluc8) were cultured to a density of 1x106 cells per mL and treated with pheromone 
concentrations ranging from 0 to 10-4 and incubated on a rotating wheel for 16 h in either 
DMM or AA media. 60  μM  EnduRen  was  added  at  14  h.  Luminescence intensity was then 
measured from the samples, results shown in Figure 7-9A, with pEC50 values shown in 
Figure 7-9B. Although there is some variability between measurements the results indicate 
that the stability of Rluc or Rluc8 expressed in either DMM or AA media is very similar.  
 
 
Figure 7-9: Comparison of the effects of different media on the luminescent reporters Rluc and 
Rluc8 
The Rluc8 reporter strain JY1552 and JY1553 (sxa2>Rluc and sxa2>Rluc8) were cultured to a 
density of 106 cells and incubated with varying concentrations of pheromone (0-10-4 M) in either AA 
media or DMM media on a rotating wheel for 16 h.  60  μM  EnduRen  was  added  at  14  h Cells were 
assayed for luminescence intensity using a Berthold Mithras LB940 BRET multimode microplate 
reader (Berthold Technologies, UK) and results shown are normalized to 106 cells and are means of 
triplicate repeats ±S.E.M. A: The pheromone dose-response B: The pEC50 values of the dose-
response of samples. 
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7.4.4 Rluc Appears More Abundant in Cells than Rluc8 in 
Response to Pheromone 
To compare the relative amounts of Rluc and Rluc8 in the cells in response to pheromone, 
SDS-PAGE and western blotting was performed. JY1552 (sxa2>Rluc) and JY1553 
(sxa2>Rluc8) were grown to a high density (~5x107 cells/ mL) and incubated with 
concentrations of pheromone ranging from 0 to 10-6 M. Whole cell extracts were prepared 
and protein concentrations were determined using the Bradford assay (Bradford 1976). 
Equal amounts of sample were then subjected to SDS-PAGE and western blotting. Figure 
7-10 shows the western blots of the expression of Rluc and Rluc8 in these strains. For strain 
JY1552 expression of Rluc appear to correlate with increasing concentrations of pheromone 
and there is a 16-fold increase in Rluc for cells treated with 10-6 M pheromone compared to 
no pheromone. For JY1553 there is a 2-fold increase in quantified Rluc at 10-6 M pheromone 
compared to no pheromone. For this strain however, there is an additional smaller band 
present (marked by the star). This band is not likely to represent non-specific binding 
because it is not present in the strain expressing Rluc, but may represent break-down 
product of Rluc8. This band has previously been identified in the literature (Venisnik, Olafsen 
et al. 2006). It is not known whether this breakdown product is catalytically functional or not.  
It is interesting that despite being present in much lower abundance than Rluc, Rluc8 is 
much more readily detected in terms of luminescence. It is also interesting that the dynamics 
of the reporters in response to pheromone is so similar for the two reporters despite their 
relative abundance (see section 7.4.1). Since the abundance of Rluc appeared to correlate 
more strongly with the administered pheromone dose, this reporter strain was chosen for 
further characterization. 
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Figure 7-10: Rluc and Rluc8 expression levels 
JY1552 (sxa2>Rluc) and JY1553 (sxa2>Rluc8) were grown to a density of ~5x107 cells per mL. Cells 
were then exposed to varying concentrations of pheromone and placed in a shaking incubator for 16 
h. Yeast whole extracts were prepared and the Bradford assay was used to determine protein 
concentration. Equal amounts of sample were loaded onto each gel. Western blots using the Rluc 
antibody were performed on the samples (Medical & Biological Laboratories Ltd, Nagoya Japan) 
shown at the top of the figure. The chemi-luminescence intensities detected on the western blots were 
normalized to the 38 kDa marker run on each gel to allow comparison across gels. The star marks 
what appears to be Rluc8 break-down product.  
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7.5 Discrete Time-Courses 
7.5.1 Rluc   Reporter   Activity   Plateau   Earlier   Than   GFP   or   β-
Galactosidase Reporter Activity 
Due to the potential issues with reporter accumulation it is desirable to use reporters with 
shorter half-life and reduced mRNA stability. Rluc has a half-life of just 0.5-1 h (Loening, 
Fenn et al. 2006) and the time-dependent dynamics of Rluc reporter activity was therefore 
measured to contrast it to the time-dependent   dynamics   of   GFP   reporter   activity   and   β-
galactosidase reporter activity. The integrated sxa2>Rluc reporter construct (JY1552) was 
cultured to a density of 106 cells per mL. Cells were then treated with pheromone and 
incubated on a rotating wheel for 0-14 h. The Rluc substrate EnduRen was added 2 h prior 
to luminescence intensity measurements, which were taken at 2 h intervals using a Berthold 
Mithras LB940 BRET multimode microplate reader (Berthold Technologies, UK). When 
uncorrected for cell number the luminescence output of cells exposed to 10-6 and 10-5 M 
pheromone was near identical (Figure 7-11A). Cells exposed to 10-4 pheromone initially 
display a similar luminescence intensity output, but at 6 h and onwards the intensity 
decreases in comparison to the lower concentrations of pheromone.  
Figure 7-11B shows the increase in cell density as a function of time. Cell cultures display 
logistic growth with an initial lag phase followed by exponential growth. At 14 h following a 
~5 fold increase in cell number the cells appear to enter the stationary phase. This ordinary 
cell growth pattern indicates that the addition of the Rluc substrate EnduRen or expression 
of Rluc is tolerated by cells.  
Plotting the luminescence intensity per 106 cells highlights the importance of normalizing 
data to the density of cells in the sample measured (Figure 7-11C). A more pronounced 
reduction in transcriptional activity is observed at later time-points compared to when plotting 
the raw data. It appears as though the Rluc reporter may be more   sensitive   than   the   β-
galactosidase reporter as a reduction in transcriptional activity is observed after 10-12 h 
rather than 16 h. It is also apparent from this graph that cells exposed to the higher 
concentrations of pheromone 10-4 and 10-5 M initially display a higher transcriptional 
response than the 10-6 M concentration. At 4 h the transcriptional response of cells exposed 
to 10-6 M pheromone surpass cells exposed to 10-4 M pheromone, and at 8 h it is higher than 
cells exposed to 10-5 M pheromone.  
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It is possible that cells treated to higher concentrations of pheromone are desensitized to 
pheromone sooner than cells exposed to lower concentrations of pheromone, however a plot 
of the morphological response suggest that desensitization occurs at the same point in time 
for all concentrations of pheromone tested here (Figure 7-11D). In the morphological 
response the cell volume is initially increased in response to pheromone at ~4 h. Cells then 
continue to grow in size, indicative of arrest in G1 (Davey and Nielsen 1994) until ~10 h when 
they are desensitized to pheromone.  
The morphological response is comparable for cells exposed to all three concentrations of 
pheromone, which is not the case for the transcriptional response. In the transcriptional 
response (Figure 7-11C) the 10-6 M concentration of pheromone initially displays a lower 
response than the two higher concentrations of pheromone, but at 8 h it elicits a higher 
response. The response of cells exposed to the two higher concentrations of pheromone 
plateau earlier than cells exposed to 10-6 M pheromone. This might reflect limitations in the 
assay design: Rluc acts on an exogenously added substrate, and this substrate might 
become limited in the assay. The substrate was added 2 h prior to luminescence readings, 
and it is possible that at high levels of Rluc transcription, there is not enough substrate in the 
media to accurately reflect Rluc activity.  
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Figure 7-11: Time-course 
of Rluc reporter activity 
JY1552 (sxa2>Rluc) was 
cultured in YE media to a 
density of 106 cells. 10-6, 10-
5 or 10-4 M pheromone was 
added to samples and 
placed on a rotating wheel 
for 0-14 h. 60 μM  EnduRen  
was added 2 h prior to 
measurements which were 
taken every two h. Cells 
were assayed for 
luminescence intensity using 
a Berthold Mithras LB940 
BRET multimode microplate 
reader (Berthold 
Technologies, UK). Results 
shown are means of 
triplicate results ±S.E.M. A: 
The luminescence intensity 
uncorrected for cell number. 
B: The change in cell 
number. C: The 
luminescence intensity per 
106 cells. D: The change in 
cell volume.    
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7.5.2 Additions of the Rluc Substrate at the Start of the Assay 
Result in Lower Luminescence Measurements 
As discussed in section 7.2, the reduction in Rluc activity could be due to depletion of the 
Rluc substrate EnduRen, rather than reflecting a reduction in transcription. To test whether 
EnduRen is depleted in the reporter assay a time-course was performed where EnduRen 
was added 2 h prior to the start of the assay rather than 2 h prior to measurements. The 
experiment was performed as in section 7.2 but EnduRen was added at the beginning of the 
experiment instead of prior to measurements. Measurements were also taken at 1 h 
intervals rather than every 2 h to provide better resolution of the data. Figure 7-12A shows 
the measured luminescence intensity over time of cells exposed to 10-5 and 10-4 pheromone. 
A peak in luminescence intensity was observed at ~13 h, which then decreased, similar to 
when pheromone was added 2 h prior to measurements (Figure 7-11A). The peak was 
about ~20% lower however, despite there being more cells present in the samples; ~8x106 
(Figure 7-12B) compared to 4.7x106 in the previous assay (Figure 7-11B).   
When the luminescence intensity per 106 cells was plotted there was a pronounced 
difference when adding the EnduRen substrate at the start of the assay compared to adding 
the substrate 2 h prior to measurements. Figure 7-12C shows a comparison of the data 
where substrate was added 2 h prior to starting the assay (solid lines) compared to adding 
the substrate 2 h prior to measurements (dashed lines). Up to and including the 4 h time-
point the data appears near identical. At 6 h and on however, the measured transcriptional 
activity of cells that had EnduRen added prior to starting the assay decrease steadily, 
whereas it does not decrease until the ~10 h time-point for cells where EnduRen was added 
2 h prior to measurements.   
The morphological response appeared normal in this assay (Figure 7-12D) indicating that 
there were no other variable that could be attributed to the change in transcriptional 
response other than the EnduRen substrate. It is unclear whether the substrate is 
destabilized or depleted. According   to   the  manufacturer’s  manual,   the  substrate  should  be  
stable in solution for ≥24  h (Promega 2009) however, assaying conditions in Sz. pombe may 
differ from the experimental conditions in mammalian cell-lines used by the manufacturer.  
 
 Page 216 
 
Figure 7-12: Time-course of 
Rluc reporter activity with 
substrate addition at the start 
of the assay 
JY1552 (sxa2>Rluc) was 
cultured in YE media to a 
density of 106 cells. 10-5 or 10-4 
M   pheromone   and   60   μM  
EnduRen was added to samples 
and placed on a rotating wheel 
for 0-16 h. Cells were assayed 
for luminescence intensity every 
1 h using a Berthold Mithras 
LB940 BRET multimode 
microplate reader (Berthold 
Technologies, UK). Results 
shown are means of triplicate 
results ±S.E.M. A: The 
luminescence intensity 
uncorrected for cell number. B: 
The change in cell number. C: 
The luminescence intensity per 
106 cells. The results from the 
assay where EnduRen was 
added 2 h prior to 
measurements are shown in the 
dotted line D: The change in cell 
volume.    
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7.5.3 Fewer Cells Cannot Be Used In the Assay 
In the time-courses performed in this section, 106 JY1552 cells (sxa2>Rluc) were used per 
assay. The manufacturer recommends using cell densities below 104 cells to provide stable 
luminescence readings and to avoid overcrowding effects (Promega 2009). Adding the 
substrate EnduRen at the start of the assay resulted in lower luminescence readings than 
when adding it 2 h prior to measurements. This could either be due to a depletion of the 
substrate or degradation of the substrate over the time-course, however the manufacturer 
claims that the substrate is stable ≥24   h in solution (Promega 2009). If the substrate is 
depleted then using fewer cells might solve this issue. The pheromone-response of a serial 
dilution of Sz. pombe cells strain JY1552 (sxa2>Rluc) (1x102, 3x102, 1x103, 3x103, 1x104, 
3x104, 1x105 and 3x106) was therefore measured to see if using fewer cells would improve 
the luminescence readings when EnduRen was added 2 h prior to the start of the assay, 
compared to adding it 2 h prior to measurements. Despite the recommendations made by 
the manufacturer a pheromone-response could not be detected for cell densities <106 cells. 
This could be the result of insufficient levels of expression of Rluc but the manufacturer 
makes no recommendations regarding the amounts of protein needed for detection.  
7.5.4 Increasing the Amount of Substrate Does Not Improve the 
Signal 
If substrate depletion is the factor leading to lower luminescence reading when EnduRen is 
added at the start of the assay, then adding more substrate could resolve the issue, rather 
than using fewer cells. JY1552 cells (sxa2>Rluc) were cultured to a density of 106 cells and 
incubated with varying concentrations of pheromone on a rotating wheel for 16 h. At 0 or 14 
h varying  concentrations  of  EnduRen  was  added  to  the  samples  (6  μM,  60  μM,  240  μM, 480 
μM   or   600   μM).  Figure 7-13A shows the transcriptional pheromone dose-response when 
EnduRen is added 2 h prior to measurements. Addition  of  6  μM  substrate  results  in  a  much  
lower  signal  than  adding  60  μM  EnduRen 2 h prior to measurements. The addition of higher 
concentrations of EnduRen however does not increase the measured response suggesting 
that the amount of EnduRen is not limiting luminescence readings. In contrast, when adding 
the substrate at the start of the assay (Figure 7-13B), the response is decreased for all 
concentrations of EnduRen. Higher concentrations of EnduRen does not result in higher 
luminescence suggesting that EnduRen is not depleted, but is possibly not stable in solution 
for the duration of the time-course.  
 Page 218 
 
 
Figure 7-13: The effects of varying the concentration of EnduRen on luminescent signal 
The Rluc reporter strain JY1552 (sxa2>Rluc) was cultured to a density of 106 cells and incubated with 
varying concentrations of pheromone (0 and 10-8-10-4 M) on a rotating wheel for 16 h. At 0 or 14 h 
varying  concentrations  of  EnduRen  was  added  to  the  samples:  6  μM,  60  μM,  240  μM, 480  μM  or  600  
μM.  Cells  were  assayed  for  luminescence  intensity  using  a  Berthold  Mithras  LB940  BRET  multimode 
microplate reader (Berthold Technologies, UK) and results shown are normalized to 106 cells. A: 
Adding substrate 2 h prior to measurements. B: Adding substrate at the start of the assay. Results 
shown are the means of triplicate repeats ±S.E.M 
0
0
50
100
150
200
250
[60 M]
[480 M]
[600 M]
-8 -7 -6 -5 -4
[6 M]
[EnduRen]
[240 M]
Log [P-factor) (M)
Lu
m
in
es
ce
nc
e 
pe
r 1
06
 c
el
ls
0
0
50
100
150
200
250 [6 M]
[60 M]
[240 M]
[480 M]
-8 -7 -6 -5 -4
[600 M]
[EnduRen]
Log [P-factor) (M)
Lu
m
in
es
ce
nc
e 
pe
r 1
06
 c
el
ls
A
B
 Page 219 
 
7.6 Automated Time-Courses 
The discrete time-course presented in 7.2 seemed to accurately reflect the transcriptional 
pheromone-response. Discrete time-courses are however extremely laborious to perform as 
cells must be assayed manually at regular intervals over long periods of time. Since time-
courses provide dynamic details for modelling the pheromone-response it was of interest to 
develop an automated time-course. In an automated time-course, cells, substrate and 
pheromone are added to the microplate wells before the start of the assay, and readings are 
taken automatically at regular intervals. The Berthold Mithras LB940 BRET multimode 
microplate reader (Berthold Technologies, UK) allows temperature control for optimal growth 
temperature.  
7.6.1 An Automated Time-Course in Suspension Is Not As 
Sensitive As the Discrete Time-Course   
To perform an automated time-course, the strain JY1552 (Sxa2>Rluc) was cultured to a 
density of 106 cells per mL. 107 cells were spun down, re-suspended in 150 μL AA media 
and incubated for 1 h with 60  μM  EnduRen. Samples were then added to tubes containing 
pheromone to final concentrations of 10-7 to 10-6 M. Cells were incubated for 0.5 h to allow 
mixing with pheromone. Samples were added to a micro-well plate and a plastic film lid was 
placed on top of the microplate to prevent evaporation. Luminescence readings were 
automatically recorded hourly for 24 h. The results shown in Figure 7-14 show that cells 
responded to pheromone in a time and dose-dependent manner. Compared to the discrete 
time-course presented in section 7.5.2 however, there was a lag before luminescence was 
detected. In the discrete assay, a response to pheromone could be detected after 1 h, 
whereas this automated time-course only detected an increase after 6 h. This indicates that 
some factor in the experimental set-up influence measurements.  
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Figure 7-14: Time courses in suspension 
106 JY1552 (Sxa2>Rluc) cells suspended in 150 μL AA media were incubated with 60  μM  EnduRen  
for 1 h on a rotating wheel followed by incubation with 10-7 or 10-6 M P-factor for 0.5 h. Luminescence 
readings were then taken each h using a Berthold Mithras LB940 BRET multimode microplate reader 
(Berthold Technologies, UK) with a plastic film lid placed on top of the plate to prevent evaporation. 
Results shown are means of triplicate repeats ± S.E.M  
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7.6.2 Cell Settling Effects 
The experiments performed in sections 7.5.1 and 7.6.1 show that there is a difference in 
luminescence readings when cells are grown in the plate-reader compared to on a rotating 
wheel, despite being grown at the same temperature. In the plate-reader cells were 
observed to respond to pheromone at >6 h whereas in the discrete time-course cells were 
observed to respond >2 h. The main difference between growing cells in the plate-reader 
compared to on a rotating wheel is that in the plate-reader cells are allowed to settle to the 
bottom of the wells rather than remaining in suspension.  It is unclear whether the delayed 
measured response is an effect of growing cells in the plate-reader that cannot be reversed 
by re-suspending the cells, or whether re-suspension would reverse the effects meaning that 
cells are responding but somehow luminescence readings cannot be taken as readily from 
settled cells.  
To determine whether a decrease in luminescence intensity is correlated with cells settling, 
JY1552 cells (sxa2>Rluc) were grown to a density of 106 cells and incubated with 
pheromone   for   16   h.   60   μM   EnduRen   was   added   at   14   h.   Figure 7-15A shows the 
luminescence measurements which were taken at 16 h (cells in suspension, represented by 
the yellow line) and 17 h when cells had settled to the bottom of the well (red line) and 17 h 
when cells had been re-suspended (blue line).  When cells had been allowed to settle, the 
maximum of the dose-response was reduced; from 183 luminescence units per 106 cells to 
162 luminescence units per 106 cells for cells exposed to 10-5 M pheromone. When 
resuspending the cells however the maximum signal measured increase to 230 
luminescence units per 106 cells. Cells also appeared more sensitive to pheromone than 
was apparent when the cells were settled (compare the blue and red lines).  
Cells settling clearly reduce the amount of signal measured; Figure 7-15B shows the 
difference over time for when 10-6 M pheromone is added. The dramatic increase in the 
pheromone-response observed when cells are resuspended is interesting because it clearly 
shows that cells are responding to pheromone when they are settled, but the measured 
luminescence intensity does not reflect this. It is unclear why the luminescence intensity from 
settled cells is lower than for cells in suspension. It may be due to cell crowding effects 
affecting the luminescence emitted from the sample. Another possible explanation is that the 
substrate EnduRen partitions from the media. EnduRen is initially dissolved in DMSO before 
addition to samples, and if the substrate precipitates in stagnant suspension, cells may not 
be able to absorb the substrate.  
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Figure 7-15: The effects of cells settling 
JY1552 (sxa2>Rluc) was incubated on a rotating wheel with concentrations of pheromone ranging 
from 0 to 10-4 and   60   μM   EnduRen.   Luminescence measurements were taken using a Berthold 
Mithras LB940 BRET multimode microplate reader (Berthold Technologies, UK) and results shown 
are means of triplicate repeats ± S.E.M A: At 16 h the luminescence of cells was measured. Cells 
were then allowed to settle and further measurements were taken at 16.5 and 17 h. Cells were then 
resuspended by pipetting and a second measurement was taken at ~17 h. B: The effects of settling 
on cells incubated with 10-6 M pheromone over time.  
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7.6.3 Time-Courses on Agarose Plugs 
As shown in sections 7.6.1 and 7.6.2, automated time-courses performed in suspension 
result in delayed reporter activity possibly due to cells settling in the wells. A different 
protocol was therefore utilized using 24-well plates where each well is used as a petri-dish 
containing agarose media, as opposed to growing cells in suspension. This protocol has 
previously been used for the GFP reporter (Smith 2009). 2.5 mL of AA media containing 1% 
Agarose and pheromone (concentrations of 0, 10-7 and 10-6  M) was added to each well and 
allowed to dry in a flow-cabinet. 100 μL of AA media containing 105, 106, 107, or 108 JY1552 
(sxa2>Rluc) cells and   60   μM   EnduRen was then uniformly   “plated”   onto each well and 
luminescence measurements were taken every 10 minutes.   
Using less than 107 cells did not result in a detectable response as shown in Figure 7-16A 
(105 cells) and Figure 7-16B (106 cells). When assaying 107 cells luminescence was detected 
for cells treated with 10-6 M pheromone as shown in Figure 7-16C, with a maximum 
luminescence intensity of 726 recorded at 24 h. A time-dependent increase in luminescence 
intensity could not be detected for cells treated with 10-7 M pheromone. When 108 cells were 
assayed, luminescence was detected for samples treated with both 10-6 M pheromone and 
10-7 M pheromone as shown in Figure 7-16D, note the difference in scale compared to 
Figure 7-16C. The maximum luminescence intensity measured from cells treated with 10-6 M 
pheromone was 19578 recorded at the end time-point 24 h, and 11076 for cells treated with 
10-6 M.  
Luminescence intensity was not observed to tail off or decrease in any of the assays 
regardless of cell concentration or pheromone concentration. This may reflect, or in part 
reflect, cell growth not accounted for over the course of the assay. The 100 μL media 
containing cells and EnduRen added to the wells was however found to evaporate over the 
duration of the time-course and cells appeared to form colonies on the plugs at the 24 h 
time-point, indicating cell growth. Furthermore, luminescence could only be detected after 
>10 h, which is later than the >6 h observed for cultures in suspension. Cells were added to 
the  wells  suspended  in  100  μl  media; however the pheromone was added to the agar-media. 
These experiments may therefore indicate that cells only sense the pheromone once the 
liquid media has sufficiently dried out for cells to start growing on the agar.   
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Figure 7-16: Time-course 
on agarose plugs  
Agarose-plugs were prepared 
in the wells of a 24-well 
microplate. Plugs contained 
1% agarose and 0-10-4 M 
pheromone dissolved in AA 
media. 105, 106, 107 or 108 
cells suspended in 100 μL AA 
media   containing   60   μM  
EnduRen were uniformly 
distributed on each plug. The 
Luminescence intensity from 
samples was then measured 
every 10 min for 24 h using a 
Berthold Mithras LB940 
BRET multimode microplate 
reader (Berthold 
Technologies, UK). A: 
Luminescence intensity of 105 
cells over time. B: 
Luminescence intensity of 106 
cells over time. C: 
Luminescence intensity of 107 
cells over time. D: 
Luminescence intensity of 108 
cells over time. Note the shift 
in scale. 
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7.6.4 The Amount of Liquid Media Used on Plugs Does Not Seem 
to Influence Measurements 
The results presented in the previous section showed that cells plated onto the micro-well 
agar  plugs  when  suspended  in  100  μL media only responded to pheromone after a period of 
~10 h. This is significantly different from the discrete time-courses where cells appeared to 
respond after ~2 h and the automated time-course in suspension where cells responded 
after ~6 h. This may be caused by cells only starting to respond to the pheromone in the 
agarose-AA media once the liquid AA media has evaporated sufficiently for cells to settle on 
the agarose containing AA plug.  
To test whether plating a smaller amount of liquid would allow cells to respond to pheromone 
sooner, 108 JY1552 cells (sxa2>Rluc) were resuspended in 20, 30, 40, or 50 μL liquid AA 
media   containing   60   μM   EnduRen (instead of 100 μL media used in the previous 
experiment). Cells were uniformly distributed on plugs in a 24-well microplate containing 1% 
agarose, pheromone (0, 10-7 or 10-6 M) and AA media. Measurements of the luminescence 
intensity from the cells were then recorded over a 22 h time-period. Figure 7-17A shows the 
result when plating 20 μL media, B: 30 μL media, C: 40 μL media and D: 50 μL media onto 
pheromone-containing agarose AA plugs. For all liquid volumes, cells responded earlier than 
when plating 100 μL media; 2 h as opposed to >10 h, suggesting that uptake of pheromone 
is indeed dependent upon cell growth on the agar. In  comparison  to  plating  100  μL  media,  
the response seemed to tail off towards the later time-points rather than exhibiting an 
exponential increase. For all volumes higher concentrations of pheromone resulted in higher 
luminescence intensities.  
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Figure 7-17: Varying the amount of 
media used in cell suspensions 
added to plugs 
Agarose-AA plugs were prepared in 
the wells of a 24-well microplate. Plugs 
contained 1% agarose and 0-10-4 M 
pheromone dissolved in AA media. 108 
JY1552 cells (sxa2>Rluc) suspended 
in 20, 30, 40 or 50 μL AA media 
containing   60   μM   EnduRen   were  
uniformly distributed on each plug. The 
Luminescence intensity from samples 
was then measured every 10 minutes 
for 24 h using a Berthold Mithras 
LB940 BRET multimode microplate 
reader (Berthold Technologies, UK) A: 
Luminescence intensity of 108 cells 
over time suspended in 20 μL AA 
media B: Luminescence intensity of 
108 cells over time suspended in 30 μL 
AA media C: Luminescence intensity 
of 108 cells over time suspended in 40 
μL AA media. D: Luminescence 
intensity of 108 cells over time 
suspended in 50 μL AA media. 
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7.7 Summary 
Two new Sz. pombe reporters were successfully constructed incorporating the Rluc or Rluc8 
genes in place of sxa2 in the yeast genome.  A discrete assay measuring the changes in 
luminescence intensity produced from cells successfully depicted the pheromone-response, 
and luminescence was found to increase linearly with increased amounts of cells used in the 
assays. The Rluc reporter appeared more sensitive than the previously characterized GFP 
reporter   and   to   some   extent   the   β-galactosidase reporter because cells were found to 
respond earlier. Higher sensitivity was likely achieved through low background noise levels, 
short half-life of the Rluc enzyme and minimized signalling from dead cells within 
populations. The Rluc8 enzyme produced brighter luminescence readings compared to Rluc, 
although it was unclear if this is due to increased activity of the enzyme or other factors. 
Western blots showed that Rluc is more abundant in cells compared to Rluc8 in response to 
pheromone, possibly because of degradation of Rluc8 as indicated by the Rluc8 break-down 
product. The use of different media did not appear to influence signals however the choice of 
microplate proved important for reproducible measurements. The black plate with white wells 
provided the most repeatable measurements but autoluminescence of the plate meant that a 
delay of 2 minutes was implemented prior to measurements.  
A continuous automated assay proved difficult to develop. This in part appeared to be due to 
destabilization of the Rluc substrate EnduRen with time, which is needed for production of 
photons, because increased concentrations of EnduRen did not result in higher 
luminescence measurements. Another factor making continuous monitoring of the 
pheromone-response challenging was the settling of cells to the bottom of wells and settling 
was shown to decrease the measured response. The pheromone-response also did not 
appear to tail-off, which is observed both in the discrete time-resolved assay and when using 
the lacZ reporter, but instead increased at a constant rate similar to the GFP reporter (Smith 
2009). When continuous measurements were performed on agarose plugs, rather than in 
suspension, the amount of media used for plating was found to influence the onset of the 
pheromone-response, possibly because cells need to settle onto the pheromone-containing 
agar before pheromone can be sensed.    
 Page 228 
 
8 DISCUSSION 
8.1 Overview 
GPCRs couple extracellular ligands to intracellular signalling components, enabling cells to 
sense and respond to their environment. These receptors all adopt a common structural 
topology consisting of seven transmembrane-spanning domains and contrary to the 
traditional view that these domains merely act as anchors to the lipid bilayer, they appear to 
influence many processes such as protein function, localization, activation, structure, ligand 
binding and protein-protein interactions. A better understanding of GPCRs has the potential 
to lead to better therapeutics; however, the study of GPCR signalling in mammalian cells is 
complicated by the existence of multiple, overlapping signalling pathways. The model 
organism fission yeast Sz. pombe in contrast provides a simplified system in which to 
investigate isolated signalling pathways.  
This thesis mainly focused on the first transmembrane domain of the Sz. pombe GPCR 
Mam2 and the Sc. cerevisiae GPCR STE2 and their roles in the pheromone-signalling 
response as well as putative GPCR-GPCR interactions. Both STE2 (Overton, Chinault et al. 
2003) and Mam2 (Ladds, Davis et al. 2005) have previously been shown to form oligomeric 
complexes, although the nature and role of these oligomers are largely unknown. Therefore, 
this thesis focused on elucidating the effects of mutating the GxxxG motif of TM1 in STE2 to 
investigate the effects on subcellular localization, oligomerization, as well as its overall 
effects on pheromone signalling in Sz. pombe. This was done with the view to compare it to 
mutations of small residues found in the Sz. pombe pheromone receptor Mam2 that are 
potentially homologous to the GxxxG motif. A wide range of techniques was employed in 
order to characterize the TM domains. These included confocal microscopy to elucidate 
subcellular localization   of   the   full   length   receptor,   the   β-galactosidase reporter assay to 
quantify pheromone signalling in vivo, resonance energy transfer to study oligomerization of 
full-length receptor, the TOXCAT reporter system as well as in silico modelling to investigate 
the dimerization of individual TM domains. Additionally, this thesis also discusses the 
development of a novel reporter assay to study pheromone signalling in Sz. pombe. 
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8.2 Effects of Mutating Small Residues in the First Transmembrane 
Domain of STE2 and Mam2 
8.2.1 Positioning of the SmallxxxSmall Motif in TM1 
The GxxxG motif in STE2 has been implicated in the oligomerization of the receptor in 
several studies (Overton and Blumer 2002; Overton, Chinault et al. 2003; Gehret, Bajaj et al. 
2006). This thesis presented homology models of STE2, which in comparison to a previously 
published model appeared to be more accurate because key features in GPCRs appeared 
better conserved. The homology models suggested that the GxxxG motif is located at the 
protein:lipid interface, making it accessible to form a contact surface for receptor:receptor 
interactions. The Mam2 receptor contained two putative SmallxxxSmall motifs in TM1; one 
consisting of G49xxxS53 and one consisting of S53xxxA57. Sequence alignments of Mam2 
to STE2 shown in Chapter 4 suggested that the S53xxxA57 motif represented the 
homologous residues to the GxxxG motif in STE2. This was further supported by TOXCAT 
and modelling data presented in Chapter 5, where S53xxxA57 was implicated in the 
oligomerization of TM1, but not G49xxxS53. The effect of mutations in the smallxxxsmall 
motif on the cellular level was explored in Chapter 4 where it was further shown that 
mutations to S53 and A57 had greater effects compared to mutating G49, as is discussed in 
the following sections.  
8.2.2 Effects of Conservative Mutations 
The cellular effects of conservative mutations to the GxxxG motif in STE2 and GxxxSxxxA in 
Mam2 are summarized in Table 8-1. From the summary it appears as though mutations in 
Mam2 had a greater effect than mutations in STE2. This may in part be due to the 
differences observed between wild-type Mam2 and STE2 i.e. wild-type STE2 had reduced 
plasma membrane localization compared to Mam2 and the receptor was found internalized 
to a greater extent.  
For the conservative Mam2 mutants, a reduced transcriptional response was observed but 
not a reduced morphological response. Differences in activation of the morphological 
pathway and transcriptional pathway have previously been observed in Sz. pombe (Ladds, 
Goddard et al. 2007) although the reasons for this phenomenon are yet unknown. It is 
possible that Ras1 and STE6, which are the transcriptional activators, somehow interact with 
the receptor, either directly or via scaffolding mechanisms and these interactions may be 
altered in the mutants. The conservative Mam2 mutants were furthermore all localized to the 
plasma membrane to a greater extent than wild-type Mam2, suggesting that the functionality 
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of the receptor, rather than expression at the plasma membrane, was affected. In the 
TOXCAT assay, Mam2 TM1 was found to oligomerize strongly, an effect not observed for 
STE2. Mutations to the SxxxA residues were found to have a greater effect on cellular 
signalling as well as oligomerization of the TM domain, compared to the GxxxS residues. 
This data was also supported by in silico CHI modelling of receptor dimerization. This may 
suggest that the transcriptional response is amplified by receptor oligomers. In contrast, 
mutations to the STE2 GxxxG motif had less of an effect on the cellular signalling, but this 
domain was not however found to oligomerize strongly in neither the TOXCAT assay nor in 
silico CHI modelling. Other studies on STE2 have suggested that the presence of TM2 is 
necessary to form stable receptor oligomers (Overton and Blumer 2002) which is not 
contradictory to the findings here. The studies on TM2 presented in this thesis however 
seemed to be hampered by the presence of high amounts of polar residues in the TM 
domain. 
 
  
Conservative  
mutation 
Transcriptional 
response 
Morphological 
response 
Plasma 
membrane 
localization 
Ratio of 
internalized 
receptor 
STE2 G56A - - -  - 
  G60A - - -  - 
  G56A,G60A ↓ ↓ ↓ ↑  
Mam2 G49A - - ↑ ↑ 
  S53A ↓ - ↑ ↑ 
  A57G ↓ - ↑ ↑ 
  S53A,A57G ↓ - ↑ ↑ 
      Table 8-1: The effects of conservative mutations on STE2 and Mam2 
The effects of conservative mutations made in TM1 of STE2 and Mam2 on the transcriptional 
pheromone-response, the morphological pheromone-response, plasma membrane localization and 
the ratio of internalized receptor to receptor found on the plasma membrane are summarized. A – 
indicates that no significant difference could be detected compared to wild-type receptor. Cells 
colored in orange indicate that a moderately decreased effect was observed compared to wild-type 
receptor. Green cells indicate that an increased effect was observed compared to wild-type receptor. 
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8.2.3 Effects of Non-Conservative Mutations 
In comparison to the conservative mutations, the leucine mutations all had a much greater 
effect on the cellular responses observed, as illustrated in Table 8-2. In particular, leucine 
mutations to any of the STE2 GxxxG residues greatly reduced the observed responses. 
Because there was a decrease both in the pheromone-response as well as plasma 
membrane localization, it appears likely that the reduction in signaling is due to few 
receptors being available for signal transduction. It therefore appears likely that these mutant 
receptors are either not transported to the plasma membrane as effectively as wild-type 
receptor, or they get internalized at a greater rate. The confocal images suggest that the 
receptors localized to endosomes and/or vacuoles suggesting that they were not trapped in 
the ER. Previous studies on misfolded mutants of STE2 have shown that in Sc. cerevisiae, 
errors in folding in the ER may lead to transport of the receptor from the ER to vacuolar 
structures, without the receptor reaching the plasma membrane (Jenness, Li et al. 1997) 
which could explain this phenomenon.  
Mam2 also displayed a reduction in activity when the small G49, S53 and A57 residues were 
mutated to leucine, although these effects were less severe than for STE2. Most notably, the 
mutants did not display a significant decrease in plasma membrane expression, with the 
exception of the GxxxS double mutant, suggesting that the functionality of the receptor was 
affected rather than the amounts available for signal transduction. In general, mutations to 
the S53 and A57 residues had a greater effect than for the G49 residue. Additionally, SxxxA 
was implied as an oligomerization motif in the in silico modelling, and mutations to this motif 
decreased oligomerization. It therefore appears likely that Mam2 oligomers may form via the 
SxxxA motif.  Unfortunately, the BRET assay was not successfully implemented in the lab in 
time for completion of this thesis. Work is currently underway to clone different fusions of 
acceptors and donors, to find a suitable pair, including Rluc, Rluc8, GFP and YFP.   
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Disfavored  
mutation 
Transcriptional 
response 
Morphological 
response 
Plasma 
membrane 
localization 
Ratio of 
internalized 
receptor 
STE2 G56L ↓ ↓ ↓ ↑ 
  G60L ↓ ↓ ↓ ↑ 
  G56L,G60L ↓ ↓ ↓ ↑ 
Mam2 G49L ↓ ↓ - - 
  S53L ↓ ↓ - ↑ 
  A57L ↓ ↓ - ↑ 
  S53L,A57L ↓ ↓ ↓ ↑ 
      Table 8-2: The effects of disfavored mutations on STE2 and Mam2 
The effects of disfavored mutations made in TM1 of STE2 and Mam2 on the transcriptional 
pheromone-response, the morphological pheromone-response, plasma membrane localization and 
the ratio of internalized receptor to receptor found on the plasma membrane are summarized. A – 
indicates that no significant difference could be detected compared to wild-type receptor. Cells 
colored in orange indicate that a moderately decreased effect was observed compared to wild-type 
receptor. Red cells indicate that a greatly decreased effect was observed compared to wild-type 
receptor. 
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8.3 Prospects of Modelling Interactions between Single 
Transmembrane Domains from Polytopic Transmembrane 
Proteins 
CHI has previously been used to successfully model the dimerization or higher-order 
oligomerization of a range of single-spanning membrane proteins such as GpA (Adams, 
Engelman et al. 1996), phospholamban (Adams, Arkin et al. 1995), holin (Pang, Savva et al. 
2009), granulocyte colony-stimulating factor receptor (Plo, Zhang et al. 2009) or the bovine 
papillomavirus E5 protein (King, Oates et al. 2011). Although CHI has been used to predict 
the structure of the bitopic protein Carnitine Palmitoyltransferase (Jenei, Borthwick et al. 
2009), it has not traditionally been used extensively to model the oligomerization of 
transmembrane domains from polytopic proteins.  
In the studies presented in Chapter 5, it was attempted to exploit modelling to predict 
interactions between wild-type and mutated TM domains and to draw parallels between the 
two and extrapolate the findings to full-length receptor. The results appear mixed. Modelling 
of the relatively hydrophobic TM1 domain of Mam2 produced structures that could be 
interpreted relatively readily and which agreed with experimental data. Similarly the 
modelling of TM1 from STE2 agreed with experimental data and indicated that this TM 
domain is not sufficient to drive oligomerization, similar to findings that TM2 is also needed 
for interactions (Overton and Blumer 2002). In comparison, the relatively long hydrophilic 
TM2 domains from STE2 and Mam2 produced complex and inconclusive results, which were 
difficult to interpret. This was probably in part due to the sheer amount of interactions that 
could be formed by the relatively polar domains through intra- or inter-molecular contacts. 
These results suggested that the stability of isolated TM domains may depend on their 
relative hydrophobicity.  
To investigate how relevant it is to model GPCR oligomerization on the basis of isolated TM 
domains, the interactions between two TM domains from rhodopsin were modelled and 
compared to the crystal structure of the receptor. It was found that the interactions observed 
in the crystal structure could not be reproduced via CHI modelling. This raised questions as 
to whether individual domains from large polytopic proteins can be treated as individual 
stable units, as postulated by the two-stage model of membrane protein folding. Previous 
studies on the 7TM receptor bacteriorhodopsin have also shown that TM6 and TM7 are not 
stable in isolation of other TM domains (Hunt, Earnest et al. 1997). Furthermore, an existing 
NMR structure of STE2 TM1-TM2 (Neumoin, Cohen et al. 2009) did not structurally agree 
with the homology model of STE2, which further highlights disagreement both between 
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computational models and experimental data and also between full-length receptor models 
and models of isolated TM domains.  
8.4 Foundations for a More Sensitive High-Throughput 
Pheromone-response Reporter Assay 
The creation of the luminescent reporter strain JY1552 (sxa2>Rluc) allowed for the 
development of a discrete live-cell assay that is more sensitive than the assay  measuring  β-
galactosidase reporter activity in lysed cells. A continuous, high-throughput assay was also 
developed, which appeared more sensitive than the equivalent high-throughput GFP 
reporter assay.  
8.5 Future Directions 
Despite the many studies on GPCR oligomerization there still remains much to be 
understood regarding how interactions between receptors are formed. The research 
presented in this thesis has demonstrated that although the study of isolated TM domains 
from GPCRs is more amenable, it may not be physiologically relevant. There is 
consequently a need for high resolution structures of receptors in order to gain further 
understanding of GPCR pharmacology. More experimental structural data would also allow 
the development of more accurate computer algorithms in order to produce better models. It 
would be interesting to test the accuracy of the homology models presented in this thesis. 
This could be achieved for instance through mutating the residues involved in forming the 
putative ionic lock in the STE2 receptor, to see whether a CAM phenotype is observed 
similar to in the β2-adrenergic receptor.  
It would be useful to advance the work initiated on developing a BRET assay for Sz. pombe. 
Partly in order to elucidate real-time interactions between wild-type components of the 
pheromone-response pathway, but also to test the importance of individual residues on 
processes such as oligomerization. This could be achieved by testing different donor and 
acceptor combinations. Rluc may for instance couple more successfully to YFP, and Rluc8 
may provide a better donor.  
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